Erectile Dysfunction

The inability in the male to have a PENILE ERECTION due to psychological or organ dysfunction.

Synonym
Erectile Dysfunction

Excerpt	Reference
"Erectile dysfunction is a common complication of spinal cord injury."	( Chen, D; Lovell, L; Palmer, J; Rayner, S; Roth, EJ; Yarkony, GM, 1995)
"Although erectile dysfunction is frequently seen in patients with manifestations of arteriosclerotic disease, the independent contribution of serum cholesterol in predicting erectile dysfunction is unclear."	( Blair, SN; Davis, DR; Hornung, CA; Macera, CA; Nankin, HR; Wei, M, 1994)
"Erectile dysfunction is rarely caused by hypogonadism."	( Huland, H; Noldus, J, 1994)
"Erectile dysfunction is a common medical problem affecting many men."	( Linet, OI; Ogrinc, FG, 1996)
"Erectile dysfunction is frequently caused by vascular, neurological and psychosomatic disorders."	( Fujita, K; Ling, LZ; Terada, H, 1997)
"Erectile dysfunction is a common problem, particularly in diabetics."	( Ernst, E; Pittler, MH, 1998)
"Erectile dysfunction is a common condition affecting men over age 50."	( Baum, N; Mobley, DF, 1998)
"Erectile dysfunction is a common but underreported condition."	( Damen, L; Meuleman, EJ; Rabsztyn, P; Van Berkel, JT, 1998)
"Erectile dysfunction is common in men with diabetes."	( Rajfer, J; Rendell, MS; Smith, MD; Wicker, PA, 1999)
"Erectile dysfunction is a common condition in men with cardiovascular disease, probably as a result of shared factors that impair hemodynamic mechanisms in the penile and ischemic vasculature."	( Conti, CR; Pepine, CJ; Sweeney, M, 1999)
"Erectile dysfunction is a significant medical condition that shares numerous risk factors with ischemic heart disease, and hence a substantial overlap exists between these patient groups."	( Glasser, DB; Morales, A; Osterloh, IH; Zusman, RM, 1999)
"Male erectile dysfunction is defined as "the inability to attain and/or maintain penile erection sufficient for satisfactory sexual performance"."	( Andrianne, R, 1999)
"As erectile dysfunction is frequently associated with a number of systemic illnesses and surgical treatments, a wide range of doctors should be aware of the condition in their patients."	( Saenz de Tejada, I; Wagner, G, 1999)
"Erectile dysfunction is a common problem affecting men."	( Licht, MR, 1999)
"Erectile dysfunction is a common and multi-factorial disease that strongly impairs the quality of life in men."	( Goyal, RK; Umrani, DN, 1999)
"Erectile dysfunction is a common complication of spinal cord injury."	( El Masry, WS; Giuliano, F; Hultling, C; Maytom, M; Orr, M; Osterloh, IH; Smith, MD, 1999)
"Erectile dysfunction is also a common side effect of certain drugs, including many antihypertensive agents."	( Kochar, MS; Mazur, LI; Patel, A, 1999)
"Erectile dysfunction is a common late complication patients may experience after external-beam radiotherapy for prostate cancer."	( Bieri, S; Kurtz, JM; Miralbell, R; Weber, DC, 1999)
"Diagnosis of erectile dysfunction is important because sildenafil may not be the proper therapy for patients with underlying major diseases such as coronary sclerosis, arteriosclerosis of the stroke vessels, depression, etc."	( Weiske, WH, 1999)
"Erectile dysfunction is a common and distressing medical condition that is now highly amenable to treatment almost irrespective of the cause."	( Crowley, T; Gingell, C; Levy, A, 2000)
"Erectile dysfunction is common in dialysis patients."	( Feldman, HI; Kobrin, S; Rosas, SE; Wasserstein, A, 2001)
"Erectile dysfunction is a frequent condition in cardiovascular patients."	( Kingma, JH; Meuleman, EJ, 2001)
"Erectile dysfunction is a common, multi-factorial disorder."	( Boolell, M; Dinsmore, W; Eardley, I; Morgan, R; Yates, P, 2001)
"Erectile dysfunction is one of the factors influencing negatively the quality of life of patients in hemodialytic treatment."	( Costarella, M; Gentile, V; Maggi, S; Ponzio, R; Punzo, G, 2001)
"Erectile dysfunction is a common problem, especially among older men."	( Fiebiger, WC; Hejna, M; Raderer, M; Reiter, WJ, 2001)
"The rate of erectile dysfunction is high in dialysis patients."	( Altintepe, L; Karalezli, G; Tonbul, HZ; Türk, S; Yeksan, M; Yildiz, A; Yildiz, M, 2001)
"Erectile dysfunction is associated with cardiovascular risk factors (e."	( Bell, CR; Jagroop, IA; Khan, MA; Mikhailidis, DP; Miller, MA; Morgan, RJ; Sullivan, ME; Thompson, CS, 2001)
"Improvement of erectile dysfunction is associated with marked improvement in depressive symptoms and quality of life."	( Menza, MA; Roose, SP; Rosen, RC; Seidman, SN; Shabsigh, R, 2001)
"Many patients with erectile dysfunction are also being treated for systemic hypertension and/or cardiovascular disease."	( Buttler, S; Edmonds, A; Fagan, TC; Marbury, T; Taylor, A, 2001)
"Erectile dysfunction is a prevalent and distressing problem."	( Leiblum, SR, 2002)
"Erectile dysfunction is one of the more common male sexual dysfunctions encountered in the clinical setting."	( Seidman, SN, 2002)
"Erectile dysfunction is a common complication in patients with diabetes mellitus, which impairs quality of life, decreases self-esteem and can affect partners relationships."	( Escobar-Jiménez, F, 2002)
"Erectile dysfunction is a problem associated with PD and all typical treatment options are acceptable."	( Latchamsetty, KC; Levine, LA, 2002)
"Erectile dysfunction is a common sequela following potentially curative local treatment for early-stage carcinoma of the prostate gland."	( Butler, WM; Merrick, GS; Wallner, KE, 2003)
"Erectile dysfunction is usually a harbinger for other illnesses, such as coronary heart disease and depression."	( Tan, RS, 2003)
"Erectile dysfunction is a medical condition that influences the sexual life of millions of men and women worldwide."	( Lümmen, G; Rübben, H; Schneider, T; Sperling, H, 2003)
"Erectile dysfunction is a common, age-dependent functional disturbance of men associated to various comorbidities."	( Derouet, H; Osterhage, J; Sittinger, H, 2004)
"Erectile dysfunction is a familiar complication of diabetes mellitus, which results from combined factors of impairment to the vascular structure of the penis, the pathological changes in neural system and neural transmitters, and endocrine disorders."	( Gao, J; Xu, S, 2004)
"Erectile dysfunction is a prevalent problem that can affect, and can be affected by, psychosocial aspects of a man's life."	( Beeman, WW; Bodie, JA; Monga, M, 2003)
"Erectile dysfunction is common and closely associated with age and risk factors for cardiovascular disease."	( Mikhail, N, 2005)
"Erectile dysfunction is a recognized complication of radiation therapy for prostate cancer."	( Guhring, P; Mulhall, JP; Ohebshalom, M; Parker, M, 2005)
"Erectile dysfunction is related to penile arterial endothelial nitric oxide production."	( Jackson, G; Lambert-Hammill, M; Lumb, PJ; Lyttle, K; Solomon, H; Wierzbicki, AS, 2006)
"Erectile dysfunction is a public health problem."	( Mennickent, S; Vega, M; Villegas, G; Zurita, L, 2005)
"Erectile dysfunction is a common ailment in middle-aged and old men."	( Chen, B; Lu, YN, 2005)
"Erectile dysfunction is frequent in those suffering from heart disease."	( Desvaux, P, 2005)
"Diabetes-induced erectile dysfunction is one of the most prevalent complications of diabetes in males."	( Citci, S; Demirci, C; Hurdag, C; Ozkara, H; Uyaner, I, 2005)
"Erectile dysfunction is an early symptom or harbinger of cardiovascular disease, due to the common risk factors and pathophysiology mediated through endothelial dysfunction."	( Jackson, G; Kloner, RA; Kostis, JB; Rosen, RC, 2006)
"Because erectile dysfunction is often a precursor to other conditions, such limitations could compromise detection and management of underlying disease (e."	( Miner, M, 2004)
"Erectile dysfunction is currently considered a condition with high prevalence in the general population, exerting a major impact on patients' and their sexual partners' quality of life."	( Douma, S; Doumas, M, 2006)
"Erectile dysfunction is related to endothelial function."	( Jackson, G; Lambert-Hammill, M; Lumb, PJ; Solomon, H; Wierzbicki, AS, 2006)
"Erectile dysfunction is a serious and common complication of diabetes mellitus."	( Bidasee, KR; Mayhan, WG; Patel, KP; Zheng, H, 2007)
"Erectile dysfunction is a common, multifactorial disorder that is associated with aging and a range of organic and psychogenic conditions, including hypertension, hypercholesterolemia, diabetes mellitus, cardiovascular disease, and depression."	( Burnett, AL, 2006)
"Erectile dysfunction is a common multi-factorial complication of diabetes mellitus."	( Nini, A; Vardi, M, 2007)
"Aging-related erectile dysfunction is characterized by a loss of smooth muscle cells (SMCs) and fibrosis in the corpora cavernosa, and functionally by corporal veno-occlusive dysfunction (CVOD)."	( Davila, HH; Ferrini, MG; Gonzalez-Cadavid, NF; Kovanecz, I; Rajfer, J; Sanchez, S; Vernet, D, 2007)
"Erectile dysfunction is common in male kidney transplant recipients."	( Barry, JM, 2007)
"Erectile dysfunction is an important cause of decreased quality of life in men."	( Ahmed, MH, 2007)
"Erectile dysfunction is a common disease of andrology, for which current guidelines recommend oral agents as the first-line therapy."	( Tan, DQ; Yao, Y; Zhang, J, 2007)
"Erectile dysfunction is a common complication of radiation therapy."	( Mohideen, N; Mulhall, JP; Ohebshalom, M; Teloken, PE, 2007)
"Erectile dysfunction is highly prevalent in diabetic patients and PDE V inhibitors are effective and safe for the treatment of erectile dysfunction in men with diabetes."	( Choi, YH; Chung, SJ; Lee, MG, 2008)
"Erectile dysfunction is increasingly common with advancing age, yet sexual activity and intimacy are important to elderly men."	( Goldfischer, E; Hakim, LS; Natanegara, F; Sharlip, ID; Shumaker, BP; Wong, DG, 2008)
"Erectile dysfunction is a disease affecting millions of men over the age of 40."	( Costabile, RA; Hwang, K; Mammen, T, 2008)
"Erectile dysfunction is considered an early clinical manifestation of vascular disease and an independent risk factor for cardiovascular events associated with endothelial dysfunction and increased levels of pro-inflammatory cytokines."	( Brands, MW; Carneiro, FS; Carneiro, ZN; Giachini, FR; Lima, VV; San Martin, S; Sturgis, LC; Tostes, RC; Webb, RC; Wynne, BM, 2009)
"Erectile Dysfunction is one of the most prevalent sexual disorders in men."	( Esterbauer, B; Jungwirth, A, 2009)
"Erectile dysfunction is a multifactorial condition that affects approximately 40% of Australian men."	( McLeod, N; Rashid, P; Smith, IA, 2010)
"Erectile dysfunction is a major problem with an increasing prevalence in cardiovascular high-risk patients due to its association with cardiovascular risk factors."	( Baumhäkel, M; Böhm, M; Hacket, G; Hackett, G; Jackson, G; Kratz, M; Schlimmer, N, 2011)
"Erectile dysfunction is a common problem after radical prostatectomy, with almost all men experiencing this complication for at least a short period after such surgery."	( Glina, S, 2011)
"Erectile dysfunction is a serious and common complication of diabetes mellitus."	( Mayhan, WG; Patel, KP; Zheng, H, 2011)
"Erectile dysfunction is the most frequently diagnosed sexual dysfunction in the older male population."	( Albersen, M; Lue, TF; Orabi, H, 2012)
"Erectile dysfunction is a prevalent condition afflicting millions of men worldwide and can have disastrous effects on a couple's quality of life."	( Burnett, AL; Segal, R, 2012)
"Erectile dysfunction is common in the patient with cardiovascular disease."	( Jackson, G; Montorsi, P; Stefanadis, C; Vlachopoulos, C, 2013)
"Erectile dysfunction is a serious complication of diabetes mellitus."	( Liu, X; Patel, KP; Zheng, H, 2013)
"Erectile dysfunction is considered as an early sign of subclinical vascular disease and endothelial dysfunction and a highly prevalent condition in diabetic patients."	( Benedito, S; Climent, B; Contreras, C; García-Sacristán, A; Hernández, M; Martínez, P; Prieto, D; Sánchez, A, 2013)
"Erectile dysfunction is prevalent in men over 40 years, affecting their quality of life and that of their partners."	( Collard, JB; Kirby, M; Trivedi, D; Wellsted, DM, 2014)
"Erectile dysfunction is highly prevalent, affecting up to half of men in their 50-70s, and has been variably associated to a variety of causes including unhealthy lifestyles, such as smoking or overweight, or comorbidities such as hypertension, diabetes mellitus, and neurological disorders."	( Gianfrilli, D; Lenzi, A; Romanelli, F; Sansone, A, 2014)
"Erectile dysfunction is usually of vascular origin and is frequently encountered in men with cardiovascular disease."	( Athyros, V; Doumas, M; Katsiki, N; Lazaridis, A, 2015)
"Erectile dysfunction is the most common complication after pelvic radical surgery."	( Aoun, F; Peltier, A; van Velthoven, R, 2015)
"Erectile dysfunction is a common problem among patients with cardiovascular diseases and the influence of cardiovascular drugs is much debated."	( Hallas, J; Madsen, KG; Pottegård, A; Rasmussen, L, 2015)
"Erectile Dysfunction is considered a multifactorial disease, where organic and psychological aspects are often interconnected."	( Boddi, V; Boni, L; Casale, H; Castellini, G; Corona, G; Maggi, M; Rastrelli, G, 2015)
"Erectile dysfunction is highly prevalent in type II diabetes mellitus."	( Alexandre, L; Assaly-Kaddoum, R; Behr-Roussel, D; Bernabé, J; Giuliano, F; Gorny, D; Kergoat, M; Laurin, M; Vardi, Y, 2016)
"Treatment of erectile dysfunction is based on pharmacotherapy for most patients."	( Adaikan, G; Buvat, J; Carrier, S; El-Meliegy, A; Hatzimouratidis, K; Khera, M; McCullough, A; Salonia, A; Torres, LO, 2016)
"Erectile dysfunction is associated with greater risk for cardiovascular events, but the association with subclinical myocardial injury is not known."	( Einvik, G; Hrubos-Strøm, H; Omland, T; Randby, A; Røsjø, H, 2016)
"Nonorganic erectile dysfunction is a problem with unknown central mechanisms."	( Chen, G; Chen, J; Chen, Y; Dai, Y; Yang, B; Yu, W, 2019)
"Erectile dysfunction is a common condition that affects men over age 40."	( Alves-Pereira, JL; Babinski, MA; da Fonte Ramos, C; Frantz, EDC; Pires, LAS, 2019)
"Erectile dysfunction is defined as inability to achieve or maintain penile erection sufficient for sexual satisfaction."	( El-Wakeel, LM; Fouad, FA; Saber-Khalaf, M; Saleem, MD, 2020)
"Erectile dysfunction is a common condition among diabetic men."	( El Taieb, M; Hegazy, E; Ibrahim, A, 2019)
"Erectile dysfunction is common after radical prostatectomy because of damage to the cavernous nerves."	( Fode, M; Murtola, TJ; Riikonen, J; Siltari, A, 2019)
"Erectile dysfunction is a sexual dysfunction which is commonlycomorbid with major depression."	( Karaş, H; Kaşer, M, 2019)
"Background Erectile dysfunction is associated with old age, some morbidities and the use of certain medications."	( Machado-Alba, JE; Valladales-Restrepo, LF, 2021)
"If erectile dysfunction is secondary to other treatable disorders these should be treated simultaneously."	( Ann, SP; Bhimrao, FS; Debasis, B; Sonia, M, 2020)
"Arteriogenic erectile dysfunction is a common disease oftentimes not satisfactory treatable with medical therapy."	( Bechir, M; Diehm, N; Keo, HH; Knöchel, J; Kostal, F; Räber, L; Regli, C; Sammarchi, L; Schönhofen, J; Schumacher, MC, 2021)
"Erectile dysfunction is one of the most common symptoms of ADAM."	( da Silva, EL; Guimarães, ACA; Leitão, AE; Pelegrini, A; Vieira, MCS, 2021)
"Erectile dysfunction is largely unrecognized as an adverse effect of proton pump inhibitors despite increasing evidence that proton pump inhibitors may contribute to impaired nitric oxide generation and endothelial dysfunction."	( Perry, TW, 2021)
"Erectile dysfunction is a disease commonly caused by diabetes mellitus (DMED) and cavernous nerve injury (CNIED)."	( Ferrini, MG; Li, Y; Liao, H; Shen, D; Wang, G; Zhang, X, 2021)
"erectile dysfunction is associated with mortality, whereas the association between low testosterone (T) and higher mortality remains controversial."	( Antonio, L; Casanueva, FF; Dejaeger, M; Forti, G; Huhtaniemi, IT; Maggi, M; Matheï, C; Moors, H; O'Neill, TW; Punab, M; Pye, SR; Rastrelli, G; Slowikowska-Hilczer, J; Tournoy, J; Vanderschueren, D; Wu, FCW, 2022)
"Although erectile dysfunction is frequently seen in hemodialysis patients, little information is documented about the efficacy of phosphodiesterase type 5 (PDE5) inhibitors and almost all the articles evaluate sildenafil."	( Keseroglu, BB; Ozgur, BC, 2022)
"Erectile dysfunction is a common complication within many pathological conditions associated with low testosterone."	( Azeez, TA; Gordon, BS; La Favor, JD; Pierre, CJ; Rossetti, ML, 2022)
"Erectile dysfunction is characterized by a persistent inability to achieve and maintain an erection sufficient to permit satisfactory sexual activity."	( Chen, H; Deng, S; Gao, G; Li, H; Liao, X; Liu, D; Meng, F; Wang, J; Wang, L; Zhao, M, 2022)
"The erectile dysfunction is defined as an inability to achieve or maintain an erection sufficient for sexual intercourse lasting more than 3 months."	( Al-Shukri, AS; Dub, NI; Konyushiy, VS; Maksimova, AV; Petrov, SB, 2023)

Excerpt	Reference
"Erectile dysfunction has an organic etiology in most cases, with vascular disease the single most common cause."	( DeWire, DM, 1996)
"Erectile dysfunction has attracted considerable interest and research."	( Chew, KK, 2001)
"The treatment of erectile dysfunction has changed dramatically over the past two decades."	( Carson, CC, 2000)
"Discussion of erectile dysfunction has increased, information about erectile dysfunction is increasingly available, training in erectile dysfunction was improved and last, but not least, the number of patients seeking help for erectile dysfunction is growing, because satisfactory sexual function is an important part of a couple's healthy relationship and ongoing quality of life."	( Gallé, G; Trummer, H, 2003)
"Therapy of erectile dysfunction has been revolutionised in recent years, as specific pharmacological inhibitors of phosphodiesterase 5 (PDE5), such as sildenafil, tadalafil, or vardenafil, were shown to be highly effective in the treatment of erectile dysfunction."	( Kloner, RA; Reffelmann, T, 2005)
"Erectile dysfunction has also been related to cardiovascular risk factors and might be used as a marker of cardiovascular disease in the future."	( Douma, S; Doumas, M, 2006)
"The treatment of erectile dysfunction has been revolutionized in the last decade by the introduction of sildenafil."	( Patel, P; Sam, R, 2006)
"Erectile dysfunction has a major impact on quality of life."	( Peltier, A; Roumeguère, T; van Velthoven, R, 2009)
"Erectile dysfunction has usually been treated by a phosphodiesterase 5 inhibitor in men, especially in the past decade."	( Gonenc, F; Ozgur, BC; Yazicioglu, AH, 2009)
"Erectile dysfunction has been recognized as an earlier predictor of cardiovascular events; moreover, HF itself may cause and/or worsen ED because of its particular feature and co-morbidities."	( Alberti, L; Fragasso, G; Lauretta, L; Loffi, M; Maranta, F; Margonato, A; Montorsi, F; Salonia, A; Torlasco, C, 2013)
"Sexual and erectile dysfunction has been reported in several studies by patients who take lithium as monotherapy or combined with other psychotherapeutic agents."	( Dehpour, AR; Ghasemi, M; Sheibani, M, 2022)

Excerpt	Reference
"Erectile dysfunction affects approximately 10 to 20 million men in the United States."	( Colpo, LM, 1998)
"Erectile dysfunction affects 20 million to 30 million men in the United States, and it has been reported that a significant number of impotent men (2."	( Nehra, A, 2000)
"Erectile dysfunction affects a large segment of the male population, and in most cases impaired relaxation of the smooth muscle cells in the corpus cavernosum and the penile arteries is a factor."	( Archer, S; Michelakis, E; Tymchak, W, 2000)
"Erectile dysfunction affects 50 percent of men ages 40-70 in the United States and is considered an important public health problem by the National Institutes of Health."	( McKay, D, 2004)
"Erectile dysfunction affects more than 30 million men in The United States."	( Agudelo Restrepo, CA; Uribe Trujillo, CA; Velásquez López, JG; Yepes Gómez, D, 2007)
"Erectile dysfunction affects more than half of men over the age of 40."	( Legro, RS; Trussell, JC, 2007)
"Erectile dysfunction affects up to 80% of men following a radical prostatectomy (RP) and is a common concern for these patients."	( Khera, M, 2009)
"Erectile dysfunction may affect 30% to 50% of men aged 40 to 70 years, with age, smoking, and obesity being the main risk factors, although 20% of cases have psychological causes."	( Goldstein, I; Khera, M, 2011)
"Erectile dysfunction affects millions of men worldwide."	( Ahituv, N; Hoffmann, TJ; Hotaling, JM; Jarvik, GP; Jorgenson, E; Matharu, N; Palmer, MR; Shan, J; Thai, KK; Van Den Eeden, SK; Wessells, H; Yin, J; Zhou, X, 2018)
"Erectile dysfunction affects more than 50% of diabetic male patients, with a higher prevalence compared with the general population."	( Di Cesare Mannelli, L; Ghelardini, C; Lucarini, E; Murzilli, S; Nobili, S; Vanelli, A, 2021)

Excerpt	Reference
"papaverine) for the treatment of erectile dysfunction."	( Carati, CJ; Earle, CM; Keogh, EJ; Lord, DJ; Tulloch, AG; Watters, GR; Wisniewski, ZS, 1988)
"Its use in the diagnosis and treatment of erectile dysfunction has been extensively studied."	( Linet, OI; Neff, LL, 1994)
"SIN-1 is not superior to PGE1 in the treatment of erectile dysfunction caused by venous leakage, and failure of NO-mediated smooth muscle relaxation does not play a part in the entity, "venous leakage."	( Knispel, HH; Wegner, HE, 1993)
"Pharmacological treatment of erectile dysfunction includes all therapeutic modalities based on the use of erectogenic drugs, regardless of the route of administration."	( Guazzoni, G; Montorsi, F; Pozza, G; Rigatti, P, 1995)
"To evaluate the long-term results of treatment of erectile dysfunction with intracavernous self-injection of vasoactive drugs."	( Benejan Gual, J; Cuesta Presedo, JM; Gil Martínez, P; Gonzalvo Ibarra, A; Ríoja Sanz, LA; Rodríguez Vela, L, 1996)
"To investigate the efficacy in treating erectile dysfunction and to develop a natural drug without complications, the results of ginseng treatments are compared to placebo and other drug."	( Choi, HK; Rha, KH; Seong, DH, 1995)
"The recommended dose of PGE-1 as treatment for erectile dysfunction has ranged from 10-60 mcg in various studies."	( Abbott, L; Hirsch, IH; Ismail, M, 1997)
"For the treatment of erectile dysfunction, the authors recommend that prostheses be reserved for cases refractory to all other treatments."	( Giuliano, F; Jardin, A, 1998)
"Sildenafil, the first oral drug for treating male erectile dysfunction, appears effective and well tolerated."	( Licht, MR, 1998)
"Successful treatment of erectile dysfunction in a patient after prostatectomy with sildenafil citrate may depend on the presence of bilateral neurovascular bundles."	( Agarwal, A; Kedia, AW; Kedia, K; Nelson, DR; Zippe, CD, 1998)
"To evaluate the impact of treatment for erectile dysfunction on the quality of life of men and their partners."	( Abbou, CC; Amar, ET; Desvaux, P; Flam, TA; Gesundheit, N; Hall, MM; Lycklama à Nijeholt, GA; Lynch, SF; Morgan, RJ; Müller, SC; Place, VA; Porst, H; Pryor, JP; Ryan, P; Spivack, AP; Todd, LK; Williams, G; Witzsch, UK, 1998)
"Successful treatment of erectile dysfunction with sildenafil citrate after radical prostatectomy depends on the presence of the neurovascular bundles."	( Agarwal, A; Jhaveri, FM; Kedia, A; Kedia, S; Klein, EA; Lakin, MM; Montague, DK; Pasqualotto, FF; Zippe, CD, 2000)
"Current treatments of erectile dysfunction elevate either cGMP levels by blocking cGMP degrading phosphodiesterase 5 or cyclic AMP (cAMP) levels by intrapenile injection of prostaglandin E1."	( Ahmad, M; Alm, P; Andersson, KE; Aszodi, A; Fassler, R; Hedlund, P; Hofmann, F; Pfeifer, A, 2000)
"Sildenafil (Viagra), an oral treatment for erectile dysfunction, has proved popular since its introduction in 1998."	( Gittleman, M; Goldstein, I; Kaufman, J; McMurray, J; Padma-Nathan, H; Shabsigh, R, 2000)
"Of 214 patients treated for erectile dysfunction (ED), 65 were not fully satisfied with the firmness of their erections via monotherapy."	( Macchia, RJ; Mydlo, JH; Volpe, MA, 2000)
"Several pharmacological treatments for erectile dysfunction (ED) have recently been introduced."	( Hedelin, H; Jacobsson, L, 2000)
"Sildenafil is highly effective for treating erectile dysfunction (ED)."	( Cohen, JS, 2000)
"In all, 360 men were treated for erectile dysfunction using single and/or combined therapy, comprising 214 private-practice and 166 clinic patients."	( MacChia, RJ; Mydlo, JH; Volpe, MA, 2000)
"Sildenafil is an equally effective treatment for erectile dysfunction after bilateral and unilateral nerve sparing procedures, and patient response to sildenafil is confirmed by the partners."	( Aboseif, S; Feng, MI; Huang, S; Kaptein, J; Kaswick, J, 2000)
"Sildenafil is an effective and safe treatment for erectile dysfunction in most patients on chronic dialysis."	( Chen, J; Greenstein, A; Mabjeesh, NJ; Matzkin, H; Nadu, A, 2001)
"Oral sildenafil is an effective treatment for erectile dysfunction (ED), which is a common complaint for patients with hypertension and those taking antihypertensive agents."	( Brown, M; Collins, M; Kloner, RA; Prisant, LM, 2001)
"The role of sildenafil in the treatment of erectile dysfunction is discussed."	( Berger, M; Berner, M; Vauth, R; Wetterauer, U, 2001)
"Sildenafil has been registered for the treatment of erectile dysfunction since 1998."	( Heeringa, M; Straus, SM; van Grootheest, AC, 2001)
"Several drugs have been developed to treat patients with erectile dysfunction (ED)."	( Gruenwald, I; Vardi, Y, 2000)
"Sildenafil is an oral treatment for erectile dysfunction (ED)."	( Vitezic, D, 2001)
"Established and new treatments for erectile dysfunction whose effects are mediated via manipulation of the NO pathway are also described."	( Cartledge, J; Eardley, I; Minhas, S, 2001)
"Yohimbine is an effective therapy to treat organic erectile dysfunction in some men with erectile dysfunction."	( Geisser, ME; Guay, AT; Jacobson, J; Murray, FT; Spark, RF, 2002)
"Sildenafil is an effective, safe treatment for erectile dysfunction in diabetic patients."	( Escobar-Jiménez, F, 2002)
"To try combined treatment of erectile dysfunction with viagra and alprostadil in case of failure of their monotherapy; to compare effectiveness of viagra in dynamics of treatment, in various doses and dose adjustment."	( Dmitriev, DG; Gamidov, SI; Mazo, EB; Ovchinnikov, RI, 2002)
"Sildenafil is a safe and effective treatment for erectile dysfunction of broad-spectrum etiology in Thai men."	( Kongkanand, A; Ratana-Olarn, K; Ruangdilokrat, S; Tantiwong, A, 2003)
"While the newer treatments for erectile dysfunction and andropause are distinctly different and targeted at symptom relief, the presentation of the patient with erectile dysfunction or andropause offers an excellent opportunity for screening for other health states and health education strategies."	( Tan, RS, 2003)
"Sildenafil was the first drug for the treatment of erectile dysfunction, introduced in 1998."	( Kuthe, A, 2003)
"Sildenafil is commonly used in the treatment of erectile dysfunction in hypertensive male cardiac transplant recipients (CTR); however, little is known about the vascular effects of sildenafil in these patients."	( Aggarwal, R; Aranda, JM; Edwards, DG; Estrada, J; Hill, JA; Nichols, WW; Pauly, DF; Schofield, RS; Schuler, BT, 2003)
"Standard treatments for erectile dysfunction (ED) (i."	( Allona, A; Angulo, J; Cuevas, P; Fernández, A; Gabancho, S; Martín-Morales, A; Moncada, I; Sáenz de Tejada, I; Videla, S, 2003)
"Sildenafil is used for treatment of erectile dysfunction caused by diverse factors."	( Aviv, A; Shelef, A; Weizman, A, 2004)
"Sildenafil is a useful agent for the treatment of erectile dysfunction in risperidone-treated male schizophrenia patients."	( Aviv, A; Shelef, A; Weizman, A, 2004)
"Sildenafil citrate was introduced as a treatment for erectile dysfunction in April 1998 in the United States and has been available since March 1999 in Japan."	( Arai, Y; Ichioka, K; Ogura, K; Terada, N; Terai, A; Yoshimura, K, 2004)
"Sildenafil may provide an effective treatment for erectile dysfunction, frequently observed in uremic patients and after kidney transplantation."	( Brockmeier, D; Christ, B; Hauck, EW; Kamali-Ernst, S, 2004)
"Partner satisfaction with treatment of erectile dysfunction can have a substantial impact on the continuation of therapy."	( Althof, SE; Montorsi, F, 2004)
"To evaluate the results of treatment of erectile dysfunction (ED) in kidney transplant recipients before and after the advent of sildenafil."	( Abbona, A; Ferrando, U; Graziano, ME; Lasaponara, F; Mezza, E; Milan, MG; Morabito, F; Paradiso, M; Piccoli, GB; Rossetti, M; Sedigh, O, 2004)
"A series of Maxi-K openers for the treatment of erectile dysfunction based on the 3-thio-quinolinone core is described."	( Boissard, CG; Boy, KM; Dworetzky, SI; Gribkoff, VK; Guernon, JM; Hewawasam, P; Lodge, N; Natale, J; Sit, SY; Starrett, JE; Xie, K, 2004)
"Sildenafil is widely used to treat erectile dysfunction (ED)."	( Bai, WJ; Chen, GQ, 2005)
"Identifying and effectively treating erectile dysfunction (ED) can result in an improvement of the quality of life (QoL) in men with multiple sclerosis (MS)."	( Fowler, CJ; Hussain, IF; Miller, JR; Sharief, MK; Stecher, VJ; Sweeney, M, 2005)
"Seven herbal products marketed for the treatment of erectile dysfunction were purchased via the Internet or at local health food stores."	( Adomat, H; Eberding, A; Fleshner, N; Guns, E; Harvey, M; Hersey, K; Wood, C, 2005)
"To explore the aetiology, diagnosis,and treatment of erectile dysfunction (ED) after a pelvic fracture urethral injury."	( Huang, K; Jiang, XZ; Tan, J; Tang, J; Tang, YX, 2004)
"ALA plays an important role in treatment of erectile dysfunction by decreasing iNOS and increasing other isoforms of NOS."	( Citci, S; Demirci, C; Hurdag, C; Ozkara, H; Uyaner, I, 2005)
"Sildenafil is effective in treatment of erectile dysfunction but shows variable results."	( Jackson, G; Lambert-Hammill, M; Lumb, PJ; Solomon, H; Wierzbicki, AS, 2006)
"In the modern era of pharmacologic treatment of erectile dysfunction, men with heart disease increasingly approach their physicians regarding the possibility of restoring sexual activity."	( Brunner, H; Kiowski, W; Schalcher, C, 2006)
"Tadalafil is an effective treatment for erectile dysfunction after 3DCRT for prostatic carcinoma with successful intercourse reported in almost 50% of the patients, and it is well tolerated."	( Hop, WC; Incrocci, L; Slagter, C; Slob, AK, 2006)
"Sildenafil is an effective oral treatment for erectile dysfunction syndrome."	( Mukherjee, B; Shivakumar, T, 2007)
"131 previously untreated men with erectile dysfunction (ED) were enrolled in a cross-over trial and randomly allocated to 50 mg sildenafil or 2 mg apomorphine."	( Behre, HM; Burkart, M; Jungwirth, A; Porst, H, 2007)
"We examined whether treatment of erectile dysfunction with sildenafil citrate is associated with amelioration of the symptomatology of androgen decline in the aging male, and whether this alters the endocrine pattern."	( Chertin, B; Farkas, A; Fridmans, A; Koulikov, D; Shenfeld, O; Spitz, IM, 2007)
"Tadalafil is an effective drug in treating erectile dysfunction (ED), and its clinical efficacy has been confirmed by a great many researches."	( Bai, WJ, 2007)
"Bremelanotide can be an alternative treatment for erectile dysfunction with a potentially broad patient base."	( Hosseini, SY; Safarinejad, MR, 2008)
"superba products for treatment of erectile dysfunction (ED) in mature males."	( Bhuntaku, P; Cherdshewasart, W; Dahlan, W; Malaivijitnond, S; Panriansaen, R, 2008)
"The authors conclude that tadalafil treatment of male erectile dysfunction following spinal cord injuries is safe and effective and is well tolerated for over a year."	( Srámková, T; Sutorý, M, 2008)
"Alprostadil is approved for treatment of male erectile dysfunction (ED) by injection or urethral insertion."	( Mahoney, M; Nelson, M; Pfister, W; Rooney, M; Steidle, C; Yeager, J, 2009)
"Although its efficacy in the treatment of erectile dysfunction has been demonstrated in several studies, recent and continuing studies have shown vardenafil's promise as an effective agent in penile rehabilitation, decreasing lower urinary tract symptoms resulting from benign prostatic hyperplasia and management of pulmonary hypertension."	( Dean, RC; Rice, KR, 2009)
"An integrated scheme of diagnosis and treatment of erectile dysfunction, androgen deficient state and cardiovascular diseases is presented in this paper."	( Didigova, RT; Mamedov, MN; Poddubskaia, EA; Sharvadze, GG, 2011)
"To summarize the experience in the treatment of erectile dysfunction (ED) with no successful intercourse at the baseline with tadalafil."	( Du, Q; Li, ZT; Pan, BC; Song, YS; Wu, B; Xing, X, 2012)
"Its efficacy and purported role in the treatment for erectile dysfunction are reviewed here."	( Burnett, AL; Segal, R, 2012)
"Avanafil was safe and effective for treating erectile dysfunction in men with diabetes and was effective as early as 15 minutes and more than 6 hours after dosing."	( Belkoff, LH; Bowden, CH; Day, WW; Goldstein, I; Jones, LA; Karlin, GS; Peterson, CA; Trask, BA, 2012)
"A total of 226 patients visited for treatment of erectile dysfunction and were recruited for the study."	( Cho, JM; Chung, JH; Chung, JM; Kang, DH; Kim, TH; Lee, KS; Lee, SW; Lee, W; Moon, KH; Oh, CY, 2013)
"Moreover, tadalafil was effective in treating both erectile dysfunction (ED) and the signs and symptoms of BPH in a phase III trial that specifically enrolled men with both indications."	( Curran, MP, 2012)
"Further studies designed to test treatments of erectile dysfunction in patients who suffer from schizophrenia are necessary."	( Bressan, RA; Lacaz, FS; Mari, Jde J; Nunes, LV; Nunes, SO, 2013)
"Tadalafil is used to treat erectile dysfunction after prostate cancer treatment, but its role as a preventive agent is undefined."	( Bruner, DW; Buyyounouski, MK; Greenberg, RE; Kachnic, LA; Mowat, RB; Pervez, N; Pisansky, TM; Pugh, SL; Raben, A; Reed, DR; Rosenthal, SA, 2014)
"It is clinically approved for treatment of erectile dysfunction in men, including diabetic and postprostatectomy patients."	( Ashour, AE; Kassem, MG; Rahman, AF, 2014)
"Sildenafil citrate, a drug used to treat erectile dysfunction, is available in tablet form but has three major problems."	( Ahmed, OA; El-Say, KM; Hosny, KM, 2016)
"Three of these drugs are known to treat erectile dysfunction, namely, sildenafil citrate, tadalafil, and apomorphine hydrochloride, and one drug that is used as opioid analgesic, tramadol hydrochloride, which is quiet widely misused to treat premature ejaculation."	( Elhenawee, M; Hashem, H; Ibrahim, AE, 2014)
"To compare the effectiveness in the treatment of erectile dysfunction when using PDE-5 inhibitors (PDE5i), alprostadil (PG-E1) and testosterone (TES) in monotherapy or combination therapy."	( Arrondo-Arrondo, JL; García-Cenador, MB; Labairu-Huerta, L; Lorenzo-Gómez, MF; Martín-Rodríguez, A; Mirón-Canelo, JA; Padilla-Fernández, B; Silva-Abuín, JM; Valverde-Martínez, LS, 2015)
"Local treatments for erectile dysfunction include intraurethral alprostadil as well as topical alprostadil cream."	( Hatzimouratidis, K; Kalinderis, N; Moisidis, K, 2016)
"This is highly promising for future treatment of erectile dysfunction from vascular causes."	( Batbold, D; Kwon, YG; Lee, T; Park, JM; Park, SH; Ryu, DS; Ryu, JK; Song, KM; Suh, JK; Suh, YG, 2016)
"Case one was treated for erectile dysfunction (ED)."	( Lowy, M; McCann, B; Simpson, GK, 2016)
"It may be a new promising treatment for erectile dysfunction and cardiovascular disease."	( Bak, YO; Choi, BR; Huang, YR; Liu, W; Park, JK; Zhang, LT; Zhao, C; Zhou, LX, 2016)
"PDE5 inhibitors are the firstline treatment for erectile dysfunction."	( Fusco, F; Mirone, V; Parazzini, F; Zucchi, A, 2016)
"PDE5 inhibitors are effective for the treatment of erectile dysfunction secondary to SCI."	( Echeverría-García, F; García-Perdomo, HA; Tobías, A, 2017)
"The currently recommended first-line treatments of erectile dysfunction (ED), phosphodiesterase type 5 inhibitors (PDE5i), for example sildenafil, are efficacious in many patients with ED of vascular origin, but this therapy is insufficient in approximately 30-40% of men with ED where there is also a neuronal affection."	( Andersson, KE; Comerma-Steffensen, S; Simonsen, U, 2016)
"ICIs are an effective treatment of erectile dysfunction in men with SCI."	( Bonan, I; Chéhensse, C; Chochina, L; Damphousse, M; Giuliano, F; Manunta, A; Naudet, F, 2016)
"Sildenafil is the most used treatment of erectile dysfunction, however a large part of patients do not respond to therapy."	( Azevedo, AMM; Brites-Anselmi, G; Coeli-Lacchini, FB; de Almeida Belo, V; de Andrade, MF; Hirsch, E; Lacchini, R; Molina, CAF; Pinheiro, LC; Tanus-Santos, JE; Tucci, S, 2017)
"Current treatments for erectile dysfunction (ED) have some limitations."	( Eardley, I; Holland, T; Ralph, DJ; Taubel, J; Terrill, P, 2018)
"If left untreated, erectile dysfunction may lead to depression in these often young patients."	( Fanjalalaina Ralahy, M; Parfaite Randriantsoa, M; Rakototiana, A; Razafimahandry, HJ, 2019)
"Sildenafil citrate is approved to treat erectile dysfunction."	( Crownover, PH; Ernst, C; Feng, Y; LaBadie, RR; Liang, Y; Luo, BY; Lv, Y; Zhao, Q; Zhu, H, 2020)
"Developing topical sildenafil for local treatment of erectile dysfunction has been of great interest in pharmaceutical research."	( Abdallah, OY; Abdelalim, LR; Elnaggar, YSR, 2020)
"Conclusions The pharmacological treatment of erectile dysfunction was in accordance with the recommendations of clinical practice guidelines, but the high proportion of potentially inappropriate prescriptions makes it necessary to promote educational and pharmacovigilance strategies that improve the prescription habits of physicians involved in caring for this group of patients."	( Machado-Alba, JE; Valladales-Restrepo, LF, 2021)
"LM11A-31 may be used as a strategy to treat erectile dysfunction after radical prostatectomy or in men with neurovascular diseases."	( Hong, SS; Limanjaya, A; Longo, FM; Minh, NN; Ock, J; Ryu, JK; Suh, JK; Yang, T; Yin, GN, 2021)
"Combining 2 first-line treatments for erectile dysfunction (ED) or initiating other modalities in addition to a first-line therapy may produce beneficial outcomes."	( Haidich, AB; Hatzichristodoulou, G; Hatzichristou, D; Mykoniatis, I; Ouranidis, A; Pyrgidis, N; Sokolakis, I; Sountoulides, P; van Renterghem, K, 2021)
"Combination of different first-line treatments for erectile dysfunction (ED) has emerged as a promising therapeutic approach."	( Fournaraki, A; Hatzichristou, D; Kalyvianakis, D; Kapoteli, P; Mykoniatis, I; Pyrgidis, N; Zilotis, F, 2022)
"Atorvastatin may be an effective treatment for erectile dysfunction (ED)."	( Li, H; Lu, Y; Ma, C; Su, H; Su, X, 2022)
"Traditional Chinese medicine has been treating erectile dysfunction in China, but its clinical value is inconclusive."	( Chen, X; Dai, D; Fang, Y; Gao, Z; Liu, X; Wang, Q; Wu, H, 2023)
"Sildenafil citrate (Viagra®) is used to treat male erectile dysfunction; however, little is known about the effects of sildenafil overdose and intoxication."	( Choi, S; Han, S; Kim, S; Nah, S, 2023)
"Studies have shown that treatment for erectile dysfunction with PDE5-Is decreased death, heart failure, myocardial infarction, and revascularization in males with erectile dysfunction who had previous myocardial infarction, and cardiovascular events."	( Blum, A; Konstantinovsky, A; Kridin, K; Kuchersky, N, 2023)

Timeframe	Studies, This Condition (%)	All Conditions %
pre-1990	1117 (16.65)	23.3326
1990's	1109 (16.53)	12.5806
2000's	2372 (35.37)	18.1394
2010's	1633 (24.35)	28.8240
2020's	476 (7.10)	9.53

Drug	Relationship Strength	Studies	Trials
acetylcarnitine	medium	2	1
3-mercaptopyruvic acid	low	1	0
phosphoserine	low	1	0
gamma-aminobutyric acid	medium	7	1
aminolevulinic acid	low	1	0
5-hydroxytryptophan	medium	1	1
acetic acid	medium	1	1
adenine	low	1	0
allantoin	low	1	0
benzene	low	1	0
bromide	low	1	0
1-butanol	low	1	0
butyric acid	low	1	0
carbamates	low	2	0
carbon monoxide	low	10	0
carnitine	medium	14	6
methane	medium	2	1
choline	low	1	0
chlorine	low	2	0
phloroglucinol	low	1	0
hydrogen sulfide	low	13	0
bupropion	medium	7	4
n(g),n(g')-dimethyl-l-arginine	medium	11	2
creatine	low	1	0
lactic acid	low	2	0
dimethyl sulfoxide	low	1	0
glycine	low	1	0
hydrogen carbonate	medium	2	2
histamine	low	4	0
hydrogen	low	4	0
iodine	medium	1	1
dihydroxyphenylalanine	medium	6	2
thioctic acid	medium	6	2
pyruvaldehyde	low	1	0
methanol	medium	2	1
inositol	low	1	0
melatonin	medium	10	1
nickel	low	2	0
niacin	medium	3	2
nitrates	medium	45	5
nitric acid	low	1	0
nitrites	medium	9	1
nitrous oxide	low	1	0
4-aminobenzoic acid	medium	3	1
phthalic acid	low	1	0
purine	low	1	0
pyridoxine	low	1	0
pyrogallol	low	1	0
spermidine	low	1	0
spermine	low	1	0
sulfur dioxide	low	1	0
taurine	low	2	0
thiamine	low	6	0
thymine	medium	1	1
toluene	low	1	0
trimethyloxamine	low	2	0
uracil	low	1	0
uric acid	low	16	0
urea	medium	6	1
7-hydroxy-2-n,n-dipropylaminotetralin	low	1	0
4-iodo-2,5-dimethoxyphenylisopropylamine	low	1	0
1-(3-chlorophenyl)piperazine	low	1	0
1h-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one	low	1	0
2,4,5-trichlorophenoxyacetic acid	low	1	0
2,4-dichlorophenoxyacetic acid	low	1	0
3,4-methylenedioxyamphetamine	low	7	0
n-methyl-3,4-methylenedioxyamphetamine	low	3	0
3-aminobenzamide	low	1	0
4-aminopyridine	low	1	0
phenytoin	medium	3	1
oxyquinoline	low	1	0
acetazolamide	low	1	0
alaproclate	low	1	0
alfuzosin	medium	19	6
diatrizoic acid	low	4	0
pimagedine	low	3	0
theophylline	low	1	0
amiodarone	low	4	0
amitriptyline	low	3	0
acetovanillone	low	5	0
aspirin	medium	3	1
atenolol	low	3	0
azathioprine	low	2	0
baclofen	medium	5	1
barbital	low	1	0
bay-k-8644	low	1	0
bendroflumethiazide	medium	2	1
benserazide	medium	1	1
berberine	low	3	0
diminazene	low	1	0
bicalutamide	medium	7	1
bisindolylmaleimide i	low	1	0
bisoprolol	medium	1	1
bromazepam	low	1	0
bupivacaine	medium	2	1
buspirone	low	1	0
caffeine	medium	9	1
verapamil	medium	17	3
carbamazepine	medium	11	2
carvedilol	medium	2	1
cefuroxime	low	2	0
celecoxib	low	2	0
chlordiazepoxide	medium	3	1
chloroquine	low	1	0
chlorpromazine	medium	12	1
chlorpyrifos	low	1	0
chlorthalidone	low	5	0
cimetidine	medium	19	1
citalopram	medium	7	3
clofibrate	low	5	0
clofibric acid	low	1	0
clomipramine	medium	10	4
clonazepam	medium	3	1
clonidine	medium	10	1
cyproheptadine	low	2	0
amphetamine	low	4	0
diazepam	low	2	0
diazoxide	low	1	0
dibutyl phthalate	low	2	0
diclofenac	medium	1	1
dichlorodiphenyl dichloroethylene	low	1	0
pentetic acid	low	1	0
dipyridamole	low	3	0
disopyramide	low	3	0
disulfiram	low	2	0
valproic acid	low	8	0
domperidone	low	2	0
doxepin	low	1	0
epinastine	low	1	0
etilefrine	medium	3	2
felodipine	medium	3	1
fluphenazine	low	3	0
fluoxetine	medium	14	6
flutamide	medium	14	8
gabapentin	low	1	0
gemfibrozil	low	4	0
gentamicin	low	6	0
gliclazide	medium	1	1
glyburide	low	8	0
guanethidine	medium	13	1
guanidine	low	2	0
1-(5-isoquinolinesulfonyl)-2-methylpiperazine	low	2	0
fasudil	low	1	0
haloperidol	low	8	0
hydralazine	low	6	0
hydrochlorothiazide	medium	7	3
hydroxyurea	low	1	0
phenelzine	low	2	0
lidocaine	medium	12	2
ifenprodil	low	1	0
imipramine	medium	10	1
amrinone	low	1	0
indapamide	medium	1	1
indomethacin	low	3	0
iohexol	medium	2	1
iothalamic acid	low	1	0
iproniazid	low	1	0
avapro	medium	4	2
isoflurane	low	2	0
isoproterenol	low	1	0
isoxsuprine	medium	6	2
isradipine	low	1	0
ketamine	low	3	0
ketanserin	medium	4	2
khellin	low	1	0
lamotrigine	low	2	0
letrozole	medium	2	1
loratadine	medium	1	1
lorazepam	low	1	0
losartan	low	6	0
maprotiline	low	1	0
mazindol	low	1	0
mechlorethamine	low	1	0
metformin	medium	10	1
methadone	medium	21	1
methantheline	low	1	0
methazolamide	low	1	0
methyclothiazide	low	1	0
methylphenidate	low	2	0
metoclopramide	low	4	0
metoprolol	medium	14	8
mianserin	medium	4	1
midodrine	medium	4	1
minoxidil	medium	10	3
mirtazapine	low	3	0
mitotane	low	1	0
moclobemide	medium	2	1
modafinil	low	1	0
molsidomine	medium	13	3
apnea	low	1	0
naftopidil	medium	1	1
nefazodone	low	1	0
neostigmine	low	3	0
nicardipine	medium	1	1
niceritrol	medium	1	1
nifedipine	medium	6	1
nilutamide	medium	3	1
nitrendipine	medium	2	1
nortriptyline	medium	2	1
ns 1619	low	2	0
octopamine	low	1	0
ofloxacin	medium	1	1
oxazepam	low	1	0
oxidopamine	low	1	0
oxprenolol	low	1	0
oxybutynin	medium	1	1
fenclonine	medium	4	2
pantoprazole	low	1	0
pargyline	low	3	0
pemoline	medium	1	1
pentobarbital	low	1	0
pentoxifylline	medium	10	5
phenobarbital	medium	4	1
phenoxybenzamine	medium	23	3
phenylbutazone	low	1	0
moxonidine	low	1	0
pinacidil	low	2	0
pioglitazone	medium	5	1
piperazine	low	1	0
pipobroman	low	1	0
piracetam	medium	4	1
pirenzepine	medium	3	1
piribedil	low	3	0
prazosin	medium	8	2
prilocaine	low	2	0
primidone	medium	1	1
probucol	low	4	0
procaine	medium	5	1
procarbazine	low	1	0
procyclidine	low	1	0
propafenone	low	1	0
propantheline	medium	1	1
propofol	low	1	0
propranolol	medium	22	2
protriptyline	low	1	0
risperidone	medium	13	3
rolipram	low	1	0
linsidomine	medium	10	3
sodium fluoride	low	1	0
stearic acid	low	1	0
vorinostat	low	1	0
sulfasalazine	low	3	0
sulmazole	low	1	0
sulpiride	low	1	0
suramin	low	1	0
terazosin	medium	2	1
terbutaline	medium	3	1
tetraethylammonium	low	3	0
thalidomide	low	2	0
theobromine	medium	1	1
thioridazine	low	8	0
tolazoline	low	1	0
tolbutamide	low	1	0
trazodone	medium	33	10
tyramine	medium	2	1
urapidil	low	1	0
urethane	low	1	0
3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole	low	1	0
zinc chloride	low	1	0
zonisamide	low	1	0
corticosterone	low	2	0
prednisolone	low	3	0
estriol	low	3	0
lysergic acid diethylamide	low	3	0
reserpine	medium	5	1
phentolamine	medium	326	54
alloxan	low	6	0
hydroxyproline	low	2	0
thyroxine	low	16	0
carbachol	low	3	0
spironolactone	medium	7	1
aldosterone	low	2	0
penicillamine	low	1	0
lynestrenol	low	1	0
prednisone	low	9	0
estrone	medium	3	1
methylprednisolone acetate	low	1	0
oxandrolone	low	1	0
androsterone	low	5	0
etiocholanolone	low	2	0
metaraminol	low	8	0
triiodothyronine	low	3	0
alanine	low	1	0
chloramphenicol	low	1	0
aspartic acid	medium	5	3
glutamine	low	2	0
lysine	low	1	0
cyanides	low	1	0
sucrose	low	1	0
ethinyl estradiol	low	4	0
testosterone propionate	low	3	0
methyltestosterone	medium	34	8
bromodeoxyuridine	low	1	0
galactose	low	1	0
carbostyril	low	6	0
phenylephrine	low	44	0
levodopa	medium	11	3
tyrosine	medium	2	1
methoxamine	low	1	0
adenosine monophosphate	medium	1	1
methylene blue	low	4	0
androstenedione	medium	11	1
methionine	medium	2	1
desoxycorticosterone	low	3	0
colchicine	medium	3	2
chloroform	low	1	0
norethindrone	low	3	0
17-alpha-hydroxyprogesterone	medium	1	1
cytarabine	low	1	0
medroxyprogesterone acetate	low	2	0
valine	medium	9	1
mestranol	low	2	0
methandrostenolone	low	1	0
cordycepin	low	1	0
tryptophan	low	1	0
isoleucine	low	1	0
arginine	medium	69	16
propane	low	1	0
vinyl chloride	low	2	0
formaldoxime	low	1	0
fluoxymesterone	low	5	0
phencyclidine	low	1	0
pentaerythritol tetranitrate	low	1	0
isoprene	low	1	0
acrylic acid	low	1	0
bisphenol a	low	1	0
methylprednisolone	medium	6	2
brompheniramine	low	1	0
isosorbide dinitrate	medium	6	3
n-vinyl-2-pyrrolidinone	low	1	0
quinoxalines	low	1	0
xanthenes	low	1	0
synephrine	medium	2	1
1,2-dibromo-3-chloropropane	low	1	0
quinuclidines	medium	3	2
cyclohexanol	medium	2	1
pyrroles	medium	8	4
thiophenes	medium	1	1
heptanol	low	1	0
undecanoic acid	medium	1	1
pyrazolanthrone	low	1	0
diatrizoate meglumine	low	3	0
meglumine	low	1	0
1-naphthylamine	low	1	0
aminoethylpiperazine	low	1	0
cyacetacide	low	1	0
pregnenolone	low	2	0
1,2-dihydroxybenzene-3,5-disulfonic acid disodium salt	low	1	0
methohexital	low	5	0
catechin	low	2	0
quinazolines	medium	25	6
indazoles	low	1	0
azulene	low	1	0
isoxazoles	low	1	0
thiazoles	medium	11	3
pyrazines	medium	3	1
ethynodiol diacetate	low	1	0
ephedrine	medium	6	2
muscarine	low	1	0
hydrazine	low	2	0
thiocyanate	low	1	0
chlormadinone acetate	low	4	0
testosterone enanthate	medium	17	4
opipramol	low	3	0
aminophylline	medium	2	2
galantamine	low	1	0
methysergide	low	2	0
citrulline	medium	8	2
betamethasone	medium	1	1
nandrolone	low	1	0
fluorobenzenes	low	2	0
n-pentyl nitrite	low	1	0
chenodeoxycholic acid	low	1	0
nuciferine	medium	1	1
boldine	low	1	0
phenylpropanolamine	low	1	0
4-hydroxybutyric acid	low	1	0
alpha-aminopyridine	medium	2	1
thiazolidines	low	1	0
hematoxylin	low	1	0
psilocybin	low	1	0
medroxyprogesterone	low	4	0
dihydrotestosterone	medium	24	6
flavone	low	1	0
methoxyhydroxyphenylglycol	medium	3	1
methamphetamine	low	2	0
malondialdehyde	low	26	0
triethylenephosphoramide	medium	1	1
eosine yellowish-(ys)	low	1	0
paeonol	low	1	0
lithium carbonate	low	1	0
megestrol acetate	medium	2	1
acetylcysteine	low	4	0
4,4'-bisphenol f	low	1	0
formamidoxime	low	1	0
dehydroepiandrosterone sulfate	medium	16	1
diisopropylamine dichloroacetate	low	1	0
norgestrienone	low	1	0
deoxyuridine	low	2	0
dinobuton	low	1	0
tetramethylpyrazine	medium	1	1
decabromobiphenyl ether	low	1	0
vancomycin	low	7	0
d-alpha tocopherol	medium	22	4
tocopherols	medium	1	1
mesterolone	low	2	0
stearylamine	low	1	0
dronabinol	medium	2	1
pimozide	low	3	0
benperidol	low	1	0
sabinene	low	2	0
megestrol	low	2	0
tranylcypromine	medium	3	1
carbonates	medium	7	3
trimetazidine	medium	1	1
norleucine	low	1	0
floxacillin	low	1	0
olsalazine	low	1	0
n-methylaspartate	low	4	0
iridium	low	1	0
mercury	low	1	0
neodymium	medium	2	1
palladium	medium	16	3
platinum	low	1	0
ruthenium	low	1	0
silver	low	4	0
technetium	low	23	0
thulium	medium	5	1
titanium	medium	3	1
cadmium	low	1	0
gadolinium	low	1	0
helium	low	1	0
holmium	medium	9	1
yttrium	low	1	0
acetylglucosamine	medium	2	1
hypochlorous acid	low	1	0
bromine	low	1	0
zinc sulfate	medium	3	2
deuterium	low	1	0
ozone	low	2	0
trolamine salicylate	low	6	0
ammonium chloride	low	1	0
selegiline	medium	4	1
isosorbide-5-mononitrate	medium	2	1
fluorides	low	1	0
an 1	low	1	0
metergoline	low	3	0
lisuride	low	1	0
calcium dobesilate	medium	2	1
daunorubicin	low	1	0
cephapirin	low	1	0
bromocriptine	medium	62	9
phenyl acetate	medium	2	1
cetylpyridinium chloride anhydrous	low	3	0
triamcinolone	low	2	0
tris(2,3-dibromopropyl)phosphate	low	1	0
fludrocortisone	low	2	0
ursodeoxycholic acid	low	1	0
4-methoxyamphetamine	low	8	0
transferrin	low	3	0
cefazolin	low	2	0
adenosine diphosphate ribose	low	1	0
timolol	low	3	0
tramadol	low	3	0
nicergoline	low	1	0
oxcarbazepine	low	3	0
tobramycin	low	1	0
etoposide	medium	1	1
substance p	low	1	0
cartazolate	low	1	0
ribavirin	low	2	0
methyldopa	low	15	0
sq-11725	medium	1	1
diltiazem	medium	2	1
ng-nitroarginine methyl ester	low	17	0
pirfenidone	low	1	0
paroxetine	low	11	0
captopril	low	3	0
nicorandil	low	1	0
pergolide	medium	3	2
colforsin	low	2	0
buserelin	medium	3	2
fomesafen	medium	81	3
haloperidol decanoate	low	1	0
lovastatin	low	4	0
simvastatin	medium	7	2
quinpirole	low	2	0
pravastatin	low	1	0
cabergoline	medium	7	1
atomoxetine hydrochloride	medium	2	2
quinapril	medium	1	1
fura-2	low	1	0
finasteride	medium	57	9
delequamine	medium	3	1
ibutilide	medium	1	1
aripiprazole	low	4	0
atorvastatin	medium	10	5
duloxetine hydrochloride	medium	1	1
valsartan	medium	8	1
ziprasidone	low	1	0

Protein Targets (3,400)

Protein	Potency Measurements	Inhibition Measurements	Activation Measurements	Drugs
Chain A, TYROSYL-DNA PHOSPHODIESTERASE	76	0	0	76
5-hydroxytryptamine receptor 3E	0	10	1	11
acetylcholinesterase	88	0	0	88
TDP1 protein	247	0	0	247
cytochrome P450 2D6	126	0	0	126
v-jun sarcoma virus 17 oncogene homolog (avian)	102	0	0	102
cytochrome P450 2D6 isoform 1	69	0	0	69
cellular tumor antigen p53 isoform a	45	0	0	45
cytochrome P450 2C19 precursor	62	0	0	62
cytochrome P450 2C9 precursor	53	0	0	53
thyroid hormone receptor beta isoform a	66	0	0	66
thyroid hormone receptor beta isoform 2	181	0	0	181
huntingtin isoform 2	27	0	0	27
peripheral myelin protein 22	117	0	0	117
cytochrome P450 3A4 isoform 1	128	0	0	128
muscarinic acetylcholine receptor M1	85	0	0	85
Gamma-aminobutyric acid receptor subunit pi	128	18	7	153
Polyunsaturated fatty acid lipoxygenase ALOX15B	45	3	0	48
ATP-binding cassette sub-family C member 3	0	179	0	179
Multidrug resistance-associated protein 4	0	181	0	188
5-hydroxytryptamine receptor 3B	0	10	1	11
Bile salt export pump	0	257	0	257
Beta-1 adrenergic receptor	0	26	9	35
5-hydroxytryptamine receptor 1A	0	37	19	57
5-hydroxytryptamine receptor 2C	0	48	7	57
D(2) dopamine receptor	0	96	16	123
5-hydroxytryptamine receptor 2A	0	56	9	66
Gamma-aminobutyric acid receptor subunit beta-1	128	18	7	153
Alpha-1B adrenergic receptor	0	89	14	103
Gamma-aminobutyric acid receptor subunit delta	128	18	7	153
Gamma-aminobutyric acid receptor subunit gamma-2	128	18	9	155
D	0	38	0	40
5-hydroxytryptamine receptor 1A	0	97	10	110
Gamma-aminobutyric acid receptor subunit alpha-5	128	18	7	153
Gamma-aminobutyric acid receptor subunit alpha-3	128	18	7	153
Gamma-aminobutyric acid receptor subunit gamma-1	128	19	7	154
Gamma-aminobutyric acid receptor subunit alpha-2	128	18	8	154
Alpha-1D adrenergic receptor	0	60	14	75
5-hydroxytryptamine receptor 2A	0	99	10	116
5-hydroxytryptamine receptor 2C	0	94	8	104
Gamma-aminobutyric acid receptor subunit alpha-4	128	18	7	153
Gamma-aminobutyric acid receptor subunit gamma-3	128	18	7	153
5-hydroxytryptamine receptor 1B	0	74	5	79
5-hydroxytryptamine receptor 1D	0	24	5	29
Gamma-aminobutyric acid receptor subunit alpha-6	128	18	7	153
5-hydroxytryptamine receptor 1F	0	24	5	29
5-hydroxytryptamine receptor 5A	0	1	0	1
5-hydroxytryptamine receptor 2B	0	44	7	51
Sodium-dependent serotonin transporter	0	101	11	113
5-hydroxytryptamine receptor 7	0	26	5	31
5-hydroxytryptamine receptor 7	0	24	1	26
Alpha-1B adrenergic receptor	0	31	11	49
Glutamate receptor ionotropic, NMDA 1	0	19	5	31
5-hydroxytryptamine receptor 2B	0	104	5	112
Alpha-1A adrenergic receptor	0	97	16	113
5-hydroxytryptamine receptor 3A	0	13	3	17
Histamine H2 receptor	82	10	3	105
5-hydroxytryptamine receptor 6	0	80	1	84
Beta-2 adrenergic receptor	0	4	0	4
D(2) dopamine receptor	0	60	11	75
Gamma-aminobutyric acid receptor subunit alpha-1	128	20	9	157
Gamma-aminobutyric acid receptor subunit beta-3	128	18	7	153
Gamma-aminobutyric acid receptor subunit beta-2	128	18	9	155
Glutamate receptor ionotropic, NMDA 2A	0	18	4	29
Glutamate receptor ionotropic, NMDA 2B	0	22	5	34
Glutamate receptor ionotropic, NMDA 2C	0	18	4	30
Glutamate receptor ionotropic, NMDA 2D	0	18	4	29
5-hydroxytryptamine receptor 3D	0	10	1	11
Glutamate receptor ionotropic, NMDA 3B	0	18	4	29
5-hydroxytryptamine receptor 3C	0	10	1	11
GABA theta subunit	128	18	7	153
Canalicular multispecific organic anion transporter 1	0	170	0	171
Gamma-aminobutyric acid receptor subunit epsilon	128	18	7	153
Glutamate receptor ionotropic, NMDA 3A	0	18	4	29
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE	121	0	0	121
thioredoxin reductase	148	0	0	148
ATAD5 protein, partial	98	0	0	98
GLS protein	113	0	0	113
regulator of G-protein signaling 4	96	0	0	96
67.9K protein	55	0	0	55
Parkin	29	0	0	29
bromodomain adjacent to zinc finger domain 2B	51	0	0	51
IDH1	72	0	0	72
euchromatic histone-lysine N-methyltransferase 2	234	0	0	234
nuclear factor erythroid 2-related factor 2 isoform 2	56	0	0	57
ras-related protein Rab-9A	35	0	0	35
serine/threonine-protein kinase mTOR isoform 1	48	0	0	48
urokinase-type plasminogen activator precursor	37	0	0	37
plasminogen precursor	37	0	0	37
urokinase plasminogen activator surface receptor precursor	37	0	0	37
survival motor neuron protein isoform d	78	0	0	78
D(1A) dopamine receptor	31	4	0	35
Ataxin-2	115	0	0	115
ATP-dependent phosphofructokinase	115	0	0	115
aldehyde dehydrogenase 1 family, member A1	146	0	0	146
glucocorticoid receptor [Homo sapiens]	196	0	0	196
farnesoid X nuclear receptor	115	0	0	115
estrogen nuclear receptor alpha	274	0	0	274
Voltage-dependent calcium channel gamma-2 subunit	105	0	0	105
Cellular tumor antigen p53	165	0	0	165
Glutamate receptor 2	109	1	2	114
Choline O-acetyltransferase	0	3	0	5
Chain A, High-affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A	0	1	0	1
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4D	0	1	0	1
Chain A, Phosphodiesterase 9A	0	1	0	1
Chain A, JmjC domain-containing histone demethylation protein 3A	43	0	0	43
Chain A, Class I phosphodiesterase PDEB1	0	1	0	1
Chain A, High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A	0	1	0	1
Chain A, cGMP-dependent 3',5'-cyclic phosphodiesterase	0	1	0	1
Chain A, cGMP-specific 3',5'-cyclic phosphodiesterase catalytic domain, Cone cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha chimera	0	1	0	1
Chain A, cGMP-specific 3',5'-cyclic phosphodiesterase catalytic domain, Cone cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha chimera	0	1	0	1
Chain A, High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A	0	1	0	1
Chain A, High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A	0	1	0	1
glp-1 receptor, partial	64	0	0	64
thyroid stimulating hormone receptor	108	0	0	108
estrogen-related nuclear receptor alpha	212	0	0	212
Phosphodiesterase	0	7	0	7
mitogen-activated protein kinase 1	77	0	0	77
geminin	216	0	0	216
histone acetyltransferase KAT2A isoform 1	74	0	0	74
cGMP-dependent 3',5'-cyclic phosphodiesterase	0	14	0	14
Monocarboxylate transporter 4	0	1	0	1
High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A	0	8	0	8
cGMP-specific 3',5'-cyclic phosphodiesterase	0	31	2	34
High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A	0	6	0	6
Renin	0	8	0	8
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A	0	8	0	8
cAMP-specific 3',5'-cyclic phosphodiesterase 4D	0	7	0	8
cAMP-specific 3',5'-cyclic phosphodiesterase 4C	0	7	0	8
cAMP-specific 3',5'-cyclic phosphodiesterase 4B	0	7	0	9
Adenosine receptor A1	1	28	4	39
Adenosine receptor A3	0	8	0	8
Adenosine receptor A2a	0	25	11	41
Adenosine receptor A2b	0	6	4	15
Adenosine receptor A2b	0	13	3	21
Adenosine receptor A1	0	25	9	43
Adenosine receptor A2a	0	26	6	43
Sodium-dependent serotonin transporter	0	35	4	40
Adenosine receptor A2a	0	4	0	4
Cone cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha'	0	7	0	7
cAMP-specific 3',5'-cyclic phosphodiesterase 4A	0	7	0	8
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A	0	13	0	14
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B	0	8	0	8
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B	0	13	0	14
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B	0	6	0	6
cAMP-specific 3',5'-cyclic phosphodiesterase 4B	0	19	1	21
cAMP-specific 3',5'-cyclic phosphodiesterase 4D	0	20	1	22
cGMP-inhibited 3',5'-cyclic phosphodiesterase B	0	18	0	19
Voltage-dependent L-type calcium channel subunit alpha-1C	0	39	0	40
High affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A	0	8	0	8
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C	0	15	0	16
cGMP-inhibited 3',5'-cyclic phosphodiesterase A	0	19	0	20
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C	0	6	0	6
Phosphodiesterase	0	1	0	1
Phosphodiesterase	0	6	0	6
cAMP-specific 3',5'-cyclic phosphodiesterase 7B	0	6	0	6
Chain A, HADH2 protein	77	0	0	77
Chain B, HADH2 protein	77	0	0	77
RAR-related orphan receptor gamma	188	0	0	188
GLI family zinc finger 3	196	0	0	196
AR protein	252	0	0	252
estrogen receptor 2 (ER beta)	121	0	0	121
nuclear receptor subfamily 1, group I, member 3	161	0	0	161
progesterone receptor	141	0	0	141
retinoic acid nuclear receptor alpha variant 1	185	0	0	185
pregnane X nuclear receptor	176	0	0	176
aryl hydrocarbon receptor	95	0	0	95
thyroid stimulating hormone receptor	101	0	0	101
activating transcription factor 6	80	0	0	80
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a	79	0	0	79
15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1	57	0	0	57
nuclear factor erythroid 2-related factor 2 isoform 1	184	0	0	184
Kelch-like ECH-associated protein 1	0	0	2	2
Histone acetyltransferase KAT8	0	1	0	1
peroxisome proliferator activated receptor gamma	140	0	0	140
chromobox protein homolog 1	141	0	0	141
Histone H2A.x	80	0	0	80
pregnane X receptor	36	0	0	36
SMAD family member 2	68	0	0	68
SMAD family member 3	68	0	0	68
Microtubule-associated protein tau	109	0	0	110
retinoid X nuclear receptor alpha	151	0	0	151
G	116	0	0	116
vitamin D (1,25- dihydroxyvitamin D3) receptor	127	0	0	127
arylsulfatase A	96	0	0	96
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a	133	0	0	133
nuclear receptor subfamily 1, group I, member 2	27	0	0	27
lamin isoform A-delta10	176	0	0	176
Interferon beta	148	0	0	148
HLA class I histocompatibility antigen, B alpha chain	116	0	0	116
Glucocorticoid receptor	0	41	6	58
Sex hormone-binding globulin	0	1	21	22
Glycine receptor subunit alpha-1	0	37	0	37
Corticosteroid-binding globulin	0	15	0	15
Adenosine receptor A3	0	45	5	51
Replicase polyprotein 1ab	0	26	13	39
Androgen receptor	0	72	1	74
Glycine receptor subunit beta	0	36	0	36
Glycine receptor subunit alpha-2	0	36	0	36
Glycine receptor subunit alpha-3	0	36	0	36
Mitogen-activated protein kinase 3	0	3	5	8
Sodium-dependent dopamine transporter	0	92	5	98
TAR DNA-binding protein 43	51	0	0	51
Inositol hexakisphosphate kinase 1	116	0	0	116
cytochrome P450 2C9, partial	116	0	0	116
Chain A, 2-oxoglutarate Oxygenase	81	0	0	81
Chain A, Ferritin light chain	60	0	0	60
USP1 protein, partial	128	0	0	128
NFKB1 protein, partial	42	0	0	42
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)	56	0	0	56
polyunsaturated fatty acid lipoxygenase ALOX12	14	0	0	14
vitamin D3 receptor isoform VDRA	85	0	0	85
histone-lysine N-methyltransferase 2A isoform 2 precursor	26	0	0	26
M-phase phosphoprotein 8	49	0	0	49
DNA dC->dU-editing enzyme APOBEC-3G isoform 1	8	3	0	11
lethal factor (plasmid)	56	0	0	56
cytochrome P450 family 3 subfamily A polypeptide 4	171	0	0	171
D(4) dopamine receptor	0	44	10	62
D(3) dopamine receptor	0	97	11	117
dopamine D1 receptor	26	0	0	26
DNA polymerase kappa isoform 1	59	0	0	59
Adenosine receptor A1	0	2	3	5
Mu-type opioid receptor	0	20	6	27
Arginase-1	0	1	0	1
Arginase-2, mitochondrial	0	1	0	1
Luciferase	72	0	0	72
peroxisome proliferator-activated receptor delta	122	0	0	122
serine/threonine-protein kinase PLK1	18	0	0	18
Pyruvate dehydrogenase E1 component subunit alpha, mitochondrial	0	1	0	1
Pyruvate dehydrogenase E1 component subunit beta, mitochondrial	0	1	0	1
Guanine nucleotide-binding protein G	27	0	0	27
Chain A, Putative fructose-1,6-bisphosphate aldolase	47	0	0	47
endonuclease IV	28	0	0	28
15-lipoxygenase, partial	48	0	0	48
phosphopantetheinyl transferase	87	0	0	87
Fumarate hydratase	55	0	0	55
thioredoxin glutathione reductase	28	0	0	28
Smad3	55	0	0	55
EWS/FLI fusion protein	119	0	0	120
nonstructural protein 1	30	0	0	30
polyprotein	55	0	0	55
Bloom syndrome protein isoform 1	81	0	0	81
NPC intracellular cholesterol transporter 1 precursor	24	0	0	24
peripheral myelin protein 22 isoform 1	55	0	0	55
atrial natriuretic peptide receptor 2 precursor	23	0	0	23
FAD-linked sulfhydryl oxidase ALR	0	0	0	3
DNA polymerase iota isoform a (long)	68	0	0	68
Guanylate cyclase soluble subunit beta-2	0	0	0	3
Integrin beta-3	34	1	0	35
Integrin alpha-IIb	34	1	0	35
Guanylate cyclase soluble subunit alpha-2	0	0	0	3
Alpha-synuclein	26	14	1	41
Guanylate cyclase soluble subunit alpha-1	0	0	1	4
Guanylate cyclase soluble subunit beta-1	0	0	1	4
Histone acetyltransferase p300	0	4	0	4
Hypoxia-inducible factor 1-alpha	0	1	0	1
CREB-binding protein	2	4	0	6
Endothelial PAS domain-containing protein 1	0	1	0	1
Chain A, Cruzipain	45	0	0	45
Poly [ADP-ribose] polymerase 2	0	2	0	2
Poly [ADP-ribose] polymerase 1	0	6	0	6
Poly [ADP-ribose] polymerase 1	0	1	0	1
Transporter	0	28	1	30
Thrombopoietin	34	0	0	34
POU domain, class 2, transcription factor 1	0	0	0	3
Spike glycoprotein	116	4	10	130
pyruvate kinase PKM isoform a	5	0	0	5
Glycoprotein hormones alpha chain	2	0	0	2
Tubulin--tyrosine ligase	0	2	0	2
Sodium-dependent noradrenaline transporter	0	104	12	117
Sodium-dependent dopamine transporter	0	39	3	42
5-hydroxytryptamine receptor 6	0	12	5	17
5-hydroxytryptamine receptor 5A	0	12	5	17
5-hydroxytryptamine receptor 5B	0	12	5	17
5-hydroxytryptamine receptor 3A	0	17	5	22
5-hydroxytryptamine receptor 4	0	13	5	19
5-hydroxytryptamine receptor 3B	0	17	5	22
alpha-galactosidase	20	0	0	20
flap endonuclease 1	52	0	0	52
Amine oxidase [flavin-containing] A	0	28	0	30
Amine oxidase [flavin-containing] B	0	31	2	35
Genome polyprotein	0	0	1	1
transcriptional regulator ERG isoform 3	23	0	0	23
Polyphenol oxidase 2	0	16	0	21
Thiopurine S-methyltransferase	0	2	0	2
Succinate-semialdehyde dehydrogenase, mitochondrial	0	1	0	1
4-aminobutyrate aminotransferase, mitochondrial	0	2	0	3
Cytochrome P450 1B1	0	19	1	20
Dihydropteroate synthase	0	0	1	1
glucocerebrosidase	40	0	0	40
Potassium channel subfamily K member 2	0	9	11	20
Rap guanine nucleotide exchange factor 3	26	0	0	26
Potassium voltage-gated channel subfamily A member 3	0	2	1	3
Acetylcholinesterase	0	6	0	7
Pteridine reductase 1	0	2	0	2
Potassium voltage-gated channel subfamily A member 1	0	5	1	6
Potassium voltage-gated channel subfamily H member 2	0	106	0	106
Transient receptor potential cation channel subfamily A member 1	0	1	3	4
Calcium/calmodulin-dependent protein kinase type II subunit alpha	0	2	0	2
Tetraspanin	0	1	0	1
Proton-coupled amino acid transporter 1	0	10	0	10
Calcium/calmodulin-dependent protein kinase type II subunit alpha	0	2	1	3
atrial natriuretic peptide receptor 1 precursor	18	0	0	18
5-hydroxytryptamine receptor 2C	0	5	0	6
5-hydroxytryptamine receptor 2A	0	3	0	4
5-hydroxytryptamine receptor 5A	0	6	0	7
Estrogen receptor	0	36	12	50
Melatonin receptor type 1A	0	3	3	6
Melatonin receptor type 1B	0	3	3	6
Estrogen receptor beta	0	19	12	32
large T antigen	0	6	0	6
Solute carrier organic anion transporter family member 2A1	0	1	0	7
D(1A) dopamine receptor	77	0	0	77
D(3) dopamine receptor	0	33	3	39
Histamine H3 receptor	0	3	1	5
Sigma non-opioid intracellular receptor 1	0	16	1	17
Chain A, Avidin	0	0	2	2
Chain A, Avidin	0	0	2	2
Chain B, Avidin	0	0	2	2
Skn7p	0	0	0	1
glycogen synthase kinase-3 beta isoform 1	0	0	6	6
peptidyl-prolyl cis-trans isomerase NIMA-interacting 1	42	0	0	42
Pancreatic triacylglycerol lipase	0	8	0	9
Rap guanine nucleotide exchange factor 4	20	0	0	20
HSP40, subfamily A [Plasmodium falciparum 3D7]	0	0	0	2
hypoxia-inducible factor 1 alpha subunit	63	0	0	63
D(4) dopamine receptor	0	25	2	27
parathyroid hormone/parathyroid hormone-related peptide receptor precursor	34	0	0	34
muscleblind-like protein 1 isoform 1	35	0	0	35
Chain A, CARBONIC ANHYDRASE II	0	0	1	1
Chain A, CARBONIC ANHYDRASE II	0	0	1	1
Chain A, CARBONIC ANHYDRASE II	0	0	1	1
Chain A, Carbonic Anhydrase Ii	0	0	1	1
Chain A, Carbonic Anhydrase Ii	0	0	1	1
Chain A, Beta-lactamase	67	0	0	67
Chain A, Endochitinase	0	1	0	1
Chain A, Endochitinase	0	1	0	1
Chain A, Endochitinase	0	1	0	1
Chain A, Class Iii Chitinase Chia1	0	1	0	1
Chain A, Carbonic anhydrase 13	0	1	0	1
Chain A, Carbonic anhydrase II	0	1	0	1
Chain A, Carbonic anhydrase 2	0	1	0	1
Chain A, Carbonic anhydrase 2	0	1	0	1
Chain A, Carbonic anhydrase 2	0	1	0	1
Chain A, Carbonic anhydrase 2	0	1	0	1
Chain A, Carbonic anhydrase 2	0	1	0	1
Chain A, Carbonic anhydrase 2	0	1	0	1
Chain A, Carbonic anhydrase 2	0	1	0	1
Chain A, Carbonic anhydrase 2	0	1	0	1
Chain A, Carbonic anhydrase 2	0	1	0	1
Chain A, Carbonic anhydrase	0	1	0	1
Chain B, Carbonic anhydrase	0	1	0	1
Chain A, Carbonic anhydrase 2	0	1	0	1
Carbonic anhydrase	0	0	0	6
Carbonic anhydrase	0	10	0	10
GALC protein	28	0	0	28
Carbonic anhydrase	0	7	0	7
Carbonic anhydrase	0	8	0	8
Carbonic anhydrase	0	8	0	8
Carbonic anhydrase	0	5	0	5
Solute carrier family 22 member 6	0	12	0	13
Carbonic anhydrase 12	0	23	2	38
Prolyl endopeptidase	0	4	0	4
Carbonic anhydrase-related protein 11	0	1	0	3
Glycogen phosphorylase, muscle form	0	4	0	4
Carbonic anhydrase 1	0	53	2	74
Carbonic anhydrase 2	0	60	6	86
Carbonic anhydrase 2	0	3	0	3
Cytochrome P450 1A2	0	23	1	27
Carbonic anhydrase 3	0	20	2	31
Cathepsin B	0	2	0	2
Cytochrome P450 3A4	0	77	2	92
Steryl-sulfatase	0	4	0	5
Polyunsaturated fatty acid 5-lipoxygenase	0	12	0	13
Cytochrome P450 2C8	0	16	0	17
Cytochrome P450 2D6	0	50	1	55
Cytochrome P450 2A6	0	9	1	10
Cytochrome P450 2C9	0	68	2	73
Translocator protein	0	7	2	10
Cannabinoid receptor 1	0	9	2	11
Arachidonate 5-lipoxygenase-activating protein	0	3	0	3
Cytochrome P450 2B6	0	7	2	12
Carbonic anhydrase 4	0	38	2	52
Carbonic anhydrase 6	0	25	2	39
Carbonic anhydrase 5A, mitochondrial	0	3	0	3
Serum paraoxonase/arylesterase 1	0	4	0	4
Dipeptidyl peptidase 4	0	10	1	13
Endochitinase	0	1	0	1
Delta-type opioid receptor	0	21	3	31
Cytochrome P450 2C19	0	36	0	39
Delta-type opioid receptor	0	22	4	27
Mu-type opioid receptor	0	23	6	32
Carbonic anhydrase 5A, mitochondrial	0	26	4	43
Carbonic anhydrase	0	18	0	23
Kappa-type opioid receptor	0	17	3	21
Carbonic anhydrase 7	0	24	2	38
Carbonic anhydrase	0	1	0	1
Corticosteroid 11-beta-dehydrogenase isozyme 1	0	1	0	1
Carbonic anhydrase	0	6	0	12
Cholinesterase	0	12	0	13
Carbonic anhydrase	0	5	0	5
Fatty-acid amide hydrolase 1	1	5	0	6
Beta-carbonic anhydrase 1	0	9	0	9
Carbonic anhydrase 2	0	8	0	8
Squalene synthase	0	4	0	4
Neuronal acetylcholine receptor subunit alpha-7	0	7	3	11
Carbonic anhydrase 9	0	29	3	47
Carbonic anhydrase	0	2	0	2
Carbonic anhydrase, alpha family	0	8	0	8
Carbonic anhydrase	0	6	0	12
Carbonic anhydrase 3	0	5	0	5
Carbonic anhydrase	0	6	0	13
Carbonic anhydrase	0	6	0	13
Carbonic anhydrase	0	7	0	7
Sigma intracellular receptor 2	0	16	0	16
Delta carbonic anhydrase	0	7	0	7
Sigma non-opioid intracellular receptor 1	0	15	3	18
Renin	0	1	0	1
Carbonic anhydrase	0	6	0	12
Endochitinase A1	0	1	0	1
Multidrug resistance-associated protein 1	0	1	0	1
Carbonic anhydrase 13	0	11	2	15
Carbonic anhydrase 4	0	10	0	13
Carbonic anhydrase 15	0	19	0	25
Acidic mammalian chitinase	0	1	0	1
Carbonic anhydrase 13	0	14	0	25
Carbonic anhydrase 7	0	1	0	1
Carbonic anhydrase	0	4	0	4
Carbonic anhydrase 14	0	19	2	34
Carbonic anhydrase	0	1	0	1
Carbonic anhydrase 2, isoform A	0	1	0	1
Carbonic anhydrase 5B, mitochondrial	0	23	2	38
Free fatty acid receptor 3	0	0	2	2
Free fatty acid receptor 2	0	1	1	2
Tyrosine-protein kinase Lck	0	6	7	13
Tyrosine-protein kinase Fyn	0	13	6	19
Fibrinogen C domain-containing protein 1	0	1	0	1
Chain A, ATP-DEPENDENT DNA HELICASE Q1	29	0	0	29
heat shock protein beta-1	64	0	0	64
Histone deacetylase 3	0	13	1	17
Histone deacetylase 4	0	11	1	15
Histone deacetylase 1	0	17	2	22
Histone deacetylase 7	0	11	2	16
Histone deacetylase 2	0	16	2	21
Polyamine deacetylase HDAC10	0	9	1	13
Histone deacetylase 11	0	10	1	14
Histone deacetylase 8	0	14	3	20
Histone deacetylase 6	0	15	2	20
Histone deacetylase 9	0	10	1	14
Histone deacetylase 5	0	11	1	15
Putative glycosyltransferase WbgO	0	0	0	1
Killer cell lectin-like receptor subfamily B member 1A	0	1	0	1
Early activation antigen CD69	0	1	0	1
Transient receptor potential cation channel subfamily A member 1	0	1	7	11
Chain E, Purine nucleoside phosphorylase	0	1	0	1
Thymidine kinase	0	1	0	1
hemoglobin subunit beta	7	0	0	7
ubiquitin carboxyl-terminal hydrolase 2 isoform a	30	0	0	30
Solute carrier family 22 member 1	0	47	0	60
Bile salt export pump	0	38	0	38
Purine nucleoside phosphorylase	0	5	0	6
Thymidine kinase, cytosolic	0	3	0	6
POU domain, class 2, transcription factor 2	0	0	0	1
Cytochrome P450 2J2	0	32	0	33
Disintegrin and metalloproteinase domain-containing protein 17	25	2	0	27
Purine nucleoside phosphorylase	0	0	2	2
Solute carrier family 22 member 6	0	7	0	12
Thymidine kinase	0	1	0	1
Solute carrier family 22 member 8	0	8	0	14
Thymidine kinase	0	2	0	2
Chain A, MTA/SAH nucleosidase	0	1	0	1
Chain A, Ribosome-inactivating protein alpha-trichosanthin	0	0	1	1
Chain A, Ricin A chain	0	0	1	1
Chain A, Ribosome-inactivating protein 3	0	0	1	1
Chain A, Phenylethanolamine N-methyltransferase	0	0	1	1
Chain A, Phenylethanolamine N-methyltransferase	0	0	1	1
Chain A, Phenylethanolamine N-methyltransferase	0	0	1	1
Chain A, Phenylethanolamine N-methyltransferase	0	0	1	1
Chain A, Phenylethanolamine N-methyltransferase	0	0	1	1
Chain A, Phenylethanolamine N-methyltransferase	0	0	1	1
Chain A, Phenylethanolamine N-methyltransferase	0	0	1	1
Chain A, Phenylethanolamine N-methyltransferase	0	0	1	1
Chain A, Phenylethanolamine N-methyltransferase	0	0	1	1
Chain A, Phenylethanolamine N-methyltransferase	0	0	1	1
Chain A, Phenylethanolamine N-methyltransferase	0	0	1	1
Chain A, Phenylethanolamine N-methyltransferase	0	0	1	1
Chain A, Phenylethanolamine N-methyltransferase	0	0	1	1
importin subunit beta-1 isoform 1	32	0	0	32
snurportin-1	32	0	0	32
tumor susceptibility gene 101 protein	4	0	0	4
GTP-binding nuclear protein Ran isoform 1	17	0	0	17
Cyclin-dependent kinase 1	0	7	5	12
Heat shock protein HSP 90-beta	0	2	0	2
Xanthine dehydrogenase/oxidase	0	16	0	17
Protein mono-ADP-ribosyltransferase PARP15	0	3	0	3
Leucine-rich repeat serine/threonine-protein kinase 2	0	2	1	3
ATPase family AAA domain-containing protein 5	73	0	0	73
Chain A, Membrane lipoprotein tmpC	0	0	2	2
Chain A, Membrane lipoprotein tmpC	0	0	2	2
Chain A, Membrane lipoprotein tmpC	0	0	2	2
Chain A, Structure of PAE2307 in complex with adenosine	0	0	1	1
Chain B, Structure of PAE2307 in complex with adenosine	0	0	1	1
Chain A, ADENOSINE RECEPTOR A2A	0	2	0	2
Chain A, ADENOSINE RECEPTOR A2A	0	2	0	2
Chain A, tRNA (guanine-N(1)-)-methyltransferase	0	0	1	1
Chain A, Uncharacterized protein MJ0883	0	0	1	1
signal transducer and activator of transcription 6, interleukin-4 induced	2	0	0	2
NPYLR7B	0	0	4	4
nuclear receptor ROR-gamma isoform 1	80	0	0	80
high affinity choline transporter 1 isoform a	0	3	0	3
Sodium/nucleoside cotransporter 1	0	2	0	2
Calcium dependent protein kinase	0	1	0	1
Mitogen-activated protein kinase kinase kinase 7	0	0	3	3
Sodium/nucleoside cotransporter 2	0	2	0	2
Epidermal growth factor receptor	0	22	5	27
Phosphoglycerate kinase 1	0	1	0	1
Adenosine deaminase	0	0	0	1
Avidin	0	0	1	1
Adenosine deaminase	0	0	0	1
Glyceraldehyde-3-phosphate dehydrogenase	0	3	0	3
Receptor tyrosine-protein kinase erbB-2	0	7	1	8
Insulin receptor	0	1	5	7
Phosphoglycerate kinase 2	0	1	0	1
Heat shock protein HSP 90-alpha	0	4	4	8
Platelet-derived growth factor receptor beta	0	0	5	6
Heat shock 70 kDa protein 1A	0	1	0	1
Heat shock cognate 71 kDa protein	0	0	1	1
Fibroblast growth factor receptor 1	0	0	5	6
Inosine-5'-monophosphate dehydrogenase 2	0	1	4	5
Endoplasmin	0	2	2	4
Inosine-5'-monophosphate dehydrogenase 1	0	1	0	1
Fibroblast growth factor receptor 2	0	0	1	2
Fibroblast growth factor receptor 4	0	0	1	2
Fibroblast growth factor receptor 3	0	0	1	2
Streptavidin	0	0	1	1
Adenosylhomocysteinase	0	1	0	5
Adenylate kinase 2, mitochondrial	0	2	0	3
Adenylate kinase isoenzyme 1	0	2	0	3
Phosphatidylinositol 4-kinase alpha	0	3	0	4
Adenosine kinase	0	0	5	6
Adenosine deaminase	0	0	0	1
Equilibrative nucleoside transporter 2	0	2	0	2
Phosphatidylinositol 4-kinase type 2-beta	0	3	0	4
Histone-lysine N-methyltransferase, H3 lysine-79 specific	0	1	0	1
Equilibrative nucleoside transporter 1	0	4	0	4
Phosphatidylinositol 4-kinase type 2-alpha	0	3	0	4
Solute carrier family 28 member 3	0	2	0	2
Adenosine kinase	0	1	0	2
Phosphatidylinositol 4-kinase beta	0	3	1	5
5-methylthioadenosine/S-adenosylhomocysteine deaminase	0	0	0	1
Adenosine transporter 1	0	1	0	2
Transient receptor potential cation channel subfamily M member 2	0	2	1	3
Chain A, Glycogen Phosphorylase B	0	0	1	1
Chain B, Glycogen Phosphorylase B	0	0	1	1
Chain A, ADP-dependent glucokinase	0	1	0	1
Chain A, Ribonuclease pancreatic	0	1	0	1
Chain A, Ribonuclease pancreatic	0	1	0	1
Chain A, phosphodiesterase-nucleotide pyrophosphatase	0	1	0	1
Chain A, GLYCOGEN PHOSPHORYLASE B	0	0	1	1
Chain B, GLYCOGEN PHOSPHORYLASE B	0	0	1	1
Chain A, GLYCOGEN PHOSPHORYLASE B	0	0	1	1
2'-deoxynucleoside 5'-phosphate N-hydrolase 1	0	1	0	1
2'-deoxynucleoside 5'-phosphate N-hydrolase 1	0	1	0	1
5'-AMP-activated protein kinase subunit beta-2	0	0	1	1
Alcohol dehydrogenase E chain	0	2	0	2
Alcohol dehydrogenase S chain	0	2	0	2
L-lactate dehydrogenase A chain	0	3	1	4
Adenylate kinase isoenzyme 1	0	0	0	1
Fructose-1,6-bisphosphatase 1	0	1	0	1
Alkaline phosphatase, tissue-nonspecific isozyme	0	3	0	4
Fructose-1,6-bisphosphatase 1	0	3	0	3
2-dehydropantoate 2-reductase	0	1	1	2
Inosine-5'-monophosphate dehydrogenase	0	1	0	1
Proto-oncogene tyrosine-protein kinase Src	0	3	5	8
Amine oxidase [flavin-containing] B	0	12	0	13
5'-nucleotidase	0	0	0	1
Choline O-acetyltransferase	0	2	0	2
GTP:AMP phosphotransferase AK3, mitochondrial	0	0	0	1
P2Y purinoceptor 2	0	1	2	3
P2Y purinoceptor 1	0	0	1	1
P2Y purinoceptor 1	0	0	2	2
5'-AMP-activated protein kinase subunit gamma-1	0	0	7	7
5'-AMP-activated protein kinase catalytic subunit alpha-2	0	0	2	2
Adenylate kinase 2, mitochondrial	0	0	5	6
Glycine--tRNA ligase	0	1	0	1
5'-AMP-activated protein kinase catalytic subunit alpha-1	0	0	7	7
Adenosine deaminase-like protein	0	0	0	1
Protease	0	13	6	31
P2Y purinoceptor 11	0	1	2	3
5'-AMP-activated protein kinase subunit gamma-3	0	0	1	1
5'-AMP-activated protein kinase subunit gamma-2	0	0	6	6
5'-AMP-activated protein kinase subunit beta-1	0	0	2	2
Chain A, Endoplasmin	0	0	1	1
vasopressin V1b receptor	2	0	0	2
thyrotropin-releasing hormone receptor	1	0	0	1
relaxin receptor 1 isoform 1	3	0	0	3
relaxin receptor 2 isoform 1	2	0	0	2
Transmembrane domain-containing protein TMIGD3	0	1	0	1
Thyroid hormone receptor beta	0	5	0	5
Alpha-2B adrenergic receptor	0	43	11	54
Alpha-2C adrenergic receptor	0	41	11	52
Alpha-2A adrenergic receptor	0	42	11	53
Adenosine receptor A1	0	3	0	3
Alpha-1A adrenergic receptor	0	37	13	59
Aflatoxin B1 aldehyde reductase member 3	0	1	0	1
Endoplasmin	0	0	1	1
Adenosine receptor A1	0	2	0	2
Adenylate cyclase type 5	0	5	0	5
Endoplasmin	0	0	1	1
Adenosine receptor A1	0	2	0	2
Adenosine receptor A3	0	1	1	2
2-oxoglutarate receptor 1	0	1	0	1
Alanine racemase, biosynthetic	0	0	0	1
5-hydroxytryptamine receptor 1D	0	7	0	11
Adenosine deaminase	0	0	0	1
Mineralocorticoid receptor	0	9	5	15
Mineralocorticoid receptor	0	5	0	5
Solute carrier organic anion transporter family member 1A1	0	5	0	10
lysosomal alpha-glucosidase preproprotein	25	0	0	25
Alpha-1A adrenergic receptor	0	6	4	10
Neuronal acetylcholine receptor subunit alpha-4	12	10	3	26
Neuronal acetylcholine receptor subunit beta-2	12	10	3	26
Potassium voltage-gated channel subfamily E member 1	0	9	0	9
Alpha-1A adrenergic receptor	0	8	2	10
Acetylcholinesterase	0	31	1	34
Alpha-1D adrenergic receptor	0	87	8	102
Potassium voltage-gated channel subfamily KQT member 1	0	9	0	9
Sodium channel protein type 5 subunit alpha	0	27	0	27
Potassium voltage-gated channel subfamily D member 3	0	6	0	6
RGS12	6	0	0	6
Transient receptor potential cation channel subfamily V member 1	0	5	2	7
Procathepsin L	0	8	10	18
Cathepsin B	0	7	0	7
Transient receptor potential cation channel subfamily A member 1	0	0	7	7
Transient receptor potential cation channel subfamily V member 1	0	2	1	5
Cysteine protease	0	2	0	2
Mitochondrial 2-oxodicarboxylate carrier	0	1	0	1
interleukin 8	36	0	0	36
Hypoxanthine-guanine phosphoribosyltransferase	0	1	0	3
Xanthine dehydrogenase/oxidase [Includes: Xanthine dehydrogenase	0	2	0	2
Nuclear receptor ROR-gamma	0	2	0	2
Xanthine dehydrogenase/oxidase	0	12	1	15
Shiga toxin subunit A	0	2	0	2
Histamine H3 receptor	0	3	0	5
Chain A, Xcogt	0	0	1	1
Chain A, Xcogt	0	0	1	1
Chain A, Xcogt	0	0	1	1
Botulinum neurotoxin type A	0	2	0	2
Neutrophil cytosol factor 1	0	2	0	2
Nitric oxide synthase, endothelial	0	7	0	7
Nitric oxide synthase, brain	0	11	1	13
Nitric oxide synthase, brain	0	7	0	9
Nitric oxide synthase, inducible	0	7	1	11
Tyrosine-protein kinase	0	0	1	1
Melanocortin receptor 4	0	11	3	14
Melanocortin receptor 5	0	15	2	17
Melanocortin receptor 3	0	0	2	2
Melanocortin receptor 5	0	0	2	2
Melanocortin receptor 3	0	11	3	14
Melanocortin receptor 4	0	0	2	2
Melanocyte-stimulating hormone receptor	0	5	3	8
Melanocyte-stimulating hormone receptor	0	0	2	2
Adrenocorticotropic hormone receptor	0	0	1	1
Bromodomain-containing protein 4	0	1	1	2
Gamma-aminobutyric acid receptor subunit alpha-1	0	17	5	22
Gamma-aminobutyric acid receptor subunit gamma-2	0	16	4	20
Cholecystokinin receptor type A	1	6	0	7
Gamma-aminobutyric acid receptor subunit alpha-5	0	15	5	20
Gamma-aminobutyric acid receptor subunit alpha-3	0	15	4	19
Gamma-aminobutyric acid receptor subunit alpha-2	0	15	5	20
Gamma-aminobutyric acid receptor subunit beta-2	0	14	4	18
Cholecystokinin receptor type A	0	5	0	5
Thromboxane-A synthase	0	13	0	13
Prostaglandin E2 receptor EP3 subtype	0	3	0	3
Prostaglandin E2 receptor EP4 subtype	0	3	1	4
Prostaglandin E2 receptor EP1 subtype	0	3	0	3
Prostacyclin receptor	0	4	2	6
Nuclear receptor subfamily 4 group A member 2	0	0	4	4
Nuclear receptor subfamily 4 group A member 2	0	0	1	1
Nuclear receptor subfamily 4 group A member 2	0	0	1	1
Prostaglandin E2 receptor EP2 subtype	0	3	1	4
Solute carrier organic anion transporter family member 2A1	0	1	0	5
Solute carrier organic anion transporter family member 2B1	0	2	0	2
Solute carrier organic anion transporter family member 3A1	0	0	0	1
Plasma kallikrein	0	1	0	7
Carbonic anhydrase-like protein, putative	0	0	0	7
Gamma-aminobutyric acid receptor subunit rho-1	0	1	2	4
Glutamate receptor 1	0	1	0	1
Glutamate receptor 2	0	1	0	1
Glutamate receptor 3	0	1	0	1
Glutamate receptor ionotropic, kainate 3	1	2	0	3
Solute carrier family 15 member 1	0	8	0	8
Glutamate receptor 4	0	1	0	1
Solute carrier family 15 member 1	0	4	0	4
Solute carrier family 15 member 2	0	3	0	3
PPM1D protein	37	0	0	37
caspase 7, apoptosis-related cysteine protease	45	0	0	45
caspase-3	45	0	0	45
potassium voltage-gated channel subfamily H member 2 isoform d	91	0	0	91
Voltage-dependent L-type calcium channel subunit alpha-1C	0	12	0	12
Solute carrier organic anion transporter family member 1A4	0	4	0	10
Voltage-dependent L-type calcium channel subunit alpha-1F	0	26	0	26
5-hydroxytryptamine receptor 4	0	83	1	84
Lysine-specific demethylase PHF2	0	1	0	1
Thyroid hormone receptor alpha	0	2	0	2
ATP-dependent translocase ABCB1	0	18	0	18
Aldo-keto reductase family 1 member B1	0	84	0	84
Muscarinic acetylcholine receptor M2	0	59	6	72
Muscarinic acetylcholine receptor M4	0	54	4	63
ATP-dependent translocase ABCB1	0	67	9	99
Muscarinic acetylcholine receptor M5	0	56	3	63
Alpha-2A adrenergic receptor	0	103	10	117
Thyroid hormone receptor alpha	0	3	3	6
Thyroid hormone receptor beta	0	3	3	6
Muscarinic acetylcholine receptor M1	0	60	7	75
Beta-3 adrenergic receptor	0	22	9	31
Lethal factor	0	3	0	3
Alpha-2B adrenergic receptor	0	93	7	104
Muscarinic acetylcholine receptor M3	0	61	6	72
ATP-dependent translocase ABCB1	0	19	1	21
Substance-K receptor	0	32	0	32
D(1A) dopamine receptor	0	68	4	79
Carnitine O-palmitoyltransferase 2, mitochondrial	0	3	0	3
Histamine H2 receptor	0	48	4	53
Endothelin-1 receptor	0	11	1	13
Lysine-specific demethylase 5A	0	2	0	2
B2 bradykinin receptor	0	6	1	9
C-8 sterol isomerase	0	6	0	6
Mu-type opioid receptor	0	49	11	68
Sodium channel protein type 1 subunit alpha	0	11	0	11
Sodium channel protein type 4 subunit alpha	0	14	0	17
Squalene synthase	0	1	0	1
Delta-type opioid receptor	0	32	9	50
Kappa-type opioid receptor	0	41	8	58
C-C chemokine receptor type 2	0	8	0	8
Carnitine O-palmitoyltransferase 1, liver isoform	0	3	0	3
C-C chemokine receptor type 4	0	5	0	5
Sodium channel protein type 7 subunit alpha	0	9	0	9
Voltage-dependent L-type calcium channel subunit alpha-1D	0	26	0	26
Voltage-dependent L-type calcium channel subunit alpha-1S	0	26	0	26
Squalene monooxygenase	0	1	0	1
3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase	0	7	1	8
Sodium channel protein type 9 subunit alpha	0	15	0	15
Lysine-specific demethylase 7A	0	1	0	1
Carnitine O-palmitoyltransferase 1, muscle isoform	0	3	0	3
Sodium channel protein type 2 subunit alpha	0	12	0	12
Sigma non-opioid intracellular receptor 1	0	63	1	64
NAD-dependent protein deacetylase sirtuin-3, mitochondrial	0	1	2	3
Sodium channel protein type 3 subunit alpha	0	13	0	13
Sodium channel protein type 11 subunit alpha	0	9	0	9
Histone lysine demethylase PHF8	0	1	0	1
Sodium channel protein type 8 subunit alpha	0	9	0	9
Sodium channel protein type 10 subunit alpha	0	10	0	10
Albumin	0	0	13	13
High affinity nerve growth factor receptor	0	1	7	8
Muscarinic acetylcholine receptor M1	0	23	6	34
Muscarinic acetylcholine receptor M3	0	22	6	31
Muscarinic acetylcholine receptor M4	0	21	4	28
Muscarinic acetylcholine receptor M5	0	22	4	29
Muscarinic acetylcholine receptor M2	0	23	4	32
Angiotensin-converting enzyme	0	44	0	45
Alpha-2C adrenergic receptor	0	82	8	94
D(1B) dopamine receptor	0	14	0	18
UDP-glucuronosyltransferase 1A4	0	4	0	15
Histamine H1 receptor	0	16	1	17
Histamine H1 receptor	0	64	8	76
UDP-glucuronosyltransferase 1A3	0	0	0	5
5-hydroxytryptamine receptor 7	0	25	0	26
Voltage-dependent N-type calcium channel subunit alpha-1B	0	8	0	8
Nuclear receptor subfamily 3 group C member 3	0	37	0	37
Histamine H3 receptor	0	13	2	15
acid sphingomyelinase	13	0	0	13
NEDD8-activating enzyme E1 regulatory subunit isoform a	0	1	0	1
NEDD8-conjugating enzyme Ubc12	0	1	0	1
Voltage-dependent L-type calcium channel subunit alpha-1C	0	12	0	13
Potassium channel subfamily K member 2	0	2	0	2
Solute carrier family 22 member 3	0	5	0	6
Phenylethanolamine N-methyltransferase	0	3	0	4
Substance-P receptor	0	3	0	3
Cytochrome P450 2A5	0	3	0	3
Beta-2 adrenergic receptor	0	5	6	13
tumor necrosis factor	4	0	0	4
Nuclear receptor ROR-gamma	55	1	1	57
Aurora kinase B	0	5	6	11
Broad substrate specificity ATP-binding cassette transporter ABCG2	0	36	3	42
MPI protein	0	2	0	2
hypothetical protein, conserved	9	0	0	9
perilipin-5	0	5	0	5
perilipin-1	0	5	0	5
DNA polymerase eta isoform 1	19	0	0	19
1-acylglycerol-3-phosphate O-acyltransferase ABHD5 isoform a	0	5	0	5
caspase-1 isoform alpha precursor	10	0	0	10
Aurora kinase A	0	1	6	7
cAMP-specific 3',5'-cyclic phosphodiesterase 4A	0	19	1	21
Dual specificity protein kinase TTK	0	2	6	8
cAMP-specific 3',5'-cyclic phosphodiesterase 4C	0	13	0	13
Inner centromere protein	0	1	0	1
Caspase-7	24	0	0	24
caspase-3	24	0	0	24
nuclear factor NF-kappa-B p105 subunit isoform 1	10	0	1	11
neuropeptide S receptor isoform A	34	0	0	34
Beta-glucuronidase	0	2	0	2
Cholinesterase	0	19	0	19
Aromatase	0	20	0	23
Gastrin/cholecystokinin type B receptor	1	4	1	7
Testosterone 17-beta-dehydrogenase 3	0	7	0	7
Chain A, retinol dehydratase	0	1	0	1
Glucose-6-phosphate 1-dehydrogenase	0	7	0	7
G-protein coupled bile acid receptor 1	0	1	9	10
Atrial natriuretic peptide receptor 3	0	2	0	2
Type-1A angiotensin II receptor	0	6	3	9
Type-1 angiotensin II receptor	0	0	1	1
Type-1B angiotensin II receptor	0	8	0	8
Type-1 angiotensin II receptor	0	10	5	20
Type-2 angiotensin II receptor	0	9	0	9
Type-2 angiotensin II receptor	0	6	0	6
Apelin receptor	0	1	1	2
Chain A, (3R)-hydroxymyristoyl-acyl carrier protein dehydratase	0	2	0	2
Chain B, (3R)-hydroxymyristoyl-acyl carrier protein dehydratase	0	2	0	2
Chain A, (3R)-hydroxymyristoyl-acyl carrier protein dehydratase	0	2	0	2
Chain B, (3R)-hydroxymyristoyl-acyl carrier protein dehydratase	0	2	0	2
Chain A, (3R)-hydroxymyristoyl-acyl carrier protein dehydratase	0	2	0	2
Chain B, (3R)-hydroxymyristoyl-acyl carrier protein dehydratase	0	2	0	2
Chain A, Transthyretin	0	0	2	2
Chain A, Transthyretin	0	0	2	2
Chain A, Transthyretin	0	0	2	2
Chain A, Transthyretin	0	0	2	2
Chain B, Transthyretin	0	0	2	2
Chain A, Transthyretin	0	0	2	2
Chain B, Transthyretin	0	0	2	2
Chain A, Casein kinase II subunit alpha	0	1	0	1
Chain A, Casein kinase II subunit alpha	0	1	0	1
Chain A, Casein Kinase Ii Subunit Alpha	0	1	0	1
BRCA1	4	0	0	4
apical membrane antigen 1, AMA1	18	0	0	18
Neuraminidase	0	9	0	9
pyruvate kinase	10	0	0	10
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa)	22	0	0	22
Replicase polyprotein 1ab	0	10	11	21
histone deacetylase 9 isoform 3	18	0	0	18
guanine nucleotide-binding protein G(i) subunit alpha-1 isoform 1	5	0	0	5
pyruvate kinase PKM isoform b	7	0	0	7
Gamma-aminobutyric acid receptor subunit pi	0	13	0	13
Gamma-aminobutyric acid receptor subunit delta	0	13	0	13
Aldo-keto reductase family 1 member B10	0	6	0	6
G2/mitotic-specific cyclin-B2	0	3	0	3
Poly [ADP-ribose] polymerase tankyrase-1	0	2	0	2
Lysozyme C-1	0	1	0	1
Cationic trypsin	0	2	0	2
Transthyretin	0	4	6	14
Cytochrome P450 1A1	0	11	1	12
Amyloid-beta precursor protein	2	17	1	21
Myeloperoxidase	0	9	0	9
Beta-glucuronidase	0	1	0	1
Seed linoleate 13S-lipoxygenase-1	0	5	0	9
Neutrophil elastase	0	10	0	10
Ornithine decarboxylase	7	0	0	7
Replicase polyprotein 1a	0	5	10	15
Replicase polyprotein 1ab	0	5	10	15
Replicase polyprotein 1ab	0	19	12	31
Androgen receptor	0	27	9	47
Sialidase	0	4	0	4
Serine/threonine-protein kinase pim-1	0	4	7	12
Cystic fibrosis transmembrane conductance regulator	0	2	6	8
17-beta-hydroxysteroid dehydrogenase type 1	0	5	0	6
Pyruvate kinase PKM	0	4	0	4
G2/mitotic-specific cyclin-B1	0	6	0	6
Urease subunit alpha	0	8	0	8
Aldo-keto reductase family 1 member B1	0	12	0	12
G2/mitotic-specific cyclin-B	0	2	0	2
Mucin-1	0	1	0	1
Glycogen synthase kinase-3 beta	0	4	0	4
Gamma-aminobutyric acid receptor subunit beta-1	0	13	2	15
Casein kinase II subunit alpha'	0	5	5	10
Proteasome subunit beta type-5	0	11	0	13
Gamma-aminobutyric acid receptor subunit beta-3	0	16	3	19
Substance-P receptor	0	10	0	10
Multidrug resistance-associated protein 1	0	8	1	13
Prostaglandin G/H synthase 2	0	28	4	34
Receptor-type tyrosine-protein kinase FLT3	0	5	5	10
17-beta-hydroxysteroid dehydrogenase type 2	0	5	0	5
Peroxisome proliferator-activated receptor gamma	0	1	5	6
Homeobox protein Nkx-2.5	0	1	0	1
Tyrosine-protein kinase SYK	0	3	7	10
Gamma-aminobutyric acid receptor subunit alpha-4	0	13	2	15
Glycogen synthase kinase-3 alpha	0	3	5	8
Glycogen synthase kinase-3 beta	0	7	6	13
Estrogen receptor	0	0	2	2
Death-associated protein kinase 1	0	5	1	6
Mitogen-activated protein kinase 10	0	5	6	11
Beta-secretase 1	0	8	1	10
Casein kinase II subunit beta	0	5	0	5
Casein kinase II subunit alpha	0	6	1	7
Urease subunit beta	0	8	0	8
Gamma-aminobutyric acid receptor subunit epsilon	0	13	0	13
Lactoperoxidase	0	4	0	5
MO15-related protein kinase Pfmrk	0	5	0	5
Inositol monophosphatase 1	48	0	0	48
Cyclin-dependent kinase 6	0	2	5	7
Cyclin-dependent-like kinase 5	0	3	5	8
Cyclin homolog	0	2	0	2
Transcription factor GATA-4	0	1	0	1
Cyclin-dependent kinase 5 activator 1	0	2	0	2
Gamma-aminobutyric acid receptor subunit alpha-6	0	13	2	15
Mitogen-activated protein kinase 14	0	13	5	18
Substance-K receptor	0	6	0	6
Reverse transcriptase/RNaseH	0	8	1	15
Integrase	0	10	1	11
Gamma-aminobutyric acid receptor subunit gamma-1	0	13	0	13
Casein kinase II subunit alpha 3	0	5	0	5
Inositol polyphosphate multikinase	0	3	0	3
G2/mitotic-specific cyclin-B3	0	3	0	3
Enoyl-acyl-carrier protein reductase	0	6	0	6
NACHT, LRR and PYD domains-containing protein 3	0	3	0	3
Gamma-aminobutyric acid receptor subunit gamma-3	0	13	0	13
Myocilin	0	0	1	1
Cyclin-dependent kinase 1	0	2	0	2
Prenyltransferase homolog	0	0	0	5
Poly [ADP-ribose] polymerase tankyrase-2	0	3	0	3
MAP kinase-interacting serine/threonine-protein kinase 2	0	1	2	3
Carboxylic ester hydrolase	0	3	0	4
NADPH oxidase 4	0	2	0	2
Dipeptidyl peptidase 3	0	4	0	4
Estrogen receptor beta	0	0	2	2
Inositol hexakisphosphate kinase 2	0	3	0	3
Short transient receptor potential channel 5	0	2	0	2
Gamma-aminobutyric acid receptor subunit theta	0	13	0	13
Sialidase-2	0	4	0	4
2,3-bisphosphoglycerate-independent phosphoglycerate mutase	5	0	0	5
Tryptophan 5-hydroxylase 1	0	8	0	8
D(2) dopamine receptor	0	14	0	14
D(1B) dopamine receptor	0	22	0	22
E3 ubiquitin-protein ligase Mdm2	0	3	0	3
D	0	4	0	4
D	0	13	0	13
Chain A, ADIPOCYTE LIPID-BINDING PROTEIN	0	0	1	1
Chain A, SERUM ALBUMIN	0	0	1	1
Chain A, SERUM ALBUMIN	0	0	1	1
lethal(3)malignant brain tumor-like protein 1 isoform I	12	0	0	12
Fatty-acid amide hydrolase 1	0	5	0	5
Prostaglandin G/H synthase 1	0	10	0	12
Trypsin	0	3	0	4
Coagulation factor VII	0	5	0	5
60 kDa chaperonin	0	6	0	6
60 kDa heat shock protein, mitochondrial	0	8	0	8
Tissue factor	0	7	0	7
Fatty acid-binding protein, adipocyte	0	1	2	3
10 kDa heat shock protein, mitochondrial	0	8	0	8
Calmodulin	0	1	2	4
Prostaglandin G/H synthase 2	0	11	0	12
Fatty acid-binding protein 5	0	1	0	1
Fatty acid-binding protein 5	0	0	1	1
Thiosulfate sulfurtransferase	0	8	0	8
Lanosterol 14-alpha demethylase	0	11	1	12
60 kDa chaperonin	0	9	0	9
10 kDa chaperonin	0	9	0	9
Solute carrier organic anion transporter family member 1B3	0	25	0	32
Cytosolic phospholipase A2 gamma	0	2	0	2
Transient receptor potential cation channel subfamily V member 2	0	2	1	3
Solute carrier organic anion transporter family member 1B1	0	31	0	38
Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN	0	0	1	1
Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN	0	0	1	1
Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN	0	0	1	1
Nitric oxide synthase, endothelial	0	4	0	6
Nitric oxide synthase, inducible	0	8	0	9
Cationic amino acid transporter 3	0	2	0	2
mu-type opioid receptor isoform MOR-1	0	0	3	3
5-hydroxytryptamine receptor 2A	0	0	3	3
Solute carrier family 22 member 2	0	26	0	32
5-hydroxytryptamine receptor 3A	0	2	1	3
Histamine H1 receptor	0	7	5	13
3-hydroxy-3-methylglutaryl-coenzyme A reductase	0	10	0	10
Multidrug and toxin extrusion protein 2	0	18	0	18
Multidrug and toxin extrusion protein 1	0	34	0	34
Chain A, Hyaluronidase, phage associated	0	1	0	1
Pancreatic alpha-amylase	0	2	0	2
Albumin	0	2	1	4
Urease	0	5	0	6
Prolyl 4-hydroxylase subunit alpha-1	0	0	0	1
Tyrosinase	0	6	0	6
Hyaluronate lyase	0	1	0	1
Prolyl hydroxylase EGLN2	0	0	0	1
Egl nine homolog 1	0	0	0	1
Prolyl hydroxylase EGLN3	0	0	0	1
Hypoxia-inducible factor 1-alpha inhibitor	0	1	0	2
Solute carrier family 23 member 1	0	1	0	1
Metabotropic glutamate receptor 6	0	0	1	1
Excitatory amino acid transporter 4	0	1	0	1
Glutamate transporter homolog	0	0	1	1
N(4)-(beta-N-acetylglucosaminyl)-L-asparaginase	0	1	0	1
Excitatory amino acid transporter 1	0	1	0	1
Excitatory amino acid transporter 2	0	1	0	1
Excitatory amino acid transporter 3	0	1	0	1
Metabotropic glutamate receptor 1	0	0	1	1
Metabotropic glutamate receptor 2	0	0	1	1
Chain A, Phospholipase A2 isoform 3	0	0	1	1
GTP-binding protein (rab7)	0	0	2	2
ras protein, partial	0	0	2	2
Rac1 protein	0	0	2	2
cell division cycle 42 (GTP binding protein, 25kDa), partial	0	0	2	2
Prostaglandin-H2 D-isomerase	0	2	0	2
Prostaglandin G/H synthase 2	0	6	0	7
Fatty acid-binding protein, liver	0	9	1	10
Prostaglandin G/H synthase 1	0	14	2	17
Glutathione hydrolase 1 proenzyme	0	1	0	1
Prostaglandin G/H synthase 1	0	22	0	23
Urotensin-2 receptor	0	2	1	3
4-aminobutyrate aminotransferase, mitochondrial	0	1	0	1
Ras-related protein Rab-2A	0	0	2	2
Rho-associated protein kinase 2	0	4	0	4
Nicotinate phosphoribosyltransferase	0	3	0	3
Solute carrier family 22 member 20	0	5	0	5
Solute carrier family 22 member 6	0	5	0	5
Beta-1 adrenergic receptor	0	2	6	10
Beta-2 adrenergic receptor	0	22	11	34
Solute carrier organic anion transporter family member 2B1	0	10	0	13
3-hydroxy-3-methylglutaryl-coenzyme A reductase	0	8	0	8
Insulin receptor	0	6	0	6
Dipeptidyl peptidase 4	0	1	0	1
Endothelin receptor type B	2	6	0	8
Endothelin receptor type B	0	8	1	9
Endothelin-1 receptor	2	5	1	8
Endothelin receptor type B	0	1	0	1
Atrial natriuretic peptide receptor 1	0	1	1	2
Atrial natriuretic peptide receptor 1	0	0	1	1
cystic fibrosis transmembrane conductance regulator	0	3	0	3
DNA polymerase beta	28	0	0	28
short transient receptor potential channel 6 isoform 1	0	0	3	3
Muscarinic acetylcholine receptor M1	0	2	2	6
Muscarinic acetylcholine receptor M4	0	3	1	5
Muscarinic acetylcholine receptor	0	6	2	9
cGMP-specific 3',5'-cyclic phosphodiesterase	0	3	0	3
Thromboxane A2 receptor	0	2	1	7
Sodium/bile acid cotransporter	0	8	1	9
Leukotriene B4 receptor 2	1	1	2	5
DNA (cytosine-5)-methyltransferase 1	0	4	0	4
Histone-lysine N-methyltransferase EHMT2	0	3	0	3
P53	4	0	0	4
Protein-arginine deiminase type-4	0	6	0	6
Gamma-aminobutyric acid type B receptor subunit 2	0	2	2	4
Gamma-aminobutyric acid type B receptor subunit 2	0	3	0	3
Gamma-aminobutyric acid type B receptor subunit 1	0	2	2	4
Gamma-aminobutyric acid type B receptor subunit 1	0	2	0	2
Chain A, RNA-directed RNA polymerase NS5	0	2	0	2
WRN	5	0	0	5
Lysine-specific demethylase 4E	0	4	0	4
dual specificity tyrosine-phosphorylation-regulated kinase 1A	0	0	0	3
Lysine-specific histone demethylase 1A	0	15	0	16
Progesterone receptor	0	15	6	22
Trypsin-1	0	2	0	2
Trypsin-2	0	2	0	2
Tyrosine-protein kinase Yes	0	2	5	7
Lysosomal alpha-glucosidase	0	2	0	2
Polyunsaturated fatty acid 5-lipoxygenase	0	5	0	6
Sucrase-isomaltase, intestinal	0	2	0	2
Cytochrome P450 11B1, mitochondrial	0	2	0	2
Polyunsaturated fatty acid lipoxygenase ALOX15	0	5	0	6
Cyclic AMP-responsive element-binding protein 1	0	0	0	1
Polyunsaturated fatty acid lipoxygenase ALOX12	0	4	0	5
Glutamate receptor 1	5	1	2	10
Glutamate receptor 3	5	1	2	10
Glutamate receptor 4	5	1	2	10
UDP-glucuronosyltransferase 1A1	0	14	0	18
Sucrase-isomaltase, intestinal	0	4	0	4
Sodium- and chloride-dependent GABA transporter 1	0	6	0	6
Sodium- and chloride-dependent GABA transporter 2	0	6	0	6
Sodium- and chloride-dependent GABA transporter 3	0	6	0	6
Trypsin-3	0	2	0	2
Prostaglandin G/H synthase 2	0	7	0	7
Linoleate 9S-lipoxygenase-4	0	1	0	1
G protein-coupled receptor kinase 6	0	1	4	5
1-deoxy-D-xylulose 5-phosphate reductoisomerase	0	2	0	2
Sodium- and chloride-dependent betaine transporter	0	6	0	6
Prolyl endopeptidase	0	5	0	5
Serine/threonine-protein kinase PLK1	0	2	5	7
Lactoylglutathione lyase	0	7	0	7
Receptor-type tyrosine-protein phosphatase S	0	1	0	1
Prostaglandin G/H synthase 1	0	7	0	7
Polyunsaturated fatty acid lipoxygenase ALOX15B	0	1	0	1
Serine/threonine-protein kinase PLK3	0	1	1	2
G-protein coupled receptor 35	0	7	5	12
Serine/threonine-protein kinase PLK2	0	1	1	2
Chain A, cGMP-specific 3',5'-cyclic phosphodiesterase	0	2	0	2
Chain A, cGMP-specific 3',5'-cyclic phosphodiesterase	0	2	0	2
Guanylate cyclase soluble subunit alpha-1	0	0	0	1
Voltage-dependent L-type calcium channel subunit alpha-1D	0	8	0	9
Voltage-dependent L-type calcium channel subunit alpha-1S	0	7	0	8
Zinc finger protein mex-5	0	0	1	1
POsterior Segregation	0	0	5	5
Genome polyprotein	0	1	0	1
Hexokinase-2	0	1	0	1
Chain A, Integrase	0	1	0	1
Chain A, Integrase	0	1	0	1
Chain A, T4 LYSOZYME	0	0	1	1
Chain A, GCN4P1	0	0	1	1
Chain B, GCN4P1	0	0	1	1
Chain C, GCN4P1	0	0	1	1
Chain A, T4 LYSOZYME	0	0	1	1
Chain A, T4 LYSOZYME	0	0	1	1
Chain A, Replicase polyprotein 1ab	0	1	0	1
Chain A, 3C-like proteinase	0	1	0	1
Endolysin	0	0	2	2
Spike glycoprotein	0	4	10	14
Transmembrane protease serine 2	0	4	10	14
Angiotensin-converting enzyme 2	0	7	10	17
Telomerase reverse transcriptase	0	2	0	2
Acetylcholinesterase	0	15	0	16
Neuraminidase	0	2	0	2
Neuraminidase	0	2	0	2
Tyrosine-protein phosphatase non-receptor type 1	0	8	0	8
Aldo-keto reductase family 1 member C3	0	5	0	5
Aldo-keto reductase family 1 member C2	0	4	0	4
Chain A, D-MALTODEXTRIN BINDING PROTEIN	0	0	1	1
Chain A, Limit Dextrinase	0	0	1	1
Chain A, Solute-binding protein	0	0	1	1
Chain A, Solute-binding protein	0	0	1	1
Chain B, SusD	0	0	1	1
Chain A, SusD	0	0	1	1
Chain A, SusD	0	0	1	1
Chain A, Alpha-hemolysin	0	0	1	1
Chain B, Alpha-hemolysin	0	0	1	1
Chain C, Alpha-hemolysin	0	0	1	1
Chain D, Alpha-hemolysin	0	0	1	1
Chain E, Alpha-hemolysin	0	0	1	1
Chain F, Alpha-hemolysin	0	0	1	1
Chain G, Alpha-hemolysin	0	0	1	1
galanin receptor type 3	0	2	0	2
ORF73	0	0	3	3
tyrosine-protein kinase Yes	5	0	0	5
Progesterone receptor	0	2	0	2
Glucocorticoid receptor	0	3	1	4
Androgen receptor	0	2	3	5
Progesterone receptor	0	2	0	2
ALK tyrosine kinase receptor	0	3	1	4
Caspase-7	9	0	0	9
Chain A, Protein kinase C, iota	0	1	0	1
3-phosphoinositide-dependent protein kinase 1	0	2	2	4
G1/S-specific cyclin-E2	0	1	0	1
cAMP-dependent protein kinase catalytic subunit alpha	0	3	0	3
Protein kinase C gamma type	0	3	0	3
Protein kinase C beta type	0	3	5	8
Cyclin-dependent kinase 4	0	3	5	8
Protein kinase C alpha type	0	5	6	11
cAMP-dependent protein kinase catalytic subunit alpha	0	6	5	11
Phosphorylase b kinase regulatory subunit alpha, skeletal muscle isoform	0	1	0	1
cAMP-dependent protein kinase catalytic subunit gamma	0	5	4	9
cAMP-dependent protein kinase catalytic subunit beta	0	5	5	10
G1/S-specific cyclin-D1	0	3	0	3
Protein kinase C eta type	0	3	1	4
G1/S-specific cyclin-E1	0	1	0	1
Cyclin-dependent kinase 2	0	5	7	12
cAMP-dependent protein kinase catalytic subunit alpha	0	2	0	2
Protein kinase C iota type	0	3	5	8
Protein kinase C epsilon type	0	4	1	5
Protein kinase C theta type	0	3	5	8
Protein kinase C zeta type	0	3	3	6
Protein kinase C delta type	0	3	5	8
Peroxisome proliferator-activated receptor alpha	1	3	6	10
NAD-dependent protein deacetylase sirtuin-2	0	3	1	4
NAD-dependent protein deacetylase sirtuin-1	0	3	1	6
Serine/threonine-protein kinase LMTK3	0	1	0	1
Beta-1 adrenergic receptor	0	4	1	5
Chain A, Estrogen-related receptor gamma	0	0	1	1
Chain A, Estrogen-related receptor gamma	0	0	1	1
Chain A, Estrogen-related receptor gamma	0	0	1	1
Chain A, Estrogen-related receptor gamma	0	0	1	1
GTPase KRas	0	0	1	1
Sarcoplasmic/endoplasmic reticulum calcium ATPase 1	0	9	0	9
Polyunsaturated fatty acid lipoxygenase ALOX15	0	24	0	24
Estrogen-related receptor gamma	0	2	1	3
GTP-binding protein Rheb	0	0	1	1
Myosin-2 heavy chain, non muscle	0	1	0	1
Myosin-2 heavy chain	0	1	0	1
Myosin IC heavy chain	0	1	0	1
Myosin-9	0	1	0	1
Myosin-10	0	1	4	5
Unconventional myosin-X	0	1	0	1
Myosin-7	0	1	0	1
Unconventional myosin-Ib	0	1	0	1
Myosin-4	0	1	0	1
Myosin-14	0	1	0	1
Nonmuscle myosin heavy chain	0	1	0	1
Unconventional myosin-Va	0	1	0	1
Myosin heavy chain, non-muscle	0	1	0	1
Unconventional myosin-XV	0	1	0	1
MSRA protein	0	1	0	1
Neuronal acetylcholine receptor subunit beta-2	0	6	1	8
Neuronal acetylcholine receptor subunit alpha-7	0	6	2	8
Neuronal acetylcholine receptor subunit alpha-4	0	5	1	7
Sclerostin	0	1	0	1
Chain H, Proteasome component PUP1	0	1	0	1
Chain I, Proteasome component PUP3	0	1	0	1
Chain K, Proteasome component PRE2	0	1	0	1
Chain L, Proteasome component C5	0	1	0	1
Chain K, Proteasome component PRE2	0	1	0	1
Chain L, Proteasome component C5	0	1	0	1
Proteasome subunit beta type-11	0	1	0	2
26S proteasome non-ATPase regulatory subunit 11	0	1	0	1
26S proteasome non-ATPase regulatory subunit 12	0	1	0	1
26S proteasome non-ATPase regulatory subunit 14	0	2	0	2
Proteasome subunit alpha type-7	0	1	0	2
26S proteasome non-ATPase regulatory subunit 3	0	1	0	1
Prothrombin	0	4	3	8
Chymotrypsinogen A	0	6	0	7
Cathepsin G	0	2	0	2
Lysosomal protective protein	0	1	0	1
Chymotrypsinogen B	0	2	0	2
26S proteasome regulatory subunit 6A	0	1	0	1
Nuclear factor NF-kappa-B p105 subunit	0	3	0	3
Proteasome subunit beta type-1	0	2	0	4
Chymase	0	1	0	1
Proteasome subunit alpha type-1	0	1	0	2
Proteasome subunit alpha type-2	0	1	0	2
Proteasome subunit alpha type-3	0	1	0	2
Proteasome subunit alpha type-4	0	1	0	2
Proteasome subunit beta type-8	0	1	0	2
Proteasome subunit beta type-8	0	1	0	1
Proteasome subunit beta type-9	0	1	0	2
Proteasome subunit alpha type-5	0	1	0	2
Proteasome subunit beta type-4	0	1	0	2
Proteasome subunit beta type-6	0	1	0	2
26S proteasome regulatory subunit 7	0	1	0	1
Lon protease homolog, mitochondrial	0	1	0	1
Proteasome subunit beta type-10	0	1	0	2
26S proteasome regulatory subunit 6B	0	1	5	6
26S proteasome non-ATPase regulatory subunit 8	0	1	0	1
Proteasome subunit beta type-3	0	1	0	2
Proteasome subunit beta type-2	0	2	0	4
26S proteasome non-ATPase regulatory subunit 7	0	1	0	1
26S proteasome non-ATPase regulatory subunit 4	0	1	0	1
26S proteasome complex subunit SEM1	0	1	0	1
Proteasome subunit alpha type-6	0	1	3	5
26S proteasome regulatory subunit 4	0	1	0	1
26S proteasome regulatory subunit 8	0	1	0	1
26S proteasome regulatory subunit 10B	0	1	0	1
Nuclear factor NF-kappa-B p100 subunit	0	3	0	3
Transcription factor p65	0	3	0	3
26S proteasome non-ATPase regulatory subunit 2	0	1	0	1
26S proteasome non-ATPase regulatory subunit 6	0	1	0	1
Proteasomal ubiquitin receptor ADRM1	0	1	0	1
ATP-dependent Clp protease proteolytic subunit	0	1	1	2
NACHT, LRR and PYD domains-containing protein 3	0	3	0	3
Proteasome subunit alpha-type 8	0	1	0	2
Proteasome subunit beta type-7	0	1	0	2
26S proteasome non-ATPase regulatory subunit 1	0	1	0	1
26S proteasome non-ATPase regulatory subunit 13	0	1	0	1
Nuclear receptor subfamily 1 group I member 2	0	1	14	15
Endothelin receptor type B	0	0	1	1
Deoxyhypusine synthase	0	1	0	1
Endothelin-1 receptor	0	3	0	3
Multidrug resistance-associated protein 6	0	0	0	1
Solute carrier organic anion transporter family member 1A5	0	0	0	5
Canalicular multispecific organic anion transporter 1	0	4	0	7
Solute carrier organic anion transporter family member 1B2	0	0	0	4
Angiotensin-converting enzyme	0	9	1	11
B2 bradykinin receptor	0	1	0	1
B1 bradykinin receptor	0	1	0	1
Olfactory receptor 51E2	0	1	4	5
Genome polyprotein	0	3	1	4
Nuclear hormone receptor family member daf-12	0	0	1	1
oxysterols receptor LXR-beta isoform 1	0	0	1	1
Thymidine phosphorylase	0	0	1	3
Thymidylate kinase	0	1	0	1
Thymidine kinase	0	0	0	1
Thymidylate kinase	0	1	0	1
Potassium channel subfamily K member 3	0	4	0	4
Potassium channel subfamily K member 3	0	1	0	1
Potassium channel subfamily K member 9	0	1	0	1
Acetylcholine receptor subunit alpha	0	3	1	4
Acetylcholine receptor subunit gamma	0	3	1	4
Integrin alpha-5	0	1	0	1
Acetylcholine receptor subunit beta	0	3	1	4
UDP-glucuronosyltransferase 2B7	0	6	0	12
UDP-glucuronosyltransferase 1-6	0	5	0	6
Neuronal acetylcholine receptor subunit beta-4	0	3	1	5
Neuronal acetylcholine receptor subunit alpha-3	0	3	1	4
UDP-glucuronosyltransferase 2B10	0	4	0	4
Acetylcholine receptor subunit delta	0	3	1	4
Beta-2 adrenergic receptor	0	9	1	11
Beta-1 adrenergic receptor	0	12	3	17
Beta-3 adrenergic receptor	0	6	1	7
Alpha-2A adrenergic receptor	0	3	0	3
5-hydroxytryptamine receptor 2A	0	2	0	2
Lysosomal alpha-glucosidase	0	2	0	2
Chain A, Nitrile Hydratase alpha subunit	0	1	0	1
Chain B, Nitrile Hydratase beta subunit	0	1	0	1
Methyl-accepting chemotaxis protein NahY	0	0	1	1
Chain A, Glycogen Phosphorylase	0	1	0	1
Chain A, Glycogen phosphorylase, liver form	0	0	2	2
Chain A, glycogen phosphorylase, liver form	0	0	2	2
Chain A, Glycogen phosphorylase, liver form	0	0	2	2
Chain A, Glycogen phosphorylase, liver form	0	0	2	2
Chain A, Chitinase	0	1	0	1
Glycogen phosphorylase, liver form	0	1	0	1
Glycogen phosphorylase, muscle form	0	1	0	1
Vasopressin V2 receptor	0	0	0	2
Serine/threonine-protein kinase mTOR	0	6	3	9
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform	0	3	1	4
DNA-dependent protein kinase catalytic subunit	0	3	0	3
Adenylate cyclase type 1	0	1	1	4
Chitotriosidase-1	0	4	1	5
Serine-protein kinase ATM	0	2	0	2
Serine/threonine-protein kinase ATR	0	2	2	4
Adenosine receptor A2b	0	1	0	3
Palmitoleoyl-protein carboxylesterase NOTUM	0	2	3	5
Endochitinase B1	0	4	1	5
Guanine deaminase	0	2	0	3
ClpP	12	0	0	12
electroneutral potassium-chloride cotransporter KCC2	0	0	1	1
TSHR protein	2	0	0	2
LacZ protein (plasmid)	0	0	2	2
XBP1	0	2	0	2
serine-protein kinase ATM isoform a	8	0	0	8
hexokinase-4 isoform 1	9	0	0	9
type-1 angiotensin II receptor	0	2	0	2
glucokinase regulatory protein	9	0	0	9
apelin receptor	0	3	0	3
heat shock protein HSP 90-alpha isoform 2	0	3	0	5
DNA damage-inducible transcript 3 protein	0	2	0	2
Vpr	10	0	0	10
streptokinase A precursor	0	0	9	9
heat shock protein 90, putative	0	0	0	2
Chain A, Vitamin D Nuclear Receptor	0	0	1	1
Vitamin D3 receptor	0	0	1	1
Vitamin D-binding protein	0	0	1	1
Vitamin D3 receptor	0	5	6	14
Vitamin D3 receptor	0	1	1	3
Retinoic acid receptor RXR-alpha	0	1	4	5
Vitamin D3 receptor	0	0	2	2
1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial	0	2	1	3
Vitamin D3 receptor	0	1	1	2
Transporter	0	9	0	9
Vitamin D3 receptor A	0	0	2	2
Calpain-9	0	1	0	1
Calpain-1 catalytic subunit	0	1	0	1
Cathepsin D	0	2	0	2
Calpain-1 catalytic subunit	0	2	0	2
Pro-cathepsin H	0	1	0	1
Calpain-2 catalytic subunit	0	2	0	2
Calpain-1 catalytic subunit	0	2	0	2
Vascular endothelial growth factor receptor 2	0	6	1	7
Falcipain 2B	0	1	0	1
Cysteine proteinase falcipain 2a	0	2	0	2
Sodium/glucose cotransporter 1	0	1	2	3
Sodium/glucose cotransporter 2	0	2	2	4
Liver carboxylesterase 1	0	1	0	5
transient receptor potential cation channel subfamily V member 1	5	0	0	5
NADH-ubiquinone oxidoreductase chain 1	0	1	0	1
Cannabinoid receptor 1	0	9	1	11
Cannabinoid receptor 2	0	7	2	10
Corticotropin-releasing factor receptor 2	0	1	0	1
Transient receptor potential cation channel subfamily V member 4	0	1	1	2
Chain A, angiotensin converting enzyme	0	1	0	1
Chain A, angiotensin converting enzyme	0	1	0	1
Metallo-beta-lactamase type 2	0	1	1	3
Neprilysin	0	1	0	1
Neprilysin	0	2	0	2
Leukotriene A-4 hydrolase	0	5	1	6
EEF1AKMT4-ECE2 readthrough transcript protein	0	1	0	1
Leukotriene A-4 hydrolase	0	1	0	1
Endothelin-converting enzyme 1	0	1	0	1
Succinyl-diaminopimelate desuccinylase	0	4	0	4
Angiotensin-converting enzyme	0	5	1	6
Beta-lactamase TEM	0	1	0	1
Beta-lactamase	0	2	0	3
Beta-lactamase	0	2	0	2
Beta-lactamase class B VIM-2	0	1	1	3
thyrotropin-releasing hormone receptor	13	0	0	13
Neuronal acetylcholine receptor subunit alpha-3	0	4	2	7
Neuronal acetylcholine receptor subunit alpha-2	0	4	2	7
Neuronal acetylcholine receptor subunit beta-3	0	4	2	7
Neuronal acetylcholine receptor subunit beta-4	0	4	2	7
Neuronal acetylcholine receptor subunit alpha-5	0	4	2	7
Neuronal acetylcholine receptor subunit alpha-6	0	4	2	7
Neuronal acetylcholine receptor subunit alpha-9	0	4	2	7
Muscarinic acetylcholine receptor M3	0	1	2	6
Muscarinic acetylcholine receptor M2	0	1	1	6
Neuronal acetylcholine receptor subunit alpha-10	0	4	2	7
Major prion protein	0	0	5	5
Sodium channel protein type 1 subunit alpha	0	5	0	5
Sodium channel protein type 2 subunit alpha	0	7	0	7
Sodium channel protein type 3 subunit alpha	0	4	0	4
Frizzled-8	0	0	1	1
P2X purinoceptor 4	0	3	0	3
Chain A, serum paraoxonase	0	1	0	1
Solute carrier family 22 member 5	0	0	0	2
Solute carrier family 22 member 5	0	0	0	1
Solute carrier family 22 member 16	0	0	0	1
Solute carrier family 22 member 21	0	0	0	1
Solute carrier family 22 member 5	0	0	0	2
Toll-like receptor 4	0	2	0	2
Potassium channel subfamily K member 10	0	1	0	1
Arginase	0	3	0	3
Dihydroorotate dehydrogenase	0	3	0	3
Solute carrier family 22 member 11	0	4	0	9
Solute carrier family 22 member 8	0	4	0	5
Beta-lactamase	0	1	0	1
Beta-lactamase	0	0	0	1
Beta-lactamase	0	0	0	1
Beta-lactamase	0	1	0	1
Metallo-beta-lactamase VIM-11	0	0	0	1
Metallo-beta-lactamase VIM-2	0	0	0	1
Metallo-beta-lactamase VIM-19	0	0	0	1
Metallo-beta-lactamase	0	0	0	1
Beta-lactamase	0	1	0	1
Solute carrier family 22 member 8	0	1	0	1
Beta-lactamase	0	0	0	1
Beta-lactamase	0	0	0	1
Beta-lactamase	0	0	0	1
Beta-lactamase	0	0	0	1
Metallo-beta-lactamase VIM-2	0	0	0	1
Beta-lactamase	0	0	0	1
Metallo-beta-lactamase	0	0	0	1
Beta-lactamase	0	0	0	1
Metallo-b-lactamase	0	0	0	1
BlaVIM-1	0	0	0	1
Beta-lactamase	0	0	0	1
Carbapenem-hydrolyzing beta-lactamase KPC	0	0	0	1
Chain A, Carbonic anhydrase II	0	1	0	1
interferon gamma precursor	0	0	0	5
prostaglandin E2 receptor EP2 subtype	1	0	0	4
Prostaglandin E synthase	0	4	0	4
Cytochrome c oxidase subunit 1	0	1	0	1
Cytochrome c oxidase subunit 2	0	1	0	1
Catechol O-methyltransferase	0	1	0	1
Cytochrome c oxidase subunit 2	0	3	0	3
Quinolone resistance protein NorA	0	4	0	5
Prostaglandin G/H synthase 1	0	2	0	2
Cruzipain	0	5	0	5
Sodium/hydrogen exchanger 1	0	1	0	1
Indoleamine 2,3-dioxygenase 1	0	5	0	5
Bifunctional epoxide hydrolase 2	0	5	0	5
Prostaglandin G/H synthase 2	0	3	0	4
Prostaglandin G/H synthase 1	0	1	0	1
Cyclooxygenase-2	0	2	0	2
P2Y purinoceptor 12	0	3	1	4
Gonadotropin-releasing hormone receptor	0	2	1	3
Caspase-2	0	0	2	2
Retinoic acid receptor RXR-alpha	0	1	1	2
Ileal sodium/bile acid cotransporter	0	2	0	2
Bile acid receptor	0	0	1	1
Bile acid receptor	0	3	4	7
Dihydroxyacetone phosphate acyltransferase	0	0	0	2
30S ribosomal protein S6	0	3	1	4
30S ribosomal protein S7	0	3	1	4
50S ribosomal protein L15	0	3	1	4
50S ribosomal protein L10	0	3	1	4
50S ribosomal protein L11	0	3	1	4
50S ribosomal protein L7/L12	0	3	1	4
50S ribosomal protein L19	0	3	1	4
50S ribosomal protein L1	0	3	1	4
50S ribosomal protein L20	0	3	1	4
50S ribosomal protein L27	0	3	1	4
50S ribosomal protein L28	0	3	1	4
50S ribosomal protein L29	0	3	1	4
50S ribosomal protein L31	0	3	1	4
50S ribosomal protein L31 type B	0	3	1	4
50S ribosomal protein L32	0	3	1	4
50S ribosomal protein L33	0	3	1	4
50S ribosomal protein L34	0	3	1	4
50S ribosomal protein L35	0	3	1	4
50S ribosomal protein L36	0	3	1	4
30S ribosomal protein S10	0	3	1	4
30S ribosomal protein S11	0	3	1	4
30S ribosomal protein S12	0	3	1	4
30S ribosomal protein S13	0	3	1	4
30S ribosomal protein S16	0	3	1	4
30S ribosomal protein S18	0	3	1	4
30S ribosomal protein S19	0	3	1	4
30S ribosomal protein S20	0	3	1	4
30S ribosomal protein S2	0	3	1	4
30S ribosomal protein S3	0	3	1	4
30S ribosomal protein S4	0	3	1	4
30S ribosomal protein S5	0	3	1	4
30S ribosomal protein S8	0	3	1	4
30S ribosomal protein S9	0	3	1	4
50S ribosomal protein L13	0	3	1	4
50S ribosomal protein L14	0	3	1	4
50S ribosomal protein L16	0	3	1	4
50S ribosomal protein L23	0	3	1	4
30S ribosomal protein S15	0	3	1	4
50S ribosomal protein L17	0	3	1	4
50S ribosomal protein L21	0	3	1	4
50S ribosomal protein L30	0	3	1	4
50S ribosomal protein L6	0	3	1	4
30S ribosomal protein S14	0	3	1	4
30S ribosomal protein S17	0	3	1	4
30S ribosomal protein S1	0	3	1	4
50S ribosomal protein L18	0	3	1	4
50S ribosomal protein L2	0	3	1	4
50S ribosomal protein L3	0	3	1	4
50S ribosomal protein L24	0	3	1	4
50S ribosomal protein L4	0	3	1	4
50S ribosomal protein L22	0	3	1	4
50S ribosomal protein L5	0	3	1	4
30S ribosomal protein S21	0	3	1	4
50S ribosomal protein L25	0	3	1	4
50S ribosomal protein L36 2	0	3	1	4
Methionine--tRNA ligase, mitochondrial	0	0	1	1
Gamma-aminobutyric acid receptor subunit alpha-1	0	4	0	5
Gamma-aminobutyric acid receptor subunit beta-1	0	4	0	5
Gamma-aminobutyric acid receptor subunit alpha-2	0	4	0	5
Gamma-aminobutyric acid receptor subunit alpha-3	0	4	0	5
Gamma-aminobutyric acid receptor subunit alpha-4	0	4	0	5
Gamma-aminobutyric acid receptor subunit gamma-2	0	4	0	5
Chain A, BCL-2-RELATED PROTEIN A1	0	0	1	1
PAX8	0	0	0	4
PINK1	9	0	0	9
heat shock protein 90	0	0	2	2
calcineurin A1, putative	0	0	1	1
hepatocyte nuclear factor 4-alpha isoform 2	0	1	0	1
ubiquitin-conjugating enzyme E2 N	0	4	0	4
protein AF-9 isoform a	0	0	0	3
melanocortin receptor 4	0	1	0	1
CAAX prenyl protease	0	0	0	2
bcl-2-related protein A1	0	4	0	4
glycogen synthase kinase-3 alpha	0	0	0	2
hexokinase HKDC1	0	1	0	1
DNA repair protein RAD52 homolog isoform a	0	0	0	3
bcl-2-like protein 11 isoform 1	0	0	1	1
Synaptojanin-2	0	1	0	1
Synaptojanin-1	0	1	0	1
Solute carrier family 22 member 3	0	17	0	19
Glutathione reductase, mitochondrial	0	7	0	9
72 kDa type IV collagenase	0	6	0	6
Matrix metalloproteinase-9	0	4	0	4
Trypanothione reductase	0	7	0	7
Peroxisomal N(1)-acetyl-spermine/spermidine oxidase	0	1	0	1
Spermine oxidase	0	1	0	1
glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase	0	3	0	3
glucose-6-phosphate 1-dehydrogenase isoform b	0	3	0	3
Dihydrofolate reductase	0	3	0	3
DNA ligase	0	1	0	1
Riboflavin-binding protein	0	0	1	1
Histidine-rich protein PFHRP-II	0	1	0	2
Spike glycoprotein	0	1	0	1
Ribosyldihydronicotinamide dehydrogenase [quinone]	0	6	6	12
DNA ligase 1	0	1	0	1
Calcium-dependent protein kinase 1	0	0	1	1
DNA ligase A	0	1	0	1
Sigma intracellular receptor 2	0	4	0	4
Phosphoethanolamine N-methyltransferase	0	1	0	1
Cysteine proteinase falcipain 2a	0	1	0	1
NADPH oxidase 1	0	2	0	2
Snq2p	0	0	0	5
Adenylate cyclase type 1	0	4	0	4
Glutamate receptor ionotropic, NMDA 2D	0	6	1	7
Glutamate receptor ionotropic, NMDA 3B	0	5	1	6
Albumin	0	8	17	36
Major prion protein	0	0	1	1
Cys-loop ligand-gated ion channel	0	1	0	1
Calmodulin-1	0	6	1	7
Sphingomyelin phosphodiesterase	0	2	0	2
Adenylate cyclase type 3	0	4	0	4
Adenylate cyclase type 2	0	4	1	5
Adenylate cyclase type 4	0	4	0	4
Pleiotropic ABC efflux transporter of multiple drugs	0	5	0	10
Adenylate cyclase type 8	0	4	0	4
Gastrin/cholecystokinin type B receptor	0	5	0	5
Aldehyde oxidase 1	0	1	0	1
Adenylate cyclase type 6	0	4	0	4
Glutamate receptor ionotropic, NMDA 1	0	9	1	10
Aldehyde oxidase	0	6	0	8
Glutamate receptor ionotropic, NMDA 2A	0	8	1	9
Glutamate receptor ionotropic, NMDA 2B	0	9	2	11
Glutamate receptor ionotropic, NMDA 2C	0	6	1	7
Adenylyl cyclase 7	0	4	0	4
Glutamate receptor ionotropic, NMDA 3A	0	5	1	6
Acetylcholinesterase	0	1	0	1
Carboxylic ester hydrolase	0	1	0	1
cystic fibrosis transmembrane conductance regulator ATP-binding cassette sub-family C member 7	0	0	0	3
Glycine receptor subunit alpha-1	0	2	7	9
Ubiquitin carboxyl-terminal hydrolase 2	0	2	0	2
Phospholipase A2	0	2	1	3
G-protein coupled bile acid receptor 1	0	1	1	2
Chain A, Acetylcholinesterase	0	0	1	1
Chain A, Acetylcholinesterase	0	0	1	1
Chain A, Acetylcholinesterase	0	0	1	1
Chain A, Acetylcholinesterase	0	0	1	1
Chain A, Acetylcholinesterase	0	0	1	1
Chain A, Acetylcholinesterase	0	0	1	1
Chain A, Acetylcholinesterase	0	0	1	1
Chain A, Putative Glycine Betaine-binding Abc Transporter Protein	0	0	1	1
Chain A, PUTATIVE GLYCINE BETAINE-BINDING ABC TRANSPORTER PROTEIN	0	0	1	1
Chain A, Glycine betaine/carnitine/choline-binding protein	0	0	1	1
Chain A, Glycine betaine/carnitine/choline-binding protein	0	0	1	1
Chain A, Glycine betaine/carnitine/choline-binding protein	0	0	1	1
Chain A, Glycine betaine/carnitine/choline-binding protein	0	0	1	1
Chain A, Choline-binding protein	0	0	1	1
Solute carrier family 22 member 1	0	4	0	6
Solute carrier family 22 member 2	0	3	0	4
Sodium- and chloride-dependent creatine transporter 1	0	1	0	1
Solute carrier family 22 member 1	0	20	0	26
High affinity choline transporter 1	0	1	0	1
Solute carrier family 22 member 2	0	15	0	20
Potassium-transporting ATPase alpha chain 1	0	2	0	2
Potassium-transporting ATPase subunit beta	0	2	0	2
Histamine H4 receptor	0	7	4	12
Solute carrier family 22 member 4	0	3	0	3
shiga toxin 1 variant A subunit	1	0	0	1
shiga toxin 1 B subunit	1	0	0	1
Cell division protein FtsZ	0	1	0	3
chaperonin-containing TCP-1 beta subunit homolog	4	0	0	4
Estrogen receptor 1	0	2	0	2
estrogen receptor beta isoform 1	0	4	0	4
Sodium-dependent noradrenaline transporter	0	5	0	5
Aldo-keto reductase family 1 member B1	0	7	0	7
Aromatase	0	1	0	1
Sodium-dependent serotonin transporter	0	5	0	5
Sodium-dependent dopamine transporter	0	8	0	8
N(G),N(G)-dimethylarginine dimethylaminohydrolase 1	0	7	0	9
General amino-acid permease GAP1	0	0	0	1
Peroxisome proliferator-activated receptor alpha	0	1	3	4
Peroxisome proliferator-activated receptor gamma	0	4	12	17
Fatty acid-binding protein, intestinal	0	2	0	2
Peroxisome proliferator-activated receptor delta	0	1	2	3
Trypanothione reductase	0	1	0	1
Envelope glycoprotein	0	0	6	6
Translocator protein	0	2	0	2
Translocator protein	0	4	0	4
Alpha-1B adrenergic receptor	0	0	2	2
Membrane primary amine oxidase	0	1	0	1
Alpha-2B adrenergic receptor	0	3	0	5
Alpha-2C adrenergic receptor	0	3	0	5
Alpha-2A adrenergic receptor	0	3	0	5
Nischarin	0	3	0	3
Nischarin	0	3	0	3
5-hydroxytryptamine receptor 3A	0	5	0	5
D(2) dopamine receptor	0	2	0	2
D(3) dopamine receptor	0	2	0	2
D(2) dopamine receptor	0	4	0	4
5-hydroxytryptamine receptor 2B	0	3	0	3
5-hydroxytryptamine receptor 4	0	2	1	4
5-hydroxytryptamine receptor 1A	0	5	0	5
Chain A, CHIMERA OF IG KAPPA CHAIN: HUMAN CONSTANT REGION AND MOUSE VARIABLE REGION	0	0	1	1
Chain B, CHIMERA OF IG GAMMA-1 CHAIN: HUMAN CONSTANT REGION AND MOUSE VARIABLE REGION	0	0	1	1
Chain H, Fab M82G2, Heavy chain	0	0	1	1
Chain L, Fab M82G2, Light chain	0	0	1	1
Chain H, Fab M82g2, Heavy Chain	0	0	1	1
Chain L, Fab M82g2, Light Chain	0	0	1	1
Fatty acid-binding protein, heart	0	1	0	1
Muscarinic acetylcholine receptor M2	0	2	1	3
Lysosomal Pro-X carboxypeptidase	0	2	0	2
Leukotriene B4 receptor 1	1	1	0	3
nuclear receptor subfamily 0 group B member 1	0	3	0	3
steroidogenic factor 1	0	3	0	3
Tubulin alpha-1A chain	0	3	1	4
Tubulin beta chain	0	3	1	4
Tubulin beta-4A chain	0	3	2	6
Tubulin beta chain	0	3	2	6
Tubulin alpha-3C chain	0	3	2	6
Tubulin alpha-1B chain	0	3	2	6
Tubulin alpha-4A chain	0	3	2	6
Tubulin beta-4B chain	0	3	2	6
Vesicular acetylcholine transporter	0	1	0	1
Tubulin beta-3 chain	0	3	2	6
Tubulin beta-2A chain	0	3	2	6
Tubulin polymerization-promoting protein	0	0	1	1
Tubulin beta-8 chain	0	3	2	6
Tubulin beta-2B chain	0	4	0	4
Tubulin alpha-3E chain	0	3	2	6
Tubulin alpha-1A chain	0	3	2	6
Similar to alpha-tubulin isoform 1	0	3	0	3
Similar to alpha-tubulin isoform 1	0	3	0	3
Tubulin alpha-1C chain	0	3	2	6
Tubulin beta-6 chain	0	3	2	6
Tubulin beta-2B chain	0	3	2	6
Tubulin beta-1 chain	0	3	2	6
Solute carrier family 2, facilitated glucose transporter member 1	0	1	1	2
Adenylate cyclase type 8	0	0	1	1
Relaxin receptor 1	0	0	1	1
Nuclear receptor subfamily 1 group I member 2	0	0	4	4
B2 bradykinin receptor	0	3	0	3
Dihydrofolate reductase	0	6	0	9
Dihydrofolate reductase	0	2	0	2
Beta-lactamase	0	5	0	5
Beta-lactamase	0	2	0	3
Beta-galactosidase	0	2	0	3
Ectonucleotide pyrophosphatase/phosphodiesterase family member 2	0	2	0	2
PH domain leucine-rich repeat-containing protein phosphatase 2	0	1	0	1
Chymotrypsin-C	0	2	0	2
TPA: protein transporter TIM23	0	2	0	2
Sterol 14-alpha demethylase	0	1	0	1
RNA-directed RNA polymerase	0	1	2	4
Sodium- and chloride-dependent creatine transporter 1	0	1	0	1
ATP-binding cassette sub-family C member 9	0	2	2	4
ATP-binding cassette sub-family C member 8	0	2	2	4
ATP-sensitive inward rectifier potassium channel 11	0	3	2	5
ATP-sensitive inward rectifier potassium channel 8	0	0	1	1
Chain A, Breast cancer type 1 susceptibility protein	3	0	0	3
Nrf2	4	0	0	4
alkaline phosphatase, intestinal	0	1	1	2
toll-like receptor 9	0	1	0	1
TPA: protein transporter TIM10	0	2	0	2
alkaline phosphatase, tissue-nonspecific isozyme isoform 1 preproprotein	0	1	1	2
intestinal alkaline phosphatase precursor	0	1	1	2
alkaline phosphatase, germ cell type preproprotein	0	1	1	2
hypothetical protein SA1422	0	1	0	1
DNA dC->dU-editing enzyme APOBEC-3F isoform a	5	0	0	5
D-amino-acid oxidase	0	1	0	1
Neuronal proto-oncogene tyrosine-protein kinase Src	0	1	0	1
Heme oxygenase 1	0	3	0	3
Glutathione S-transferase P	0	2	0	2
Microtubule-associated protein tau	0	3	1	5
Sarcoplasmic/endoplasmic reticulum calcium ATPase 2	0	1	0	1
Aminopeptidase N	0	1	0	1
Aminopeptidase N	0	2	0	2
Sarcoplasmic/endoplasmic reticulum calcium ATPase 2	0	2	0	2
Heme oxygenase 2	0	3	0	3
Serine/threonine-protein kinase PAK 1	0	2	1	3
Nuclear factor erythroid 2-related factor 2	0	0	3	5
Thioredoxin reductase 1, cytoplasmic	0	3	0	4
Thioredoxin reductase 3	0	2	0	2
Sortase A	0	1	0	1
Sarcoplasmic/endoplasmic reticulum calcium ATPase 3	0	2	0	2
Thioredoxin reductase 2, mitochondrial	0	2	0	2
CDGSH iron-sulfur domain-containing protein 1	0	12	0	12
Lymphocyte antigen 96	0	0	1	1
Beta lactamase (plasmid)	0	1	0	1
Multidrug resistance-associated protein 5	0	3	0	4
Interferon regulatory factor 3	0	0	1	1
Stimulator of interferon genes protein	0	0	2	2
Stimulator of interferon genes protein	0	1	2	3
chaperonin GroEL	2	0	0	2
Glycogen phosphorylase, brain form	0	1	5	6
Glycogen phosphorylase, muscle form	0	1	0	1
Histone-lysine N-methyltransferase SETD7	0	2	0	2
LMP1 [Human herpesvirus 4]	0	0	0	3
nuclear receptor coactivator 1 isoform 1 [Homo sapiens]	0	3	0	3
transactivating tegument protein VP16 [Human herpesvirus 1]	0	4	0	4
nuclear receptor coactivator 3 isoform a	0	3	0	3
Thymidine kinase 2, mitochondrial	0	1	0	1
Thymidine kinase	0	1	0	1
Thymidylate synthase	0	3	0	4
Thymidine kinase	0	1	0	1
Deoxycytidine kinase	0	0	5	7
Probable deoxycytidylate deaminase	0	0	0	1
Cytidine deaminase	0	1	0	2
Enoyl-[acyl-carrier-protein] reductase [NADH]	0	3	0	3
Deoxynucleoside kinase	0	1	0	1
Alpha-tocopherol transfer protein	0	0	1	1
rac GTPase-activating protein 1 isoform a	0	1	0	1
Aldehyde dehydrogenase, mitochondrial	0	2	0	2
Tyrosinase	0	5	0	5
Beta-hydroxyacyl-ACP dehydratase precursor (Fatty acid synthesis protein)	0	4	0	4
runt-related transcription factor 1 isoform AML1b	6	0	0	6
core-binding factor subunit beta isoform 2	6	0	0	6
NADH-ubiquinone oxidoreductase chain 4	0	0	0	1
DNA topoisomerase 2-alpha	0	4	6	16
Carbonyl reductase [NADPH] 1	0	2	0	4
Platelet-activating factor receptor	1	1	0	3
Beta-glucuronidase	0	1	0	1
Glucose-6-phosphate 1-dehydrogenase	0	1	0	1
NPC1-like intracellular cholesterol transporter 1	0	0	1	1
Solute carrier organic anion transporter family member 1A2	0	1	0	4
Solute carrier organic anion transporter family member 1A3	0	2	0	6
ATP-binding cassette sub-family C member 11	0	0	0	2
Solute carrier organic anion transporter family member 1A1	0	0	0	1
AAA family ATPase	0	0	0	1
Sterol O-acyltransferase 1	0	1	0	1
Chain A, Dutpase	0	0	1	1
Chain A, Dutpase	0	0	1	1
Chain B, Dutpase	0	0	1	1
Chain A, Dutpase	0	0	1	1
Chain B, Dutpase	0	0	1	1
Trace amine-associated receptor 1	0	0	5	5
Hsf1 protein	0	0	5	6
Gamma-aminobutyric acid	0	2	1	3
Alpha-1-acid glycoprotein 1	0	0	0	1
Gamma-aminobutyric acid receptor subunit alpha-6	0	2	1	3
Gamma-aminobutyric acid receptor subunit gamma-2	0	2	1	3
Gamma-aminobutyric acid receptor subunit delta	0	2	1	3
Gamma-aminobutyric acid receptor subunit alpha-2	0	2	1	3
Gamma-aminobutyric acid receptor subunit alpha-3	0	2	1	3
Gamma-aminobutyric acid receptor subunit gamma-3	0	2	1	3
Gamma-aminobutyric acid receptor subunit beta-1	0	2	1	3
Gamma-aminobutyric acid receptor subunit alpha-1	0	2	1	3
Gamma-aminobutyric acid receptor subunit beta-3	0	2	1	3
Gamma-aminobutyric acid receptor subunit alpha-5	0	2	1	3
Gamma-aminobutyric acid receptor subunit pi	0	2	1	3
Sphingosine-1-phosphate lyase 1	0	1	0	1
Gamma-aminobutyric acid receptor subunit alpha-4	0	2	1	3
Gamma-aminobutyric acid receptor subunit theta	0	2	1	3
Gamma-aminobutyric acid receptor subunit gamma-1	0	2	1	3
Nicotinamide phosphoribosyltransferase	0	0	1	1
Cathepsin B	0	1	0	1
UDP-glucuronosyltransferase 1A9	0	2	0	6
Interleukin-8	0	2	0	2
C-X-C chemokine receptor type 1	0	2	0	2
UDP-glucuronosyltransferase 1A7	0	1	0	1
UDP-glucuronosyltransferase 1A10	0	1	0	2
NAD	0	1	0	1
NAD	0	1	0	2
Mitogen-activated protein kinase 1	0	3	5	8
ATP phosphoribosyltransferase	0	1	0	1
Proprotein convertase subtilisin/kexin type 7	0	2	0	2
Vasopressin V1a receptor	0	9	2	11
UDP-glucose 4-epimerase	0	1	0	1
Cysteinyl leukotriene receptor 1	0	2	0	2
STAT3, partial	0	1	0	1
signal transducer and activator of transcription 1-alpha/beta isoform alpha	0	1	0	1
Sodium/potassium-transporting ATPase subunit alpha-1	0	4	0	4
Sodium/potassium-transporting ATPase subunit beta-1	0	4	0	4
Sodium/potassium-transporting ATPase subunit alpha-2	0	1	0	1
Sodium/potassium-transporting ATPase subunit alpha-3	0	1	0	1
Sodium/potassium-transporting ATPase subunit beta-1	0	1	0	1
Sodium/potassium-transporting ATPase subunit alpha-3	0	3	0	3
Sodium/potassium-transporting ATPase subunit beta-2	0	3	0	3
Sodium/potassium-transporting ATPase subunit alpha-2	0	4	0	4
Sodium/potassium-transporting ATPase subunit alpha-1	0	1	0	1
Sodium/potassium-transporting ATPase subunit beta-3	0	3	0	3
Sodium/potassium-transporting ATPase subunit gamma	0	3	0	3
Sodium/potassium-transporting ATPase subunit alpha-4	0	3	0	3
Sodium/potassium-transporting ATPase subunit alpha-4	0	1	0	1
Solute carrier organic anion transporter family member 4C1	0	1	0	3
Solute carrier organic anion transporter family member 4C1	0	0	0	2
Solute carrier organic anion transporter family member 1A4	0	0	0	1
Chain A, Sex Hormone-Binding Globulin	0	0	1	1
Sex hormone-binding globulin	0	1	0	1
Cannabinoid receptor 2	0	2	2	4
Neuropeptide FF receptor 2	0	0	0	3
Cereblon isoform 4	0	5	0	5
Insulin-like growth factor-binding protein 5	0	0	1	1
Protein cereblon	0	9	1	11
Furin	0	1	0	1
Amiloride-sensitive amine oxidase [copper-containing]	0	1	0	1
Diamine acetyltransferase 1	0	1	0	1
Acid-sensing ion channel 1	0	1	0	1
Acid-sensing ion channel 2	0	1	0	1
Prostaglandin E2 receptor EP1 subtype	0	3	2	5
Prostaglandin E2 receptor EP4 subtype	0	3	1	5
Prostaglandin F2-alpha receptor	0	2	0	2
Prostaglandin F2-alpha receptor	0	2	2	4
Prostaglandin E2 receptor EP3 subtype	0	3	2	6
Prostaglandin E2 receptor EP2 subtype	0	3	1	4
Prostaglandin F2-alpha receptor	0	0	1	1
Prostaglandin D2 receptor	0	1	0	1
Solute carrier family 22 member 7	0	2	0	5
Solute carrier organic anion transporter family member 2A1	0	1	0	1
Solute carrier family 22 member 7	0	1	0	4
Prostaglandin E2 receptor EP4 subtype	0	1	1	2
Prostaglandin E2 receptor EP2 subtype	0	1	1	2
Solute carrier family 22 member 7	0	0	0	1
90-kda heat shock protein beta HSP90 beta, partial	0	3	0	3
DNA polymerase III, partial	5	0	0	5
isocitrate dehydrogenase 1, partial	6	0	0	6
LANA	0	0	0	1
eyes absent homolog 2 isoform a	3	0	0	3
kelch-like ECH-associated protein 1	0	0	0	3
Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta	0	6	0	6
3',5'-cyclic-AMP phosphodiesterase	0	6	0	6
Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha	0	6	0	6
Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma	0	6	0	6
Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit beta	0	6	0	6
Retinal cone rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma	0	6	0	6
Exopolyphosphatase PRUNE1	0	1	0	1
Single-stranded DNA cytosine deaminase	4	0	0	4
Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A	0	6	0	6
Phosphodiesterase	0	4	0	4
cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A	0	7	0	8
beta-2 adrenergic receptor	6	0	0	6
polypyrimidine tract-binding protein 1 isoform a	1	0	0	1
bifunctional UDP-N-acetylglucosamine pyrophosphorylase/glucosamine-1-phosphate N-acetyltransferase	0	2	0	2
Carbamate kinase	0	1	0	1
Retinal dehydrogenase 1	0	1	0	1
C-X-C chemokine receptor type 2	0	2	0	2
Protein-lysine 6-oxidase	0	1	0	1
Caspase-1	0	3	0	4
C-C chemokine receptor type 5	0	3	2	6
Gasdermin-D	0	1	0	1
Lysyl oxidase homolog 3	0	1	0	1
Lysyl oxidase homolog 4	0	1	0	1
Monoglyceride lipase	0	2	0	2
Gasdermin-D	0	1	0	1
Histone-lysine N-methyltransferase EHMT1	0	1	0	1
Lysyl oxidase homolog 2	0	1	0	1
hypothetical protein CAALFM_CR05890CA	0	0	0	2
H3 histone acetyltransferase	0	0	0	2
Chain A, PFV integrase	0	1	0	1
Chain A, PFV integrase	0	1	0	1
Chain A, PFV integrase	0	1	0	1
Integrase	0	0	1	1
Vesicular acetylcholine transporter	0	3	0	3
Interstitial collagenase	0	4	1	5
Fatty acid-binding protein, liver	0	1	0	1
Cannabinoid receptor 1	0	4	0	4
N-arachidonyl glycine receptor	0	0	1	1
Lysophosphatidylserine lipase ABHD12	0	2	0	2
Monoacylglycerol lipase ABHD6	0	2	0	2
Cannabinoid receptor 2	0	2	0	2
G-protein coupled receptor 55	0	1	1	2
3-oxo-5-alpha-steroid 4-dehydrogenase 1	0	3	0	3
3-oxo-5-alpha-steroid 4-dehydrogenase 2	0	4	0	4
3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase	0	2	0	2
Mas-related G-protein coupled receptor member X2	0	0	4	4
Chain A, POL POLYPROTEIN	0	1	0	1
Chain A, POL POLYPROTEIN	0	1	0	1
Chain B, POL POLYPROTEIN	0	1	0	1
Chain A, POL POLYPROTEIN	0	1	0	1
Chain B, POL POLYPROTEIN	0	1	0	1
Chain A, Pol Polyprotein	0	1	0	1
Chain B, Pol Polyprotein	0	1	0	1
Prothrombin	0	2	0	2
Gag-Pol polyprotein	0	6	0	6
Gag-Pol polyprotein	0	7	0	7
Microsomal triglyceride transfer protein large subunit	0	1	0	1
Envelope glycoprotein gp160 [Cleaved into: Surface protein gp120	0	1	0	1
Fructose-1,6-bisphosphatase 1	0	0	0	1
Reverse transcriptase	0	1	1	2
Cholesterol 24-hydroxylase	0	2	2	4
Chain A, Protein (peroxisome Proliferator Activated Receptor (ppar-delta))	0	1	0	1
Oxoeicosanoid receptor 1	0	1	0	1
Opioid receptor, delta 1b	0	2	0	2
Opioid receptor homologue	0	2	0	2
Proenkephalin-B	0	0	1	1
Kappa-type opioid receptor	0	7	2	12
Kappa-type opioid receptor	0	8	4	14
Mu-type opioid receptor	0	6	2	13
Mu-type opioid receptor	0	2	0	2
Aldo-keto reductase family 1 member A1	0	2	0	2
Aldo-keto reductase family 1 member A1	0	2	0	2
Aldo-keto reductase family 1 member A1	0	3	0	3
Enoyl-[acyl-carrier-protein] reductase [NADH]	0	2	0	2
Sorbitol dehydrogenase	0	2	0	2
Aldo-keto reductase family 1 member B7	0	2	0	2
Chain A, Troponin C, slow skeletal and cardiac muscles	0	0	1	1
Chain A, Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1	0	0	1	1
Chain A, POLYMERASE PA	0	1	0	1
Chain A, Polymerase Pa	0	1	0	1
Chain A, Polymerase Pa	0	1	0	1
Chain A, Polymerase Pa	0	1	0	1
Chain A, Polymerase Pa	0	1	0	1
galactokinase	2	0	0	2
Polycomb protein EED	0	0	1	1
NAD kinase	0	2	1	3
Urokinase-type plasminogen activator	0	2	0	2
Tissue-type plasminogen activator	0	1	0	1
Polymerase acidic protein	0	1	1	2
Plasminogen activator inhibitor 1	0	1	0	1
Urokinase-type plasminogen activator	0	1	0	1
Hepatocyte growth factor receptor	0	3	5	8
Matrilysin	0	2	0	2
Enoyl-[acyl-carrier-protein] reductase [NADH] FabI	0	2	0	2
Alpha-amylase 1A	0	2	0	2
Apoptosis regulator Bcl-2	0	2	0	2
Glucose-6-phosphate 1-dehydrogenase	0	1	0	1
Fatty acid synthase	0	1	0	1
CPG DNA methylase	0	1	0	1
Phosphoglycerate mutase 1	0	1	0	1
Signal transducer and activator of transcription 1-alpha/beta	0	0	1	1
DNA repair protein RAD52 homolog	0	2	0	2
Fatty acid synthase	0	8	0	8
Matrix metalloproteinase-14	0	1	0	1
4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT6	0	1	0	1
Squalene monooxygenase	0	1	0	1
6-phosphogluconate dehydrogenase, decarboxylating	0	3	0	3
BH3-interacting domain death agonist	0	1	0	1
Bcl-2-like protein 1	0	2	0	2
Induced myeloid leukemia cell differentiation protein Mcl-1	0	1	0	1
Alpha-(1,3)-fucosyltransferase 7	0	1	0	1
CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1	0	1	0	1
Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1	0	1	0	1
Dual specificity tyrosine-phosphorylation-regulated kinase 1A	0	1	5	6
Bcl-2-related protein A1	0	1	0	1
Dual specificity tyrosine-phosphorylation-regulated kinase 1A	0	1	0	1
3-oxoacyl-[acyl-carrier-protein] reductase	0	1	0	1
MAP kinase-activated protein kinase 5	0	2	4	6
Histone acetyltransferase KAT2B	0	1	0	1
Bcl-2-like protein 2	0	1	0	1
Bcl2-associated agonist of cell death	0	1	0	1
Histone acetyltransferase KAT5	0	1	0	1
3-oxoacyl-acyl-carrier protein reductase	0	2	0	2
Bcl-2-like protein 10	0	1	0	1
Zinc finger protein mex-5	0	0	4	4
Motilin receptor	0	0	1	1
low molecular weight phosphotyrosine protein phosphatase isoform c	0	1	0	1
Motilin receptor	0	1	1	2
Chitinase B	0	1	0	1
Low molecular weight phosphotyrosine protein phosphatase	0	1	0	1
Tyrosine-protein phosphatase non-receptor type 11	0	1	0	1
Lanosterol 14-alpha demethylase	0	0	1	1
Ghrelin O-acyltransferase	0	1	0	1
Cytochrome P450 2B1	0	2	0	2
3-oxo-5-alpha-steroid 4-dehydrogenase 1	0	4	0	4
Sulfotransferase 1A1	0	3	1	5
Nuclear receptor subfamily 1 group I member 3	0	1	0	1
D(3) dopamine receptor isoform e	2	0	0	2
Chain H, IGG1-KAPPA DB3 FAB (HEAVY CHAIN)	0	1	0	1
Chain L, IGG1-KAPPA DB3 FAB (LIGHT CHAIN)	0	1	0	1
Chain H, IGG1-KAPPA DB3 FAB (HEAVY CHAIN)	0	1	0	1
Chain L, IGG1-KAPPA DB3 FAB (LIGHT CHAIN)	0	1	0	1
Chain H, IGG1-KAPPA DB3 FAB (HEAVY CHAIN)	0	1	0	1
Chain L, IGG1-KAPPA DB3 FAB (LIGHT CHAIN)	0	1	0	1
Regulatory protein E2	0	0	1	1
DNA topoisomerase 1	0	4	0	5
DNA topoisomerase 2	0	0	0	1
Caspase-3	0	1	0	1
DNA topoisomerase 2-alpha	0	0	0	1
DNA topoisomerase 2-beta	0	1	6	13
Bone morphogenetic protein receptor type-1B	0	0	5	5
Cell division cycle 7-related protein kinase	0	0	3	3
Serine/threonine-protein kinase PLK4	0	0	6	6
ATP-dependent RNA helicase DDX3X	0	0	5	5
Pyridoxal kinase	0	0	5	6
Citron Rho-interacting kinase	0	0	5	5
Serine/threonine-protein kinase Chk1	0	1	5	6
Cyclin-G-associated kinase	0	0	6	6
Ephrin type-B receptor 6	0	0	5	5
Peroxisomal acyl-coenzyme A oxidase 3	0	0	5	5
Receptor-interacting serine/threonine-protein kinase 2	0	0	5	5
Mitotic checkpoint serine/threonine-protein kinase BUB1	0	0	5	5
Dynamin-like 120 kDa protein, mitochondrial	0	0	5	5
Eukaryotic translation initiation factor 5B	0	0	4	4
Rho-associated protein kinase 2	0	6	5	11
Serine/threonine-protein kinase ULK1	0	0	5	5
Serine/threonine-protein kinase/endoribonuclease IRE1	0	1	5	6
Ribosomal protein S6 kinase alpha-5	0	3	6	9
U5 small nuclear ribonucleoprotein 200 kDa helicase	0	0	5	5
Ribosomal protein S6 kinase alpha-4	0	0	5	5
Serine/threonine-protein kinase 16	0	0	6	6
Serine/threonine-protein kinase 10	0	0	5	5
Serine/threonine-protein kinase D3	0	2	5	7
Structural maintenance of chromosomes protein 2	0	0	4	4
Mitogen-activated protein kinase kinase kinase 6	0	0	5	5
Mitogen-activated protein kinase kinase kinase kinase 4	0	0	5	5
Serine/threonine-protein kinase LATS1	0	0	5	5
Serine/threonine-protein kinase PAK 4	0	0	5	5
Tyrosine-protein kinase ABL1	0	5	7	13
Guanine nucleotide-binding protein G(i) subunit alpha-2	0	0	3	3
ADP/ATP translocase 2	0	0	5	5
Glycogen phosphorylase, liver form	0	1	5	6
Tyrosine-protein kinase Fes/Fps	0	0	5	5
Adenine phosphoribosyltransferase	0	0	4	4
Tyrosine-protein kinase Lyn	0	0	5	5
Proto-oncogene tyrosine-protein kinase receptor Ret	0	1	5	6
Insulin-like growth factor 1 receptor	0	1	5	6
Signal recognition particle receptor subunit alpha	0	0	5	5
Cytochrome c1, heme protein, mitochondrial	0	0	5	5
Tyrosine-protein kinase HCK	0	0	5	5
Tyrosine-protein kinase Fgr	0	0	4	4
Serine/threonine-protein kinase A-Raf	0	0	5	5
Breakpoint cluster region protein	0	1	6	8
ADP/ATP translocase 3	0	0	5	5
cAMP-dependent protein kinase type II-alpha regulatory subunit	0	0	4	4
Serine/threonine-protein kinase B-raf	0	1	5	6
Phosphorylase b kinase gamma catalytic chain, liver/testis isoform	0	0	6	6
Tyrosine-protein kinase Fer	0	0	5	5
General transcription and DNA repair factor IIH helicase subunit XPD	0	0	5	5
Ras-related protein Rab-6A	0	0	5	5
Ephrin type-A receptor 1	0	0	5	5
Multifunctional protein ADE2	0	0	5	5
Ferrochelatase, mitochondrial	0	0	5	5
Ribosomal protein S6 kinase beta-1	0	1	5	6
Tyrosine-protein kinase JAK1	0	3	6	11
Beta-adrenergic receptor kinase 1	0	1	8	9
Probable ATP-dependent RNA helicase DDX6	0	0	5	5
MAP/microtubule affinity-regulating kinase 3	0	0	5	5
Ephrin type-A receptor 2	0	0	5	5
Ephrin type-B receptor 2	0	0	5	5
Non-receptor tyrosine-protein kinase TYK2	0	3	6	11
UMP-CMP kinase	0	0	4	4
Phosphatidylethanolamine-binding protein 1	0	0	4	4
Wee1-like protein kinase	0	0	5	5
Heme oxygenase 2	0	0	5	5
S-adenosylmethionine synthase isoform type-2	0	0	5	5
DnaJ homolog subfamily A member 1	0	0	5	5
RAC-alpha serine/threonine-protein kinase	0	4	5	9
RAC-beta serine/threonine-protein kinase	0	0	5	5
DNA replication licensing factor MCM4	0	0	4	4
Dual specificity mitogen-activated protein kinase kinase 2	0	0	5	5
Bone morphogenetic protein receptor type-1A	0	0	5	5
Activin receptor type-1B	0	0	5	5
TGF-beta receptor type-1	0	0	5	5
TGF-beta receptor type-2	0	0	5	5
Electron transfer flavoprotein subunit beta	0	0	4	4
Tyrosine-protein kinase CSK	0	2	5	7
Glycine--tRNA ligase	0	0	5	5
Exosome RNA helicase MTR4	0	0	5	5
Tyrosine-protein kinase Tec	0	1	5	6
Tyrosine-protein kinase ABL2	0	1	5	6
Tyrosine-protein kinase FRK	0	0	5	5
Mitogen-activated protein kinase 8	0	2	6	8
Mitogen-activated protein kinase 9	0	1	6	7
Dual specificity mitogen-activated protein kinase kinase 3	0	0	5	5
Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha	0	0	4	4
Casein kinase I isoform alpha	0	0	5	5
Casein kinase I isoform delta	0	0	5	5
MAP kinase-activated protein kinase 2	0	1	5	6
Elongation factor Tu, mitochondrial	0	0	5	5
Choline-phosphate cytidylyltransferase A	0	0	3	3
Cysteine--tRNA ligase, cytoplasmic	0	0	5	5
Casein kinase I isoform epsilon	0	0	6	6
Very long-chain specific acyl-CoA dehydrogenase, mitochondrial	0	0	5	5
Dual specificity protein kinase CLK1	0	0	5	5
Dual specificity protein kinase CLK2	0	0	6	6
Dual specificity protein kinase CLK3	0	0	5	5
Cyclin-dependent kinase 7	0	0	5	5
Cyclin-dependent kinase 9	0	0	5	5
Ras-related protein Rab-27A	0	0	4	4
Interleukin-1 receptor-associated kinase 1	0	0	5	5
Ribosomal protein S6 kinase alpha-3	0	1	5	6
Serine/threonine-protein kinase Nek2	0	1	5	6
Serine/threonine-protein kinase Nek3	0	0	5	5
Dual specificity mitogen-activated protein kinase kinase 6	0	0	5	5
LIM domain kinase 1	0	0	5	5
LIM domain kinase 2	0	0	5	5
Tyrosine--tRNA ligase, cytoplasmic	0	0	5	5
Ephrin type-B receptor 3	0	0	5	5
Ephrin type-A receptor 5	0	0	5	5
Ephrin type-B receptor 4	0	0	5	5
Ephrin type-A receptor 4	0	0	5	5
Ras-related protein Rab-10	0	0	5	5
Actin-related protein 3	0	0	5	5
Actin-related protein 2	0	0	4	4
GTP-binding nuclear protein Ran	0	0	5	5
Casein kinase I isoform gamma-2	0	0	5	5
Cyclin-dependent kinase 3	0	0	4	4
Cyclin-dependent kinase 16	0	0	6	6
Cyclin-dependent kinase 17	0	0	5	5
ATP-dependent 6-phosphofructokinase, platelet type	0	0	5	5
Dual specificity mitogen-activated protein kinase kinase 1	0	1	5	6
Activin receptor type-1	0	0	5	5
Macrophage-stimulating protein receptor	0	0	5	5
Focal adhesion kinase 1	0	1	5	6
Tyrosine-protein kinase BTK	0	1	5	6
Activated CDC42 kinase 1	0	0	5	5
Epithelial discoidin domain-containing receptor 1	0	0	5	5
Mitogen-activated protein kinase kinase kinase kinase 2	0	0	5	5
Serine/threonine-protein kinase 4	0	0	6	6
Dual specificity mitogen-activated protein kinase kinase 5	0	0	5	5
Mitogen-activated protein kinase 7	0	0	5	5
Serine/threonine-protein kinase PAK 2	0	0	5	5
Serine/threonine-protein kinase 3	0	0	5	5
Mitogen-activated protein kinase kinase kinase 1	0	0	5	5
Integrin-linked protein kinase	0	0	5	5
Rho-associated protein kinase 1	0	6	5	11
Non-receptor tyrosine-protein kinase TNK1	0	0	5	5
Calcium/calmodulin-dependent protein kinase type II subunit gamma	0	0	5	5
Calcium/calmodulin-dependent protein kinase type II subunit delta	0	0	5	5
Activin receptor type-2B	0	0	5	5
Bone morphogenetic protein receptor type-2	0	0	5	5
Protein-tyrosine kinase 6	0	0	5	5
cGMP-dependent protein kinase 1	0	0	5	5
Cyclin-dependent kinase 13	0	0	5	5
Inhibitor of nuclear factor kappa-B kinase subunit epsilon	0	0	5	5
Protein-tyrosine kinase 2-beta	0	0	5	5
Maternal embryonic leucine zipper kinase	0	0	5	5
Structural maintenance of chromosomes protein 1A	0	0	4	4
Chromodomain-helicase-DNA-binding protein 4	0	0	5	5
Peroxisomal acyl-coenzyme A oxidase 1	0	0	4	4
Ephrin type-A receptor 7	0	0	4	4
Delta(24)-sterol reductase	0	0	4	4
Ribosomal protein S6 kinase alpha-1	0	0	5	5
Dual specificity testis-specific protein kinase 1	0	0	4	4
Myosin light chain kinase, smooth muscle	0	3	5	8
Mitogen-activated protein kinase 11	0	1	5	6
Serine/threonine-protein kinase STK11	0	0	5	5
Serine/threonine-protein kinase N1	0	2	5	7
Serine/threonine-protein kinase N2	0	2	5	7
Calcium/calmodulin-dependent protein kinase type IV	0	0	5	5
Mitogen-activated protein kinase kinase kinase 11	0	0	5	5
Discoidin domain-containing receptor 2	0	0	5	5
AP2-associated protein kinase 1	0	0	6	6
Myosin light chain kinase 3	0	0	5	5
Putative heat shock protein HSP 90-beta 2	0	0	5	5
Serine/threonine-protein kinase MRCK alpha	0	0	5	5
Serine/threonine-protein kinase MRCK gamma	0	0	5	5
Acyl-CoA dehydrogenase family member 10	0	0	5	5
Serine/threonine-protein kinase N3	0	0	4	4
Serine/threonine-protein kinase ULK3	0	0	5	5
Uncharacterized protein FLJ45252	0	0	5	5
Acyl-CoA dehydrogenase family member 11	0	0	4	4
Serine/threonine-protein kinase/endoribonuclease IRE2	0	0	5	5
Serine/threonine-protein kinase MARK2	0	0	6	6
ATP-dependent RNA helicase DHX30	0	0	4	4
Serine/threonine-protein kinase TAO1	0	0	5	5
STE20-related kinase adapter protein alpha	0	0	5	5
Myosin-14	0	0	5	5
AarF domain-containing protein kinase 1	0	0	5	5
ATP-dependent RNA helicase DDX42	0	0	3	3
Mitogen-activated protein kinase kinase kinase kinase 3	0	0	5	5
Eukaryotic peptide chain release factor GTP-binding subunit ERF3B	0	0	3	3
Regulatory-associated protein of mTOR	0	2	0	2
Atypical kinase COQ8A, mitochondrial	0	0	5	5
Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma	0	0	5	5
Mitogen-activated protein kinase 15	0	0	5	5
Serine/threonine-protein kinase Nek9	0	0	5	5
Serine/threonine-protein kinase Nek7	0	0	4	4
ATP-dependent RNA helicase DDX1	0	0	5	5
Mitogen-activated protein kinase kinase kinase kinase 1	0	0	5	5
MAP/microtubule affinity-regulating kinase 4	0	0	4	4
Serine/threonine-protein kinase Nek1	0	0	5	5
PAS domain-containing serine/threonine-protein kinase	0	0	5	5
Calcium/calmodulin-dependent protein kinase kinase 2	0	0	6	6
EKC/KEOPS complex subunit TP53RK	0	0	5	5
Dual specificity testis-specific protein kinase 2	0	0	4	4
Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase	0	0	5	5
Mitogen-activated protein kinase kinase kinase 5	0	0	5	5
Mitogen-activated protein kinase kinase kinase 3	0	0	5	5
Eukaryotic translation initiation factor 2-alpha kinase 1	0	0	5	5
Target of rapamycin complex subunit LST8	0	2	0	2
Nucleolar GTP-binding protein 1	0	0	5	5
Serine/threonine-protein kinase D2	0	0	5	5
NUAK family SNF1-like kinase 2	0	0	4	4
RNA cytidine acetyltransferase	0	0	5	5
Serine/threonine-protein kinase SIK2	0	0	5	5
STE20-like serine/threonine-protein kinase	0	0	6	6
Serine/threonine-protein kinase TAO3	0	0	5	5
dCTP pyrophosphatase 1	0	0	5	5
Dual specificity protein kinase CLK4	0	0	6	6
Casein kinase I isoform gamma-1	0	0	6	6
Phenylalanine--tRNA ligase beta subunit	0	0	5	5
BMP-2-inducible protein kinase	0	0	6	6
Obg-like ATPase 1	0	0	4	4
Midasin	0	0	5	5
Interleukin-1 receptor-associated kinase 4	0	0	5	5
Mitogen-activated protein kinase kinase kinase 20	0	0	5	5
Cyclin-dependent kinase 12	0	0	5	5
NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 13	0	0	4	4
Serine/threonine-protein kinase 26	0	0	5	5
Succinate--CoA ligase [ADP-forming] subunit beta, mitochondrial	0	0	5	5
Serine/threonine-protein kinase NLK	0	0	5	5
Serine/threonine-protein kinase TBK1	0	1	5	6
Septin-9	0	0	5	5
Ribosomal protein S6 kinase alpha-6	0	0	5	5
TRAF2 and NCK-interacting protein kinase	0	0	6	6
Serine/threonine-protein kinase TAO2	0	0	5	5
Long-chain-fatty-acid--CoA ligase 5	0	0	4	4
RAC-gamma serine/threonine-protein kinase	0	0	5	5
Serine/threonine-protein kinase SIK3	0	0	5	5
Mitogen-activated protein kinase kinase kinase 2	0	0	5	5
Thyroid hormone receptor-associated protein 3	0	0	5	5
Mitogen-activated protein kinase kinase kinase kinase 5	0	0	5	5
Receptor-interacting serine/threonine-protein kinase 3	0	0	5	5
Serine/threonine-protein kinase MRCK beta	0	0	5	5
Interleukin-1 receptor-associated kinase 3	0	0	5	5
Casein kinase I isoform gamma-3	0	0	5	5
Mitogen-activated protein kinase kinase kinase 4	0	0	5	5
Chain E, cAMP-dependent protein kinase, alpha-catalytic subunit	0	3	0	3
Chain I, cAMP-dependent protein kinase inhibitor, alpha form	0	3	0	3
Chain B, Rho-associated protein kinase 1	0	3	0	3
Chain A, Rho-associated protein kinase 1	0	3	0	3
Chain A, Rho-associated protein kinase 1	0	3	0	3
Chain A, cAMP-dependent protein kinase, alpha-catalytic subunit	0	2	0	2
Chain A, cAMP-dependent protein kinase, alpha-catalytic subunit	0	2	0	2
Chain A, cAMP-dependent protein kinase, alpha-catalytic subunit	0	2	0	2
Chain I, cAMP-dependent protein kinase inhibitor alpha	0	2	0	2
Chain A, cAMP-dependent protein kinase, alpha-catalytic subunit	0	2	0	2
Chain A, cAMP-dependent protein kinase, alpha-catalytic subunit	0	2	0	2
Chain I, cAMP-dependent protein kinase inhibitor alpha	0	2	0	2
Chain A, Rho-associated protein kinase 1	0	3	0	3
cAMP-dependent protein kinase catalytic subunit alpha isoform Calpha1	0	0	0	1
serine/threonine-protein kinase 33 isoform a	0	0	1	2
cAMP-dependent protein kinase catalytic subunit alpha	0	3	0	3
C-C motif chemokine 2	0	3	0	3
Cell division control protein 42 homolog	0	1	0	1
Ras-related C3 botulinum toxin substrate 1	0	0	1	1
Myotonin-protein kinase	0	1	1	2
Rho-associated protein kinase 2	0	2	0	2
Uncharacterized aarF domain-containing protein kinase 5	0	0	4	4
5-hydroxytryptamine receptor 2A	0	3	1	4
Flavin reductase (NADPH)	0	0	3	3
Cathepsin B	0	1	0	1
procathepsin L isoform 1 preproprotein	0	2	0	2
fructose-bisphosphate aldolase	0	1	0	1
Alpha-glucosidase MAL12	0	4	0	4
Hyaluronidase-1	0	1	0	1
3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 1	0	1	0	1
3-oxo-5-alpha-steroid 4-dehydrogenase 2	0	3	0	3
Sphingosine 1-phosphate receptor 1	0	2	2	4
RCG53912, isoform CRA_a	0	0	0	1
Sphingosine kinase 1	0	0	0	1
Sphingosine kinase 2	0	1	0	2
Sphingosine kinase 1	0	1	0	2
Dihydroorotate dehydrogenase (fumarate)	0	1	0	1
Dihydroorotate dehydrogenase	0	1	0	1
Dipeptidyl peptidase 4	0	2	0	2
Acetylcholinesterase	0	3	0	3
Potassium voltage-gated channel subfamily C member 1	0	1	0	1
Gastrin/cholecystokinin type B receptor	0	1	0	1
Cocaine esterase	0	3	0	4
Arylacetamide deacetylase	0	1	0	3
Arylacetamide deacetylase	0	0	0	1
Arylacetamide deacetylase	0	0	0	1
Cytochrome P450 1A2	0	2	0	2
Chain A, Dihydrofolate reductase	0	0	1	1
Thymidylate synthase	0	4	0	4
Dihydrofolate reductase	0	5	3	8
Folylpolyglutamate synthase, mitochondrial	0	1	0	4
Folylpolyglutamate synthase, mitochondrial	0	1	0	4
Multidrug resistance associated protein	0	1	0	3
Chain A, Type Iii Chloramphenicol Acetyltransferase	0	1	0	1
Estrogen receptor	0	0	5	6
Estrogen receptor beta	0	0	5	6
Voltage-dependent calcium channel subunit alpha-2/delta-1	0	1	0	1
Lipopolysaccharide heptosyltransferase 1	0	1	0	1
PA-I galactophilic lectin	0	0	1	1
Jacalin	0	0	1	1
Chain A, ACETYLCHOLINESTERASE	0	1	0	1
Chain A, Acetylcholinesterase	0	1	0	1
Acetylcholinesterase	0	3	0	3
Vascular endothelial growth factor receptor 1	0	2	1	3
Acetylcholinesterase	0	3	0	3
Vascular endothelial growth factor receptor 3	0	2	1	3
Small conductance calcium-activated potassium channel protein 3	0	1	0	1
Carboxylic ester hydrolase	0	5	0	5
Gamma-aminobutyric acid receptor subunit rho-3	0	0	1	2
Gamma-aminobutyric acid receptor subunit rho-2	0	0	1	2
Sodium- and chloride-dependent GABA transporter 1	0	1	0	1
Sodium- and chloride-dependent taurine transporter	0	2	0	2
Sodium- and chloride-dependent GABA transporter 1	0	2	0	2
Sodium- and chloride-dependent GABA transporter 2	0	3	0	3
Sodium- and chloride-dependent GABA transporter 3	0	3	0	3
Sodium- and chloride-dependent betaine transporter	0	1	0	1
Sodium- and chloride-dependent GABA transporter 3	0	1	0	1
4-aminobutyrate aminotransferase, mitochondrial	0	0	0	1
Sterol O-acyltransferase 1	0	0	1	1
Platelet glycoprotein VI	0	1	3	5
Sodium- and chloride-dependent GABA transporter 2	0	1	0	1
Caspase 6, apoptosis-related cysteine peptidase	0	0	0	3
Free fatty acid receptor 1	0	0	2	2
Chain A, Estrogen receptor 1 (alpha)	0	1	0	1
Chain A, Transthyretin	0	0	1	1
Chain A, Transthyretin	0	0	1	1
Alpha-mannosidase	0	1	0	1
Maltase-glucoamylase, intestinal	0	3	0	3
Steroid hormone receptor ERR2	0	1	0	1
Triosephosphate isomerase	0	1	0	1
Steroid hormone receptor ERR1	0	2	0	2
Ornithine decarboxylase	0	2	0	2
Solute carrier family 2, facilitated glucose transporter member 4	0	1	0	1
Amine oxidase [flavin-containing] A	0	11	1	13
Amine oxidase [flavin-containing] A	0	6	0	6
Cystic fibrosis transmembrane conductance regulator	0	0	1	1
Alpha-glucosidase MAL32	0	1	0	1
Signal transducer and activator of transcription 3	0	1	0	1
Dual specificity mitogen-activated protein kinase kinase 4	0	1	2	3
Quinone oxidoreductase	0	0	0	1
Cytoplasmic tyrosine-protein kinase BMX	0	2	1	3
Oxysterols receptor LXR-beta	0	1	0	1
Amine oxidase [flavin-containing] B	0	7	0	7
Oxysterols receptor LXR-alpha	0	1	0	1
Tissue alpha-L-fucosidase	0	1	0	1
DNA (cytosine-5)-methyltransferase 3-like	0	1	0	1
DNA (cytosine-5)-methyltransferase 3A	0	1	0	1
beta-amyloid peptide, A beta {N-terminal} [human, cerebrospinal fluid, conditioned medium of mixed-brain cell cultures, Peptide Partial, 33 aa]	1	0	0	1
alpha synuclein, partial	1	0	0	1
luciferase	3	0	0	3
Glutamate receptor ionotropic, kainate 1	1	1	0	2
Glutamate receptor ionotropic, kainate 2	1	1	0	2
Glutamate receptor ionotropic, kainate 4	1	1	0	2
Glutamate receptor ionotropic, kainate 5	1	1	0	2
Aldo-keto reductase family 1 member C1	0	3	0	3
Asialoglycoprotein receptor 1	0	1	1	2
Chain A, Glutamine Binding Protein	0	0	1	1
Neutral amino acid transporter A	0	2	0	2
Asc-type amino acid transporter 1	0	2	0	2
Neutral amino acid transporter B(0)	0	2	0	2
Amino acid transporter	0	2	0	2
ATP synthase subunit beta, mitochondrial	0	1	0	1
ATP synthase subunit delta, mitochondrial	0	1	0	1
ATP synthase subunit gamma, mitochondrial	0	1	0	1
ATP synthase subunit epsilon, mitochondrial	0	1	0	1
Cholesteryl ester transfer protein	0	1	0	1
Malate dehydrogenase, cytoplasmic	0	3	0	3
Sodium- and chloride-dependent glycine transporter 1	0	1	0	1
Large neutral amino acids transporter small subunit 1	0	7	0	7
Serine racemase	0	1	0	1
Sodium- and chloride-dependent glycine transporter 2	0	1	0	1
Ricin	0	1	0	1
2-amino-4-hydroxy-6-hydroxymethyldihydropteridine pyrophosphokinase	0	0	1	1
Purine nucleoside phosphorylase	0	0	1	2
Chain A, Probable hydrogenase nickel incorporation protein hypB	0	0	1	1
Chain B, Probable hydrogenase nickel incorporation protein hypB	0	0	1	1
Chain A, Hypoxanthine Phosphoribosyltransferase	0	1	0	1
Chain A, HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE	0	1	0	1
Chain A, HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE	0	0	1	1
Chain B, HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE	0	0	1	1
Chain A, HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE	0	0	1	1
Chain A, Xanthine phosphoribosyltransferase	0	0	1	1
Histidine triad nucleotide-binding protein 1	0	0	1	1
Membrane-associated progesterone receptor component 1	0	0	2	2
Tyrosine-protein kinase JAK2	0	4	4	10
Cyclin-dependent kinase-like 5	0	0	3	3
Tyrosine-protein kinase Mer	0	0	3	3
Cyclin-dependent kinase 10	0	0	1	1
Rab-like protein 3	0	0	2	2
Serine/threonine-protein kinase pim-2	0	0	3	3
Serine/threonine-protein kinase ICK	0	0	3	3
Serine/threonine-protein kinase 38-like	0	0	3	3
Serine/threonine-protein kinase 24	0	0	3	3
Vitamin D-binding protein	0	1	0	1
HLA class I histocompatibility antigen, A alpha chain	0	0	1	1
Integrin beta-1	0	2	0	2
Integrin alpha-4	0	2	0	2
AP-2 complex subunit sigma	0	1	0	1
N-acetyltransferase Eis	0	2	0	2
Calcitonin gene-related peptide type 1 receptor	0	1	0	1
Genome polyprotein	0	4	0	4
Zinc finger protein 664	0	1	0	1
Chain E, Fibrin beta chain	0	2	0	2
Mcl-1	0	2	0	2
Cyclin-dependent kinase 5, regulatory subunit 1 (p35)	0	0	0	1
CDK5	0	0	0	1
major prion protein preproprotein Prp precursor	0	1	0	1
Vif	0	3	0	3
Tat	0	2	0	2
endoribonuclease toxin MazF	0	0	1	1
phosphoglycerate kinase	6	0	0	6
Chain A, CARBONIC ANHYDRASE II	0	0	1	1
Chain A, Protein (female-specific Histamine Binding Protein 2)	0	0	1	1
aryl hydrocarbon receptor nuclear translocator	0	0	0	1
transforming acidic coiled-coil-containing protein 3	0	0	0	1
Macrophage migration inhibitory factor	0	4	0	4
Metabotropic glutamate receptor 5	0	1	1	2
Histamine H3 receptor	0	1	0	1
Histamine N-methyltransferase	0	1	0	1
Glutaminyl-peptide cyclotransferase	0	2	0	2
Equilibrative nucleoside transporter 4	0	0	0	1
Histamine H4 receptor	0	1	2	3
Histamine H4 receptor	0	1	2	3
Histamine H4 receptor	0	1	0	1
N-glycosylase/DNA lyase	0	1	0	1
Aspartate aminotransferase, cytoplasmic	0	2	0	2
Stromelysin-1	0	4	1	5
Ribonucleoside-diphosphate reductase large subunit	0	1	0	1
3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase	0	1	0	1
Mast/stem cell growth factor receptor Kit	0	1	2	3
Platelet-derived growth factor receptor alpha	0	1	2	3
Cytochrome P450 3A5	0	5	0	6
Chain A, Cell Division Protein Kinase 2	0	1	0	1
Chain A, CELL DIVISION PROTEIN KINASE 2	0	1	0	1
Chain A, Cell Division Protein Kinase 2	0	1	0	1
Chain A, CELL DIVISION PROTEIN KINASE 2	0	1	0	1
Chain A, CELL DIVISION PROTEIN KINASE 2	0	1	0	1
Chain A, CELL DIVISION PROTEIN KINASE 2	0	1	0	1
Chain A, CELL DIVISION PROTEIN KINASE 2	0	1	0	1
Chain A, CELL DIVISION PROTEIN KINASE 2	0	1	0	1
Chain A, CELL DIVISION PROTEIN KINASE 2	0	1	0	1
Chain A, CELL DIVISION PROTEIN KINASE 2	0	1	0	1
Chain A, CELL DIVISION PROTEIN KINASE 2	0	1	0	1
Chain A, CELL DIVISION PROTEIN KINASE 2	0	1	0	1
Chain A, CELL DIVISION PROTEIN KINASE 2	0	1	0	1
Chain A, Cell Division Protein Kinase 2	0	1	0	1
DNA repair and recombination protein RadA	0	0	1	1
Indoleamine 2,3-dioxygenase 1	0	4	1	6
Cyclin-A2	0	1	0	1
Cyclin-A1	0	1	0	1
Chain A, PROTEIN (PROTEASE)	0	1	0	1
Chain B, PROTEIN (PROTEASE)	0	1	0	1
Chain A, PROTEIN (PROTEASE)	0	1	0	1
Chain B, PROTEIN (PROTEASE)	0	1	0	1
Chain A, HIV-1 PROTEASE	0	1	0	1
Chain B, HIV-1 PROTEASE	0	1	0	1
Chain A, HIV-II PROTEASE	0	1	0	1
Chain B, HIV-II PROTEASE	0	1	0	1
Chain A, POL polyprotein	0	0	1	1
Chain B, POL polyprotein	0	0	1	1
Chain A, POL polyprotein	0	0	1	1
Chain B, POL polyprotein	0	0	1	1
Chain A, POL polyprotein	0	0	1	1
Chain B, POL polyprotein	0	0	1	1
Chain A, POL polyprotein	0	0	1	1
Chain B, POL polyprotein	0	0	1	1
Chain A, protease RETROPEPSIN	0	1	0	1
Chain B, protease RETROPEPSIN	0	1	0	1
Chain A, protease RETROPEPSIN	0	1	0	1
Chain B, protease RETROPEPSIN	0	1	0	1
Chain A, protease RETROPEPSIN	0	1	0	1
Chain B, protease RETROPEPSIN	0	1	0	1
Chain A, POL polyprotein	0	2	0	2
Chain B, POL polyprotein	0	2	0	2
Chain A, POL polyprotein	0	2	0	2
Chain B, POL polyprotein	0	2	0	2
Chain A, HIV-1 protease	0	1	0	1
Chain B, HIV-1 protease	0	1	0	1
Chain A, Pol polyprotein	0	1	0	1
Chain B, Pol polyprotein	0	1	0	1
Chain A, Pol polyprotein	0	1	0	1
Chain B, Pol polyprotein	0	1	0	1
Chain A, Pol polyprotein	0	1	0	1
Chain B, Pol polyprotein	0	1	0	1
Chain A, Pol polyprotein	0	1	0	1
Chain B, Pol polyprotein	0	1	0	1
Chain A, Hiv-1 Protease	0	1	0	1
Chain B, Hiv-1 Protease	0	1	0	1
Chain A, Hiv-1 Protease	0	1	0	1
Chain B, Hiv-1 Protease	0	1	0	1
Chain A, Hiv-1 Protease	0	1	0	1
Chain B, Hiv-1 Protease	0	1	0	1
Gag-Pol polyprotein	0	7	0	7
Gag-Pol polyprotein	0	2	0	2
Gag polyprotein	0	2	0	2
Gag-Pol polyprotein	0	5	0	5
Gag-Pol polyprotein	0	5	0	5
Thromboxane-A synthase	0	0	0	3
Protease	0	10	6	17
Protease	0	1	0	1
Chain A, membrane-associated prostaglandin E synthase-2	0	1	0	1
Phospholipase A2, major isoenzyme	0	2	0	2
Aldo-keto reductase family 1 member C4	0	1	0	1
C-X-C chemokine receptor type 3	0	3	0	3
Prostaglandin D2 receptor	0	2	0	2
Uracil nucleotide/cysteinyl leukotriene receptor	0	2	0	2
Dehydrogenase/reductase SDR family member 9	0	1	0	1
Prostaglandin D2 receptor 2	0	1	1	2
Chain B, Pulmonary surfactant-associated protein D	0	1	0	1
Chain A, Pulmonary surfactant-associated protein D	0	1	0	1
Sodium/myo-inositol cotransporter 2	0	1	0	1
Beta-2 adrenergic receptor	0	0	1	1
Beta-3 adrenergic receptor	0	0	1	1
Vasopressin V1a receptor	0	1	1	2
Taste receptor type 2 member 38	0	0	2	4
Taste receptor type 2 member 39	0	0	1	1
Taste receptor type 2 member 40	0	0	1	1
Taste receptor type 2 member 41	0	0	1	1
Taste receptor type 2 member 43	0	0	1	1
Taste receptor type 2 member 31	0	0	1	1
Taste receptor type 2 member 45	0	0	1	1
Taste receptor type 2 member 46	0	0	2	2
Taste receptor type 2 member 30	0	0	1	1
Taste receptor type 2 member 19	0	0	1	1
Taste receptor type 2 member 20	0	0	1	1
Taste receptor type 2 member 50	0	0	1	1
Taste receptor type 2 member 60	0	0	1	1
Oxytocin receptor	0	1	1	2
Beta-2 adrenergic receptor	0	1	2	5
Taste receptor type 2 member 42	0	0	1	1
Taste receptor type 2 member 16	0	0	1	1
Taste receptor type 2 member 14	0	0	1	2
Taste receptor type 2 member 13	0	0	1	1
Taste receptor type 2 member 10	0	0	2	3
Taste receptor type 2 member 9	0	0	1	1
Taste receptor type 2 member 8	0	0	1	1
Taste receptor type 2 member 7	0	0	1	1
Taste receptor type 2 member 5	0	0	1	1
Taste receptor type 2 member 4	0	0	1	1
Taste receptor type 2 member 3	0	0	1	1
Taste receptor type 2 member 1	0	0	1	1
Ornithine decarboxylase	0	0	0	1
Retinoic acid receptor alpha	0	1	0	1
Retinoic acid receptor gamma	0	1	0	1
Retinoic acid receptor beta	0	1	0	1
Cellular retinoic acid-binding protein 2	0	0	1	1
Retinoic acid receptor RXR-beta	0	1	0	1
Retinoic acid receptor RXR-gamma	0	1	0	1
Cellular retinoic acid-binding protein 1	0	1	0	1
Cellular retinoic acid-binding protein 1	0	0	1	1
Voltage-dependent L-type calcium channel subunit alpha-1C	0	1	0	1
Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2	0	0	1	1
Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1	0	0	1	1
Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4	0	0	1	1
Sphingosine 1-phosphate receptor 2	0	2	2	5
Sphingosine 1-phosphate receptor 4	0	2	1	3
Sphingosine 1-phosphate receptor 2	0	1	0	1
Sphingosine 1-phosphate receptor 3	0	2	1	3
Sphingosine 1-phosphate receptor 5	0	2	1	3
5-hydroxytryptamine receptor 1B	0	7	1	9
Synaptic vesicular amine transporter	0	4	1	5
Estrogen receptor beta	0	2	1	3
25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial	0	1	0	1
25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial	0	2	0	2
Cytochrome P450 26A1	0	1	0	1
Camphor 5-monooxygenase	0	0	0	1
Steroid 17-alpha-hydroxylase/17,20 lyase	0	3	0	3
Epoxide hydrolase 1	0	0	0	1
Cytochrome P450 2C11	0	2	0	2
Steroid 21-hydroxylase	0	1	0	1
Steroid 17-alpha-hydroxylase/17,20 lyase	0	1	0	1
Cholesterol side-chain cleavage enzyme, mitochondrial	0	1	0	1
Cytochrome P450 2A2	0	1	0	1
Cytochrome P450 11B1, mitochondrial	0	2	0	2
Cytochrome P450 11B1, mitochondrial	0	2	0	2
Cytochrome P450 7A1	0	1	0	1
Cytochrome P450 11B2, mitochondrial	0	2	0	2
Estrogen receptor	0	2	1	3
Gonadotropin-releasing hormone receptor	0	3	1	4
Type-1 angiotensin II receptor	0	4	1	5
Cytochrome P450 4F2	0	2	0	2
1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial	0	1	0	1
Cytochrome P450 7A1	0	1	0	1
Lanosterol 14-alpha demethylase	0	2	0	2
5-hydroxytryptamine receptor 1E	0	3	0	4
Synaptic vesicle glycoprotein 2A	0	2	0	2
integrase, partial	0	2	0	2
lens epithelium-derived growth factor p75	0	2	0	2
SLC16A10 protein	0	0	0	3
Monocarboxylate transporter 10	0	0	0	3
CAAX prenyl protease 2 isoform 2	0	0	0	1
DNA gyrase subunit A	0	3	0	4
DNA primase	0	2	0	2
Potassium voltage-gated channel subfamily A member 5	0	2	0	2
Potassium voltage-gated channel subfamily D member 2	0	1	0	1
Potassium channel subfamily K member 18	0	1	0	1
N-formyl peptide receptor 2	0	1	0	1
Glucagon-like peptide 1 receptor	0	2	2	4
inositol monophosphatase 1	1	0	0	1
Chain A, protease	0	1	0	1
Chain B, protease	0	1	0	1
Chain A, protease	0	0	1	1
Chain B, protease	0	0	1	1
Chain A, protease	0	0	1	1
Chain B, protease	0	0	1	1
Chain A, protease	0	0	1	1
Chain B, protease	0	0	1	1
Chain A, protease	0	0	1	1
Chain B, protease	0	0	1	1
Chain A, protease	0	0	1	1
Chain B, protease	0	0	1	1
Chain A, Protease	0	1	0	1
Chain B, Protease	0	1	0	1
Chain A, Protease	0	1	0	1
Chain B, Protease	0	1	0	1
Chain A, Protease	0	1	0	1
Chain B, Protease	0	1	0	1
Chain A, PROTEASE RETROPEPSIN	0	1	0	1
Chain B, PROTEASE RETROPEPSIN	0	1	0	1
Chain A, Protease Retropepsin	0	1	0	1
Chain B, Protease Retropepsin	0	1	0	1
Chain A, Protease Retropepsin	0	1	0	1
Chain B, Protease Retropepsin	0	1	0	1
Gag-Pol polyprotein	0	3	0	3
CAAX prenyl protease 1 homolog	0	1	0	1
Plasmepsin V	0	2	0	2
Sodium-dependent neutral amino acid transporter B(0)AT2	0	1	0	1
Potassium channel subfamily K member 9	0	1	0	1
Type-1 angiotensin II receptor	0	2	1	3
Chain A, Antigen Cd11a (p180)	0	1	0	1
Integrin beta-2	0	1	0	1
Intercellular adhesion molecule 1	0	1	0	1
Integrin alpha-L	0	1	1	2
Acyl-CoA:cholesterol acyltransferase	0	2	0	2
Melatonin receptor type 1C	0	1	1	2
Catechol O-methyltransferase	0	2	0	2
Sodium-dependent dopamine transporter	0	1	0	1
Chain A, Ribulose-1,5 bisphosphate carboxylase/oxygenase large subunit N-methyltransferase, chloroplast	0	1	0	1
Chain A, Ribulose-1,5 bisphosphate carboxylase/oxygenase large subunit N-methyltransferase, chloroplast	0	1	0	1
histone-lysine N-methyltransferase NSD2 isoform 1	0	0	0	1
MBT domain-containing protein 1	0	2	0	2
Lethal(3)malignant brain tumor-like protein 4	0	2	0	2
Lethal(3)malignant brain tumor-like protein 3	0	2	0	2
Lethal(3)malignant brain tumor-like protein 1	0	2	0	2
C-C chemokine receptor type 5	0	1	0	1
C-C chemokine receptor type 5	0	1	0	1
bioA	0	0	0	1
Metabotropic glutamate receptor 1	0	1	0	1
Nociceptin receptor	0	1	0	1
Melatonin receptor type 1A	0	1	1	2
Melatonin receptor type 1C	0	1	1	2
Melatonin receptor type 1B	0	1	1	2
Large neutral amino acids transporter small subunit 1	0	1	0	1
Heparanase	0	0	1	1
Aldehyde oxidase 1	0	1	0	1
Synaptic vesicular amine transporter	0	4	0	4
Trace amine-associated receptor 1	0	0	1	1
Trace amine-associated receptor 1	0	0	2	2
Trace amine-associated receptor 1	0	1	3	4
corticotropin-releasing hormone receptor 2	0	1	1	2
corticotropin releasing factor-binding protein	0	1	1	2
Dopamine beta-hydroxylase	0	2	0	3
Lactoperoxidase	0	1	0	1
Chain A, Methionyl-tRNA synthetase	0	0	1	1
Chain A, Methionyl-tRNA synthetase	0	0	1	1
Chain A, Aminopeptidase	0	1	0	1
Chain A, Methionine aminopeptidase	0	1	0	1
S-ribosylhomocysteine lyase	0	1	0	1
Adenylate cyclase type 5	0	0	0	1
S-adenosylmethionine synthase isoform type-1	0	0	0	1
S-adenosylmethionine synthase isoform type-2	0	0	0	1
Chain B, DIHYDROFOLATE REDUCTASE	0	0	1	1
Chain B, DIHYDROFOLATE REDUCTASE	0	0	1	1
Chain B, DIHYDROFOLATE REDUCTASE	0	0	1	1
Thymidylate synthase	0	1	0	1
Thymidylate synthase	0	1	0	1
Fatty-acid amide hydrolase 1	0	1	0	1
ATP-binding cassette sub-family C member 3	0	1	0	2
Dihydrofolate reductase	0	2	0	3
Dihydrofolate reductase	0	1	0	1
Dihydrofolate reductase	0	2	0	3
Thymidylate synthase	0	1	0	1
Bifunctional dihydrofolate reductase-thymidylate synthase	0	1	0	1
High mobility group protein B1	0	0	1	1
Dihydrofolate reductase	0	1	0	1
Thymidylate synthase	0	1	0	1
Bifunctional dihydrofolate reductase-thymidylate synthase	0	1	0	1
Folate receptor beta	0	1	0	1
Folate receptor alpha	0	1	0	1
Dihydrofolate reductase	0	2	0	2
Histidine decarboxylase	0	1	3	4
Trifunctional purine biosynthetic protein adenosine-3	0	1	0	1
Bifunctional purine biosynthesis protein ATIC	0	3	0	3
Reduced folate transporter	0	2	0	2
Dihydrofolate reductase	0	1	0	1
Bifunctional dihydrofolate reductase-thymidylate synthase	0	1	0	1
Bifunctional dihydrofolate reductase-thymidylate synthase	0	1	0	1
Trifunctional purine biosynthetic protein adenosine-3	0	1	0	1
Dihydrofolate reductase	0	1	0	1
Dihydrofolate reductase	0	1	0	1
Proton-coupled folate transporter	0	1	0	1
Cystathionine gamma-lyase	0	3	0	3
T cell receptor, partial	1	0	0	1
luteinizing hormone receptor	1	0	0	1
Apoptotic peptidase activating factor 1	0	1	0	1
neutrophil cytosol factor 1	0	1	0	1
caspase-9 isoform alpha precursor	0	1	0	1
caspase-3 isoform a preproprotein	0	1	0	1
replicative DNA helicase	0	0	0	1
recombinase A	0	0	1	1
Glutathione reductase	0	1	0	1
Dihydrolipoyl dehydrogenase, mitochondrial	0	1	0	2
Dihydrolipoyl dehydrogenase	0	1	0	2
5-hydroxytryptamine receptor 3B	0	3	0	3
G-protein coupled receptor	0	1	0	1
Multidrug transporter MdfA	0	2	0	2
Nuclear receptor corepressor 1	0	3	0	3
Nuclear receptor corepressor 2	0	3	0	3
Acyl-CoA desaturase 1	0	1	0	1
Proteinase-activated receptor 1	0	2	1	3
Nociceptin receptor	0	1	0	1
Mu-type opioid receptor	0	1	0	1
N(G),N(G)-dimethylarginine dimethylaminohydrolase 1	0	0	0	2
N(G),N(G)-dimethylarginine dimethylaminohydrolase 1	0	0	0	1
Chain B, Exotoxin A	0	0	1	1
Chain B, Exotoxin A	0	0	1	1
Chain B, Exotoxin A	0	0	1	1
voltage-dependent T-type calcium channel subunit alpha-1H isoform a	0	0	1	1
kappa-type opioid receptor isoform 1	0	1	0	1
Beta-galactosidase	0	0	1	1
UDP-glucuronosyltransferase 1A8	0	0	0	3
Nociceptin receptor	0	1	0	1
[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial	0	2	0	2
[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrial	0	1	0	1
[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 3, mitochondrial	0	1	0	1
[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 4, mitochondrial	0	1	0	1
Chain A, Hth-type Transcriptional Regulator Ttgr	0	0	1	1
Chain A, Hth-type Transcriptional Regulator Ttgr	0	0	1	1
Chain A, Mitogen-activated protein kinase 14	0	1	0	1
Chain A, Mitogen-activated protein kinase 14	0	1	0	1
Chain A, Mitogen-activated protein kinase 14	0	1	0	1
Chain A, Mitogen-activated protein kinase 14	0	1	0	1
Chain A, Mitogen-activated protein kinase 14	0	1	0	1
Chain A, Mitogen-activated protein kinase 14	0	1	0	1
Chain A, Mitogen-activated protein kinase 14	0	1	0	1
Chain A, Mitogen-activated protein kinase 14	0	1	0	1
Chain A, Mitogen-activated protein kinase 14	0	1	0	1
Chain A, ASPARTYLPROTEASE	0	1	0	1
Chain B, ASPARTYLPROTEASE	0	1	0	1
Neuromedin-K receptor	0	0	2	2
Substance-K receptor	0	1	2	3
Substance-P receptor	0	7	1	8
Neuromedin-K receptor	0	3	2	5
Neuromedin-K receptor	0	1	1	2
Substance-K receptor	0	2	0	2
Substance-K receptor	0	2	0	2
Neuropeptide Y receptor type 1	0	2	0	2
Neuropeptide Y receptor type 2	0	2	0	2
Collagenase 3	0	5	0	5
Cholesteryl ester transfer protein	0	1	0	1
D-amino-acid oxidase	0	1	0	1
Hydroxycarboxylic acid receptor 3	0	0	1	1
Nicotinamidase	0	1	0	1
Hydroxycarboxylic acid receptor 2	0	0	1	1
Hydroxycarboxylic acid receptor 2	0	3	1	4
D-aspartate oxidase	0	1	0	1
Hydroxycarboxylic acid receptor 2	0	1	1	2
Chain A, NAD-dependent deacetylase	0	1	0	1
NAD-dependent histone deacetylase SIR2	0	1	0	1
NAD-dependent protein deacetylase HST2	0	2	0	2
NAD(+) hydrolase SARM1	0	1	0	1
NAD-dependent protein deacetylase sirtuin-6	0	1	0	1
NAD-dependent protein deacylase sirtuin-5, mitochondrial	0	5	0	5
NAD-dependent protein deacetylase	0	1	0	1
Equilibrative nucleoside transporter 1	0	1	0	1
Neuronal acetylcholine receptor subunit alpha-4	0	2	1	3
Acetylcholine receptor subunit alpha	0	2	1	3
Acetylcholine receptor subunit beta	0	2	1	3
Acetylcholine receptor subunit gamma	0	2	1	3
Acetylcholine receptor subunit delta	0	2	1	3
Neuronal acetylcholine receptor subunit alpha-4	0	1	0	1
Acetylcholine receptor subunit beta-like 2	0	2	0	2
Neuronal acetylcholine receptor subunit alpha-5	0	0	1	1
Neuronal acetylcholine receptor subunit alpha-7	0	2	0	2
Acetylcholine-binding protein	0	1	1	2
Acetylcholine receptor subunit epsilon	0	0	1	1
Neuronal acetylcholine receptor subunit beta-3	0	1	1	2
Neuronal acetylcholine receptor subunit alpha-2	0	1	0	1
Neuronal acetylcholine receptor subunit alpha-6	0	1	1	2
Cytochrome P450 2A13	0	2	1	3
Neuronal acetylcholine receptor subunit alpha-5	0	2	0	2
Liver carboxylesterase B-1	0	1	0	1
Neuronal acetylcholine receptor subunit beta-3	0	2	0	2
Neuronal acetylcholine receptor subunit beta-4	0	2	0	2
Neuronal acetylcholine receptor subunit alpha-3	0	2	0	2
Soluble acetylcholine receptor	0	1	0	1
Neuronal acetylcholine receptor subunit alpha-2	0	2	0	2
Neuronal acetylcholine receptor subunit beta-2	0	2	1	3
Neuronal acetylcholine receptor subunit alpha-6	0	2	0	2
Integrin beta	0	0	1	1
Glycoprotein IIb	0	0	1	1
Phospholipase A2, membrane associated	0	0	0	1
Voltage-dependent L-type calcium channel subunit alpha-1C	0	1	0	1
Voltage-dependent L-type calcium channel subunit alpha-1S	0	1	0	1
C-terminal-binding protein 1	1	0	0	1
Indoleamine 2,3-dioxygenase 2	0	3	0	3
Voltage-dependent L-type calcium channel subunit alpha-1D	0	1	0	1
Voltage-dependent L-type calcium channel subunit alpha-1F	0	1	0	1
Chain A, Phospholipase A2 isoform 3	0	0	1	1
Transcription factor SOX-18	0	1	0	1
Dihydroorotate dehydrogenase (quinone), mitochondrial	0	1	0	1
Transcriptional enhancer factor TEF-3	0	1	1	2
Sodium/iodide cotransporter	0	1	0	1
G-protein coupled receptor 55	0	1	0	1
Platelet-activating factor receptor	0	1	0	1
Nitric oxide synthase, inducible	0	2	0	2
Nitric oxide synthase, brain	0	2	0	2
Cytochrome P450 2D1	0	1	0	1
Cytochrome P450 2D26	0	1	0	1
Cytochrome P450 2D3	0	1	0	1
Sodium- and chloride-dependent betaine transporter	0	1	0	1
Cytochrome P450 2D4	0	1	0	1
Calcium-activated potassium channel subunit alpha-1	0	1	0	2
Calcium-activated potassium channel subunit beta-1	0	0	0	1
STE24	0	0	0	1
DNA gyrase subunit A	0	1	0	2
DNA gyrase subunit B	0	1	0	2
DNA gyrase subunit B	0	2	0	3
Bifunctional cytochrome P450/NADPH--P450 reductase	0	0	1	1
Potassium-transporting ATPase subunit beta	0	1	0	1
Potassium-transporting ATPase alpha chain 1	0	1	0	1
Bombesin receptor subtype-3	0	0	1	1
Potassium-transporting ATPase alpha chain 2	0	0	0	1
WD repeat-containing protein 5	0	1	0	1
Glutathione S-transferase omega-1	0	2	0	2
Histone-lysine N-methyltransferase 2A	0	1	0	1
Cytosolic endo-beta-N-acetylglucosaminidase	0	1	0	1
Phosphatidylserine lipase ABHD16A	0	1	0	1
Lipoprotein lipase	0	1	0	1
Hepatic triacylglycerol lipase	0	1	0	1
Pancreatic triacylglycerol lipase	0	1	0	1
Platelet-activating factor acetylhydrolase	0	3	0	3
Neutral cholesterol ester hydrolase 1	0	1	0	1
Diacylglycerol lipase-alpha	0	1	0	1
Diacylglycerol lipase-beta	0	1	0	1
Acyl-protein thioesterase 2	0	1	0	1
Diacylglycerol lipase-alpha	0	1	0	1
Endothelial lipase	0	1	0	1
polyadenylate-binding protein 1	0	2	0	2
Chain A, Bacterial leucyl aminopeptidase	0	1	0	1
Thermolysin	0	2	0	3
Catechol O-methyltransferase	0	2	0	2
Methionine aminopeptidase 2	0	1	0	1
Methionine aminopeptidase 1	0	1	0	1
Valosin-containing protein	0	1	0	1
microphthalmia-associated transcription factor isoform 9	0	1	0	1
eukaryotic translation initiation factor 4 gamma 1 isoform 4	0	2	0	2
eukaryotic translation initiation factor 4E isoform 1	0	2	0	2
Vasopressin V2 receptor	0	2	1	3
Oxytocin receptor	0	2	2	4
Vasopressin V1b receptor	0	1	1	2
Vasopressin V1b receptor	0	1	0	1
Oxytocin receptor	0	0	1	1
Vasopressin V2 receptor	0	1	0	1
Chain A, cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A	0	1	0	1
Serine hydroxymethyltransferase, mitochondrial	0	1	0	1
cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A	0	2	0	2
Pyrroline-5-carboxylate reductase 1, mitochondrial	0	1	0	1
Renin	0	1	0	1
Beta-adrenergic receptor kinase 1	0	1	0	1
Rhodopsin kinase GRK1	0	1	0	1
G protein-coupled receptor kinase 5	0	1	0	1
G protein-coupled receptor kinase 5	0	1	0	1
P2X purinoceptor 4	0	1	1	2
Rhodopsin kinase GRK1	0	1	1	2
Beta-adrenergic receptor kinase 1	0	0	0	1
Tumor necrosis factor	0	2	1	3
Chain A, Immunoglobulin	0	0	1	1
Chain B, Immunoglobulin	0	0	1	1
Cholinesterase	0	2	0	2
Muscarinic acetylcholine receptor M5	0	1	1	3
Membrane primary amine oxidase	0	1	0	1
Alpha-1B adrenergic receptor	0	6	0	6
fMet-Leu-Phe receptor	0	1	0	1
Acetylcholinesterase	0	1	0	1
Complement C1s subcomponent	0	1	0	1
Voltage-dependent T-type calcium channel subunit alpha-1G	0	0	1	1
Ubiquitin carboxyl-terminal hydrolase 1	0	1	0	1
WD repeat-containing protein 48	0	1	0	1
CDGSH iron-sulfur domain-containing protein 1	0	1	0	1
Peroxisome proliferator-activated receptor gamma	0	1	0	1
Carnitine O-palmitoyltransferase 2, mitochondrial	0	1	0	1
CDGSH iron-sulfur domain-containing protein 2	0	1	0	1
Muscarinic acetylcholine receptor DM1	0	1	0	1
Transforming growth factor beta-1 proprotein	0	1	0	1
Mothers against decapentaplegic homolog 3	0	1	0	1
C-X-C chemokine receptor type 4	0	1	0	1
Atypical chemokine receptor 3	0	0	1	1
C-X-C chemokine receptor type 4	0	2	0	4
Beta-casein	0	1	0	1
Alpha-2A adrenergic receptor	0	2	0	2
Alpha-mannosidase 2C1	0	0	1	1
Bromodomain-containing protein 2	0	2	0	2
luciferase	0	0	0	1
Glucocorticoid receptor	0	0	1	1
Glutamine synthetase	0	0	1	1
Nociceptin receptor	0	0	1	1
Voltage-dependent calcium channel subunit alpha-2/delta-1	0	2	0	3
Voltage-dependent calcium channel subunit alpha-2/delta-2	0	2	0	2
Vascular cell adhesion protein 1	0	1	0	1
Nuclear receptor subfamily 2 group E member 1	0	0	4	4
Chain A, Ferritin light chain	0	0	1	1
Chain A, Ferritin light chain	0	0	1	1
Chain A, Ferritin light chain	0	0	1	1
Chain A, Ferritin light chain	0	0	1	1
Chain A, Ferritin light chain	0	0	1	1
Chain A, Ferritin light chain	0	0	1	1
Chain A, Ferritin light chain	0	0	1	1
Cholecystokinin receptor type A	0	3	3	6
NADH-cytochrome b5 reductase 3	0	1	0	1
Thyroid peroxidase	0	1	0	1
Sulfotransferase 2A1	0	1	0	1
Chain A, Mitogen-activated protein kinase 10	0	1	0	1
Chain A, Mitogen-activated protein kinase 10	0	1	0	1
Chain A, Mitogen-activated protein kinase 10	0	1	0	1
Death-associated protein kinase 3	0	0	2	2
Interferon-induced, double-stranded RNA-activated protein kinase	0	1	1	2
Ephrin type-A receptor 3	0	0	2	2
Tyrosine-protein kinase JAK3	0	4	2	9
Mitogen-activated protein kinase 12	0	1	2	3
Calcium/calmodulin-dependent protein kinase type 1	0	0	2	2
Ribosomal protein S6 kinase alpha-2	0	0	2	2
Serine/threonine-protein kinase ULK3	0	0	1	1
Calcium/calmodulin-dependent protein kinase type 1D	0	0	2	2
Calcium/calmodulin-dependent protein kinase type 1G	0	0	3	3
Serine/threonine-protein kinase 3	0	0	1	1
Serine/threonine-protein kinase 17A	0	0	2	2
Death-associated protein kinase 2	0	0	2	2
Aurora kinase C	0	0	2	2
Prolyl 4-hydroxylase subunit alpha-1	0	1	0	1
Autoinducer 2-binding periplasmic protein LuxP	0	1	0	1
5-lipoxygenase	0	1	0	1
Chain A, APH(2')-Id	0	1	0	1
glucose-6-phosphate dehydrogenase	0	1	0	1
hexokinase	0	2	0	2
NUAK family SNF1-like kinase 1	0	1	1	2
Chymotrypsin-like elastase family member 1	0	1	0	1
Protein E6	0	1	0	1
Epoxide hydrolase 1	0	1	0	1
Heterogeneous nuclear ribonucleoprotein A1	0	0	1	1
Malate dehydrogenase	0	1	0	1
Solute carrier family 2, facilitated glucose transporter member 2	0	1	0	1
Solute carrier family 2, facilitated glucose transporter member 4	0	1	0	1
5'-nucleotidase	0	1	0	1
Glyceraldehyde-3-phosphate dehydrogenase, glycosomal	0	1	0	1
Phosphatidylinositol 3-kinase regulatory subunit alpha	0	2	0	2
Cytosol aminopeptidase	0	1	0	1
ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1	0	2	0	2
Tyrosine-protein kinase receptor UFO	0	1	1	2
Macrophage metalloelastase	0	1	0	1
Glutathione reductase	0	1	0	1
Oligo-1,6-glucosidase IMA1	0	1	0	1
Monocarboxylate transporter 1	0	1	0	1
Anthrax toxin receptor 2	0	2	0	2
Aldo-keto reductase family 1 member B1	0	1	0	1
Heat shock factor protein 1	0	1	0	1
cGMP-dependent 3',5'-cyclic phosphodiesterase	0	4	0	4
Calcium/calmodulin-dependent protein kinase type II subunit beta	0	1	1	2
ELAV-like protein 3	0	1	0	1
ELAV-like protein 1	0	1	0	1
Probable maltase-glucoamylase 2	0	1	0	1
Monocarboxylate transporter 2	0	1	0	1
Aldo-keto reductase family 1 member C21	0	2	0	2
Serine/threonine-protein kinase Nek6	0	1	1	2
Dipeptidyl peptidase 4	0	0	1	1
Metabotropic glutamate receptor 5	0	0	1	1
Chromaffin granule amine transporter	0	1	0	1
Synaptic vesicular amine transporter	0	1	0	1
Chain A, Troponin C, slow skeletal and cardiac muscles	0	0	1	1
Chain A, Leukotriene A-4 hydrolase	0	1	0	1
Chain A, Leukotriene A-4 hydrolase	0	1	0	1
Chain A, Leukotriene A-4 hydrolase	0	1	0	1
Chain A, Leukotriene A-4 hydrolase	0	1	0	1
Chain A, Leukotriene A-4 hydrolase	0	1	0	1
Chain A, Leukotriene A-4 hydrolase	0	1	0	1
Chain A, Leukotriene A-4 hydrolase	0	1	0	1
Chain A, Leukotriene A-4 hydrolase	0	1	0	1
Chain A, Leukotriene A-4 hydrolase	0	1	0	1
Chain A, Leukotriene A-4 hydrolase	0	1	0	1
Chain A, Leukotriene A-4 hydrolase	0	1	0	1
Chain A, Leukotriene A-4 hydrolase	0	1	0	1
Chain A, Leukotriene A-4 hydrolase	0	1	0	1
Chain A, Leukotriene A-4 hydrolase	0	1	0	1
Chain A, Leukotriene A-4 hydrolase	0	1	0	1
Chain A, Leukotriene A-4 hydrolase	0	1	0	1
Chain A, Leukotriene A-4 hydrolase	0	1	0	1
M18 aspartyl aminopeptidase	0	1	0	1
cathepsin L1	0	1	0	1
transcription factor p65 isoform 1	0	0	1	1
Aryl hydrocarbon receptor	0	1	0	1
Myc proto-oncogene protein	0	1	0	2
Luciferin 4-monooxygenase	0	1	0	1
DNA polymerase alpha catalytic subunit	0	1	0	1
N1L	0	1	0	1
NAD(P)H dehydrogenase [quinone] 1	0	0	0	3
Lysosomal alpha-glucosidase	0	2	0	2
Chain A, PLASMA RETINOL-BINDING PROTEIN PRECURSOR	0	0	1	1
Retinol-binding protein 4	0	0	1	1
Beta-lactoglobulin	0	0	1	1
Ribonuclease HI	0	1	0	1
NS5	0	0	2	2
Polymerase basic protein 2	0	0	1	1
RNA-directed RNA polymerase catalytic subunit	0	0	1	1
Genome polyprotein	0	0	1	1
DNA-directed RNA polymerase subunit beta	0	1	0	1
NH(3)-dependent NAD(+) synthetase	0	1	0	1
DNA-directed RNA polymerase subunit beta	0	1	0	1
Chain A, HIV-1 PROTEASE	0	1	0	1
Chain B, HIV-1 PROTEASE	0	1	0	1
Chain A, Endothiapepsin	0	1	0	1
Chain A, Endothiapepsin	0	1	0	1
Retina-specific copper amine oxidase	0	2	0	2
High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8B	0	4	0	4
cGMP-specific 3',5'-cyclic phosphodiesterase	0	4	0	4
Phosphodiesterase	0	1	0	1
Neuromedin-U receptor 2	0	0	2	2
Chain A, Lysr-type Regulatory Protein	0	0	1	1
Chain A, Lysr-type Regulatory Protein	0	0	1	1
Chain A, Lysr-type Regulatory Protein	0	0	1	1
Chain A, 146aa long hypothetical transcriptional regulator	0	0	1	1
Chain A, Anthranilate phosphoribosyltransferase	0	1	0	1
Chain A, Anthranilate phosphoribosyltransferase	0	1	0	1
Chain A, Anthranilate phosphoribosyltransferase	0	1	0	1
Chain B, Anthranilate phosphoribosyltransferase	0	1	0	1
Chain C, Anthranilate phosphoribosyltransferase	0	1	0	1
Chain A, Anthranilate phosphoribosyltransferase	0	1	0	1
Anthranilate phosphoribosyltransferase	0	1	0	1
Chain A, Hiv-1 Protease	0	1	0	1
Chain B, Hiv-1 Protease	0	1	0	1
Chain A, Protease	0	0	1	1
Chain B, Protease	0	0	1	1
Chain A, Protease	0	0	1	1
Chain B, Protease	0	0	1	1
Exoribonuclease H	0	1	0	1
Chloroquine resistance transporter	0	2	0	2
Type-1 angiotensin II receptor	0	1	0	1
Amine oxidase [flavin-containing] A	0	0	0	1
Amine oxidase [flavin-containing] B	0	0	0	1
Transcriptional activator protein LuxR	0	2	0	2
Chain A, cGMP-specific 3',5'-cyclic phosphodiesterase	0	0	1	1
Chain A, cGMP-specific 3',5'-cyclic phosphodiesterase	0	0	1	1
Chain A, cGMP-specific 3',5'-cyclic phosphodiesterase	0	0	1	1
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4B	0	2	0	2
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4B	0	2	0	2
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4B	0	2	0	2
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4B	0	2	0	2
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4B	0	2	0	2
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4B	0	2	0	2
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4D	0	2	0	2
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4D	0	2	0	2
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4D	0	2	0	2
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4D	0	2	0	2
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4B	0	2	0	2
Chain B, cAMP-specific 3',5'-cyclic phosphodiesterase 4B	0	2	0	2
Chain A, cGMP-specific 3',5'-cyclic phosphodiesterase	0	2	0	2
Chain A, cGMP-specific 3',5'-cyclic phosphodiesterase	0	2	0	2
cGMP-specific 3',5'-cyclic phosphodiesterase	0	5	2	7
Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma	0	3	0	3
Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha	0	3	0	3
Cone cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha'	0	3	0	3
Retinal cone rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma	0	3	0	3
Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit beta	0	3	0	3
Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma	0	1	0	1
Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta	0	3	0	3
photoreceptor-specific nuclear receptor	0	1	0	1
3-hydroxy-3-methylglutaryl-coenzyme A reductase	0	1	0	1
Cholecystokinin receptor type A	0	1	0	1
Gastrin/cholecystokinin type B receptor	0	2	2	4
Eukaryotic translation initiation factor 4E	0	0	1	1
Peptidyl-prolyl cis-trans isomerase FKBP1A	0	1	0	1
Serine/threonine-protein kinase receptor R3	0	0	2	2
Peptidyl-prolyl cis-trans isomerase FKBP1A	0	4	2	6
Peptidyl-prolyl cis-trans isomerase FKBP1B	0	0	2	2
Cyclin-dependent kinase 18	0	0	2	2
Peptidyl-prolyl cis-trans isomerase FKBP5	0	2	0	2
Programmed cell death protein 4	0	0	1	1
Misshapen-like kinase 1	0	0	2	2
Serine/threonine-protein kinase mTOR	0	1	0	1
Isoleucine--tRNA ligase, mitochondrial	0	0	1	1
Dual specificity tyrosine-phosphorylation-regulated kinase 1B	0	0	2	2
Eyes absent homolog 2	0	1	0	1
Sulfate anion transporter 1	0	0	0	1
C-X-C chemokine receptor type 5 isoform 1	0	1	0	1
C-C chemokine receptor type 6	0	1	0	1
Endoglycoceramidase II	0	0	0	1
Protein kinase C alpha type	0	2	0	2
Protein kinase C delta type	0	2	0	2
Protein kinase C epsilon type	0	2	0	2
Protein kinase C zeta type	0	2	0	2
Protein kinase C gamma type	0	2	0	2
Protein kinase C beta type	0	2	0	2
Protein kinase C eta type	0	2	0	2
Protein kinase C theta type	0	2	0	2
Chain A, Mineralocorticoid receptor	0	1	0	1
Chain A, Mineralocorticoid receptor	0	1	0	1
Chain A, MUSCLE FATTY ACID BINDING PROTEIN	0	0	1	1
Chain A, MUSCLE FATTY ACID BINDING PROTEIN	0	0	1	1
Chain A, MUSCLE FATTY ACID BINDING PROTEIN	0	0	1	1
Dynamin-1	0	1	0	1
Glycine receptor subunit beta	0	1	0	1
Growth hormone secretagogue receptor type 1	0	0	1	1
Chain A, MALTOPORIN	0	0	1	1
Chain B, MALTOPORIN	0	0	1	1
Chain A, Glutathione S-transferase	0	1	0	1
Fibroblast growth factor 1	0	0	1	1
Cystine/glutamate transporter	0	1	0	1
D(2) dopamine receptor	0	1	0	1
ATP-dependent 6-phosphofructokinase	0	1	0	1
Ectonucleoside triphosphate diphosphohydrolase 2	0	1	0	1
P2X purinoceptor 1	0	0	1	1
P2X purinoceptor 2	0	1	1	2
P2X purinoceptor 5	0	0	1	1
P2X purinoceptor 6	0	0	1	1
P2Y purinoceptor 4	0	0	1	1
P2X purinoceptor 3	0	0	1	1
Ectonucleoside triphosphate diphosphohydrolase 1	0	1	0	1
P2Y purinoceptor 6	0	1	0	1
Serine/threonine-protein kinase D1	0	2	1	3
Dual specificity protein phosphatase 5	0	1	0	1
Ectonucleoside triphosphate diphosphohydrolase 8	0	1	0	1
RmtA	0	1	0	1
Ectonucleoside triphosphate diphosphohydrolase 3	0	1	0	1
P2X purinoceptor 7	0	0	1	1
Protein arginine N-methyltransferase 1	0	1	0	1
Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform	0	2	0	2
Splicing factor 3B subunit 3	0	1	0	1
Chain A, CES1 protein	0	1	0	1
Lysosomal acid glucosylceramidase	0	0	1	1
Phospholipase D1	0	1	0	1
Phospholipase D1	0	1	0	1
Emopamil-binding protein-like	0	1	0	1
7-dehydrocholesterol reductase	0	1	1	2
Alpha-1D adrenergic receptor	0	1	0	1
Alpha-1B adrenergic receptor	0	1	0	1
Alpha-1A adrenergic receptor	0	1	0	1
Peroxisome proliferator-activated receptor delta	0	0	1	1
tyrosine-protein phosphatase non-receptor type 7 isoform 2	0	1	0	1
Tetracycline resistance protein, class B	0	0	0	1
Neutrophil collagenase	0	1	0	1
P2Y purinoceptor 12	0	1	0	1
Solute carrier family 22 member 4	0	0	0	1
Solute carrier family 22 member 3	0	0	0	1
Solute carrier family 22 member 4	0	0	0	1
DNA-binding protein Ikaros	0	0	0	1
DNA damage-binding protein 1	0	1	1	2
Chain A, Pyridoxal kinase	0	1	0	1
Chain A, Pyridoxal Kinase	0	1	0	1
Intestinal-type alkaline phosphatase	0	2	0	2
Phospholipase A-2-activating protein	0	2	0	2
Chain A, ykoF	0	0	1	1
Chain B, ykoF	0	0	1	1
Chain A, ThiT	0	0	1	1
Thiamine transporter ThiT	0	0	1	1
Transketolase	0	0	1	1
Thiamine-binding periplasmic protein	0	0	1	1
Ubiquitin-like modifier activating enzyme 2	0	1	0	1
SUMO1 activating enzyme subunit 1	0	1	0	1
SUMO-conjugating enzyme UBC9	0	1	0	1
Cathepsin D	0	1	0	1
Mucosa-associated lymphoid tissue lymphoma translocation protein 1	0	1	0	1
Urease subunit alpha	0	1	0	1
Urease subunit beta	0	1	0	1
Thymidine phosphorylase	0	1	0	1
Chain X, Thyroid hormone receptor beta-1	0	0	2	2
Chain X, Thyroid hormone receptor beta-1	0	0	2	2
Proliferating cell nuclear antigen	0	2	0	2
Malate dehydrogenase, mitochondrial	0	1	0	1
Monocarboxylate transporter 8	0	0	0	1
Solute carrier organic anion transporter family member 1C1	0	0	0	1
Protein Rev	0	0	1	1
Chain A, Tyrosine-protein kinase	0	1	0	1
Chain A, Tyrosine-protein kinase	0	1	0	1
Chain A, Tyrosine-protein kinase JAK2	0	1	0	1
Leukotriene C4 synthase	0	0	1	1
Serine/threonine-protein kinase Sgk1	0	1	0	1
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform	0	0	1	1
Serine/threonine-protein kinase 25	0	0	1	1
Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta	0	0	1	1
Serine/threonine-protein kinase RIO3	0	0	1	1
Dual specificity mitogen-activated protein kinase kinase 7	0	1	1	2
Inhibitor of nuclear factor kappa-B kinase subunit beta	0	0	1	1
Peripheral plasma membrane protein CASK	0	0	1	1
Serine/threonine-protein kinase DCLK1	0	0	1	1
Inhibitor of nuclear factor kappa-B kinase subunit alpha	0	0	1	1
Muscle, skeletal receptor tyrosine-protein kinase	0	0	1	1
Mitogen-activated protein kinase 13	0	1	1	2
Mitogen-activated protein kinase kinase kinase 13	0	0	1	1
Phosphatidylinositol 4-phosphate 5-kinase type-1 gamma	0	0	1	1
Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit gamma	0	0	1	1
Serine/threonine-protein kinase PAK 3	0	0	1	1
Serine/threonine-protein kinase 17B	0	0	1	1
Cyclin-dependent kinase 14	0	0	1	1
Serine/threonine-protein kinase OSR1	0	0	1	1
Serine/threonine-protein kinase Chk2	0	0	1	1
RAF proto-oncogene serine/threonine-protein kinase	0	0	1	1
Macrophage colony-stimulating factor 1 receptor	0	0	1	1
Proto-oncogene tyrosine-protein kinase ROS	0	0	1	1
Wee1-like protein kinase 2	0	0	1	1
Uncharacterized serine/threonine-protein kinase SBK3	0	0	1	1
Myosin light chain kinase, smooth muscle	0	0	1	1
Insulin receptor-related protein	0	0	1	1
Serine/threonine-protein kinase MAK	0	0	1	1
Cyclin-dependent kinase 11B	0	0	1	1
Receptor tyrosine-protein kinase erbB-3	0	0	1	1
Activin receptor type-2A	0	0	1	1
Ephrin type-A receptor 8	0	0	1	1
Leukocyte tyrosine kinase receptor	0	0	1	1
Mitogen-activated protein kinase 4	0	0	1	1
G protein-coupled receptor kinase 4	0	0	1	1
Tyrosine-protein kinase receptor Tie-1	0	0	1	1
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform	0	2	1	3
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform	0	0	1	1
Megakaryocyte-associated tyrosine-protein kinase	0	0	1	1
Tyrosine-protein kinase TXK	0	1	1	2
Tyrosine-protein kinase ZAP-70	0	0	1	1
Cyclin-dependent kinase 8	0	0	1	1
Tyrosine-protein kinase Blk	0	1	1	2
cAMP-dependent protein kinase catalytic subunit PRKX	0	0	1	1
Serine/threonine-protein kinase Nek4	0	0	1	1
Ephrin type-B receptor 1	0	0	1	1
Hormonally up-regulated neu tumor-associated kinase	0	0	1	1
Serine/threonine-protein kinase SIK1	0	0	1	1
Receptor-interacting serine/threonine-protein kinase 4	0	0	1	1
Cell division control protein 2 homolog	0	0	1	1
Calcium-dependent protein kinase 1	0	0	1	1
Tubulin alpha-1A chain	0	0	1	1
Phosphatidylinositol 5-phosphate 4-kinase type-2 beta	0	0	1	1
SRSF protein kinase 2	0	0	1	1
Mitogen-activated protein kinase kinase kinase 9	0	0	1	1
Serine/threonine-protein kinase PknB	0	0	1	1
Cyclin-dependent kinase-like 1	0	0	1	1
Angiopoietin-1 receptor	0	0	1	1
Mitogen-activated protein kinase kinase kinase 10	0	0	1	1
Tyrosine-protein kinase receptor TYRO3	0	0	1	1
Tyrosine-protein kinase ITK/TSK	0	1	1	2
Mitogen-activated protein kinase kinase kinase 12	0	0	1	1
cGMP-dependent protein kinase 2	0	0	1	1
Serine/threonine-protein kinase PRP4 homolog	0	0	1	1
Receptor-interacting serine/threonine-protein kinase 1	0	0	1	1
Serine/threonine-protein kinase 38	0	0	1	1
Receptor tyrosine-protein kinase erbB-4	0	1	1	2
NT-3 growth factor receptor	0	0	1	1
BDNF/NT-3 growth factors receptor	0	0	1	1
Mitogen-activated protein kinase 6	0	0	1	1
Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform	0	0	1	1
Serine/threonine-protein kinase SBK1	0	0	1	1
Mitogen-activated protein kinase kinase kinase 19	0	0	1	1
Serine/threonine-protein kinase TNNI3K	0	0	1	1
Tyrosine-protein kinase JAK3	0	1	0	1
Tyrosine-protein kinase JAK2	0	1	0	1
Tyrosine-protein kinase JAK3	0	1	0	1
Serine/threonine-protein kinase Nek5	0	0	1	1
Dual serine/threonine and tyrosine protein kinase	0	0	1	1
Mitogen-activated protein kinase kinase kinase 15	0	0	1	1
Serine/threonine-protein kinase tousled-like 2	0	0	1	1
Serine/threonine-protein kinase 32C	0	0	1	1
Serine/threonine-protein kinase pim-3	0	0	1	1
Serine/threonine-protein kinase VRK2	0	0	1	1
Myosin light chain kinase family member 4	0	0	1	1
Homeodomain-interacting protein kinase 1	0	0	1	1
Cyclin-dependent kinase-like 3	0	0	1	1
Serine/threonine-protein kinase BRSK2	0	0	1	1
Serine/threonine-protein kinase NIM1	0	0	1	1
Serine/threonine-protein kinase ULK2	0	0	1	1
Serine/threonine-protein kinase DCLK2	0	0	1	1
Calcium/calmodulin-dependent protein kinase kinase 1	0	0	1	1
Casein kinase I isoform alpha-like	0	0	1	1
Homeodomain-interacting protein kinase 4	0	0	1	1
Myosin-IIIa	0	0	1	1
Ankyrin repeat and protein kinase domain-containing protein 1	0	0	1	1
Serine/threonine-protein kinase Nek11	0	0	1	1
Serine/threonine-protein kinase BRSK1	0	0	1	1
Serine/threonine-protein kinase 35	0	0	1	1
Rhodopsin kinase GRK7	0	0	1	1
Serine/threonine-protein kinase 32A	0	0	1	1
Myosin-IIIb	0	0	1	1
Dual specificity tyrosine-phosphorylation-regulated kinase 2	0	0	1	1
Cyclin-dependent kinase-like 2	0	0	1	1
Serine/threonine-protein kinase Sgk3	0	0	1	1
Atypical kinase COQ8B, mitochondrial	0	0	1	1
Cyclin-dependent kinase 15	0	0	1	1
SRSF protein kinase 1	0	0	1	1
Phosphatidylinositol 4-phosphate 5-kinase type-1 alpha	0	0	1	1
Serine/threonine-protein kinase RIO1	0	0	1	1
MAP kinase-interacting serine/threonine-protein kinase 1	0	0	1	1
Serine/threonine-protein kinase RIO2	0	0	1	1
Cyclin-dependent kinase 19	0	0	1	1
Transient receptor potential cation channel subfamily M member 6	0	0	1	1
Testis-specific serine/threonine-protein kinase 1	0	0	1	1
Serine/threonine-protein kinase 33	0	0	1	1
Serine/threonine-protein kinase DCLK3	0	0	1	1
Myosin light chain kinase 2, skeletal/cardiac muscle	0	0	1	1
Homeodomain-interacting protein kinase 2	0	0	1	1
Tyrosine-protein kinase Srms	0	0	1	1
Homeodomain-interacting protein kinase 3	0	0	1	1
Serine/threonine-protein kinase PAK 6	0	0	1	1
SNF-related serine/threonine-protein kinase	0	0	1	1
Serine/threonine-protein kinase LATS2	0	0	1	1
Serine/threonine-protein kinase 36	0	0	1	1
Serine/threonine-protein kinase 32B	0	0	1	1
Serine/threonine-protein kinase MARK1	0	0	1	1
Serine/threonine-protein kinase PAK 5	0	0	1	1
eIF-2-alpha kinase GCN2	0	0	1	1
STE20/SPS1-related proline-alanine-rich protein kinase	0	0	1	1
Ephrin type-A receptor 6	0	0	1	1
Serine/threonine-protein kinase tousled-like 1	0	0	1	1
SRSF protein kinase 3	0	0	1	1
Cyclin-dependent kinase 11A	0	0	1	1
Microtubule-associated serine/threonine-protein kinase 1	0	0	1	1
Chain A, Carbonic anhydrase 1	0	1	0	1
Carbonic anhydrase 2	0	1	0	1
Cytochrome P450 2E1	0	1	0	1
Cytochrome P450 4B1	0	1	0	1
Cytochrome P450 2A7	0	1	0	1
Cytochrome P450 3A7	0	1	0	1
Cytochrome P450 2F1	0	1	0	1
Cytochrome P450 2C18	0	1	0	1
Cytochrome P450 4F8	0	1	0	1
Cytochrome P450 4A11	0	1	0	1
Cytochrome P450 4F3	0	1	0	1
Cytochrome P450 4A22	0	1	0	1
Vitamin D 25-hydroxylase	0	1	0	1
Cytochrome P450 2U1	0	1	0	1
Cytochrome P450 2W1	0	1	0	1
Cytochrome P450 2S1	0	1	0	1
Cytochrome P450 3A43	0	1	0	1
REST corepressor 3	0	2	0	2
Solute carrier organic anion transporter family member 4A1	0	0	0	1
Solute carrier organic anion transporter family member 1C1	0	1	0	1
Chain A, Trp Rna-binding Attenuation Protein	0	0	1	1
Chain K, Trp Rna-binding Attenuation Protein	0	0	1	1
Chain B, tryptophanyl-tRNA synthetase	0	0	1	1
Chain C, Tryptophanyl-tRNA synthetase II	0	0	1	1
Tryptophan 2,3-dioxygenase	0	1	0	2
Tryprostatin B synthase	0	0	0	1
2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase	0	0	1	1
guanine nucleotide-binding protein subunit alpha-15	0	1	1	2
trace amine-associated receptor 1	0	1	1	2
Chain A, CHORISMATE MUTASE	0	1	0	1
Chain A, TYROSYL-tRNA SYNTHETASE	0	0	1	1
G-protein coupled receptor 84	0	1	1	2
Chain A, Uracil-DNA Glycosylase	0	1	0	1
Solute carrier family 2, facilitated glucose transporter member 9	0	1	1	2
M1-family alanyl aminopeptidase	0	1	0	1
Chain A, Arginase 1	0	1	0	1
Aldo-keto reductase family 1 member A1	0	1	0	1
D-alanyl-D-alanine dipeptidase	0	1	0	1
Glycoprotein	0	1	0	1
Sterol 14-alpha-demethylase	0	0	1	1
14-alpha sterol demethylase	0	0	1	1
Cholesterol side-chain cleavage enzyme, mitochondrial	0	0	1	1
Lanosterol 14-alpha demethylase	0	0	1	1
Cytochrome P450 144	0	0	1	1
Steroid C26-monooxygenase	0	0	1	1
Steroid C26-monooxygenase	0	0	1	1
Sterol 14-alpha demethylase	0	0	1	1
14-alpha sterol demethylase	0	0	1	1
14-alpha sterol demethylase	0	0	1	1
Chain A, Histone deacetylase-like amidohydrolase	0	1	0	1
Chain A, Histone deacetylase-like amidohydrolase	0	1	0	1
Histone deacetylase 8	0	1	0	1
Histone deacetylase	0	1	0	1
Gli1	0	1	0	1
protein Wnt-3a precursor	0	1	0	1
Histone deacetylase 1	0	2	0	2
Protein Tat	0	0	1	1
Leukotriene A-4 hydrolase	0	1	0	1
Apoptosis regulator BAX	0	0	1	1
Histone deacetylase 1	0	1	0	1
Histone deacetylase	0	1	0	1
Renin	0	1	0	1
Histone deacetylase 3	0	1	0	1
Histone deacetylase-like amidohydrolase	0	2	1	3
Histone deacetylase	0	1	0	1
HD2 type histone deacetylase HDA106	0	2	0	2
Carboxypeptidase B2	0	1	0	1
Histone deacetylase 7	0	1	0	1
Histone deacetylase 6	0	1	0	1
Histone deacetylase 4	0	1	0	1
Histone deacetylase	0	1	0	1
Histone deacetylase 6	0	1	0	1
Histone deacetylase	0	1	0	1
Vitamin K epoxide reductase complex subunit 1-like protein 1	0	1	0	1
Vitamin K epoxide reductase complex subunit 1	0	1	0	1
Vitamin K epoxide reductase complex subunit 1-like protein 1	0	1	0	1
Vitamin K epoxide reductase complex subunit 1	0	2	0	2
M-phase inducer phosphatase 1	0	1	0	1
Alkaline phosphatase, tissue-nonspecific isozyme	0	1	0	1
Alkaline phosphatase, germ cell type	0	1	0	1
G protein-coupled receptor GPR35	0	0	1	1
G-protein coupled receptor 35	0	0	1	1
Amine oxidase [flavin-containing]	0	1	0	1
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Synonyms(1)

Research Excerpts

Overview

Context

Actions

Treatment

Research

Studies (6,707)

Protein Targets (3,400)

Erectile Dysfunction

Synonyms(1)

Research Excerpts

Overview

Context

Actions

Treatment

Research

Studies (6,707)

Drugs Studied (1,020)

Protein Targets (3,400)